Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
42 "Hemoglobin A"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Cardiovascular Risk/Epidemiology
Article image
Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD
Ga Young Heo, Hee Byung Koh, Hyung Woo Kim, Jung Tak Park, Tae-Hyun Yoo, Shin-Wook Kang, Jayoun Kim, Soo Wan Kim, Yeong Hoon Kim, Su Ah Sung, Kook-Hwan Oh, Seung Hyeok Han
Diabetes Metab J. 2023;47(4):535-546.   Published online April 25, 2023
DOI: https://doi.org/10.4093/dmj.2022.0112
  • 9,297 View
  • 276 Download
  • 8 Web of Science
  • 11 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
The optimal level of glycosylated hemoglobin (HbA1c) to prevent adverse clinical outcomes is unknown in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM).
Methods
We analyzed 707 patients with CKD G1-G5 without kidney replacement therapy and T2DM from the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD), a nationwide prospective cohort study. The main predictor was time-varying HbA1c level at each visit. The primary outcome was a composite of development of major adverse cardiovascular events (MACEs) or all-cause mortality. Secondary outcomes included the individual endpoint of MACEs, all-cause mortality, and CKD progression. CKD progression was defined as a ≥50% decline in the estimated glomerular filtration rate from baseline or the onset of end-stage kidney disease.
Results
During a median follow-up of 4.8 years, the primary outcome occurred in 129 (18.2%) patients. In time-varying Cox model, the adjusted hazard ratios (aHRs) for the primary outcome were 1.59 (95% confidence interval [CI], 1.01 to 2.49) and 1.99 (95% CI, 1.24 to 3.19) for HbA1c levels of 7.0%–7.9% and ≥8.0%, respectively, compared with <7.0%. Additional analysis of baseline HbA1c levels yielded a similar graded association. In secondary outcome analyses, the aHRs for the corresponding HbA1c categories were 2.17 (95% CI, 1.20 to 3.95) and 2.26 (95% CI, 1.17 to 4.37) for MACE, and 1.36 (95% CI, 0.68 to 2.72) and 2.08 (95% CI, 1.06 to 4.05) for all-cause mortality. However, the risk of CKD progression did not differ between the three groups.
Conclusion
This study showed that higher HbA1c levels were associated with an increased risk of MACE and mortality in patients with CKD and T2DM.

Citations

Citations to this article as recorded by  
  • Frequency of Diabetic Nephropathy among Patients of Type 2 Diabetes Mellitus
    Muhammad Irfan Jamil, Yasir Hussain, Muhammad Shahid Nawaz Khan, Anjum Shahzad, Azhar Iqbal, Adeel Ahmed, Iqra Naeem
    Pakistan Journal of Health Sciences.2025; : 18.     CrossRef
  • Type 2 diabetes mellitus modifies the relationship between coronary artery calcification and adverse kidney outcome in patients with chronic kidney disease: the findings from KNOW-CKD
    Hae-Ryong Yun, Young Su Joo, Hyung Woo Kim, Jung Tak Park, Nak-Hoon Son, Tae-Hyun Yoo, Shin-Wook Kang, Yaeni Kim, Soo Wan Kim, Yeong Hoon Kim, Kook-Hwan Oh, Seung Hyeok Han
    Journal of Nephrology.2025; 38(9): 2755.     CrossRef
  • Intervention effects of optimised carbohydrate diet in patients with type 2 diabetes: study protocol for a randomised controlled crossover trial
    Yuwei LU, Ruiqi Zhang, Jingyi Yang, Dan Liu, Qian Wu, Xiaoxue Long, Di Cheng, Jingyi Guo, Qian Li, Ying Zhang, Piao Kang, Qinyi Wang, Xiaojing Gao, Rong Zeng, Mingliang Zhang, Qichen Fang, Weiping Jia, Yueqiong Ni, Huating Li
    BMJ Open.2025; 15(10): e106756.     CrossRef
  • Interrelationship Between Dyslipidemia and Hyperuricemia in Patients with Uncontrolled Type 2 Diabetes: Clinical Implications and a Risk Identification Algorithm
    Lorena Paduraru, Cosmin Mihai Vesa, Mihaela Simona Popoviciu, Timea Claudia Ghitea, Dana Carmen Zaha
    Healthcare.2025; 13(20): 2605.     CrossRef
  • Baseline predictors of in-hospital mortality among patients with chronic kidney disease admitted to the emergency department
    Arun Prabhahar, Niranjan A Vijaykumar, Harpreet Kaur, Navneet Sharma, Ashok K Pannu
    World Journal of Nephrology.2025;[Epub]     CrossRef
  • Dietary management of patients with type 2 diabetes and chronic kidney disease: A comprehensive literature review
    Asmaa AlShammari, Ali AlSahow
    World Journal of Nephrology.2025;[Epub]     CrossRef
  • Unveiling the utility of artificial intelligence for prediction, diagnosis, and progression of diabetic kidney disease: an evidence-based systematic review and meta-analysis
    Sagar Dholariya, Siddhartha Dutta, Amit Sonagra, Mehul Kaliya, Ragini Singh, Deepak Parchwani, Anita Motiani
    Current Medical Research and Opinion.2024; 40(12): 2025.     CrossRef
  • Non-Alcoholic Fatty Liver Disease and Its Association with Kidney and Cardiovascular Outcomes in Moderate to Advanced Chronic Kidney Disease
    Cheol Ho Park, Hyunsun Lim, Youn Nam Kim, Jae Young Kim, Hyung Woo Kim, Tae Ik Chang, Seung Hyeok Han
    American Journal of Nephrology.2024; : 1.     CrossRef
  • The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
    Dong-Hwa Lee
    Diabetes & Metabolism Journal.2023; 47(4): 484.     CrossRef
  • Prevalence and predictors of chronic kidney disease among type 2 diabetic patients worldwide, systematic review and meta-analysis
    Eneyew Talie Fenta, Habitu Birhan Eshetu, Natnael Kebede, Eyob Ketema Bogale, Amare Zewdie, Tadele Derbew Kassie, Tadele Fentabil Anagaw, Elyas Melaku Mazengia, Sintayehu Shiferaw Gelaw
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Efficacy and safety of teneligliptin in patients with type 2 diabetes mellitus: a Bayesian network meta-analysis
    Miao Zhu, Ruifang Guan, Guo Ma
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
Type 1 Diabetes
Abnormal Responses in Cognitive Impulsivity Circuits Are Associated with Glycosylated Hemoglobin Trajectories in Type 1 Diabetes Mellitus and Impaired Metabolic Control
Helena Jorge, Isabel C. Duarte, Sandra Paiva, Ana Paula Relvas, Miguel Castelo-Branco
Diabetes Metab J. 2022;46(6):866-878.   Published online March 22, 2022
DOI: https://doi.org/10.4093/dmj.2021.0307
  • 8,713 View
  • 206 Download
  • 8 Web of Science
  • 8 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
Risky health decisions and impulse control profiles may impact on metabolic control in type 1 diabetes mellitus (T1DM). We hypothesize that the neural correlates of cognitive impulsivity and decision-making in T1DM relate to metabolic control trajectories.
Methods
We combined functional magnetic resonance imaging (fMRI), measures of metabolic trajectories (glycosylated hemoglobin [HbA1c] over multiple time points) and behavioral assessment using a cognitive impulsivity paradigm, the Balloon Analogue Risk Task (BART), in 50 participants (25 T1DM and 25 controls).
Results
Behavioral results showed that T1DM participants followed a rigid conservative risk strategy along the iterative game. Imaging group comparisons showed that patients showed larger activation of reward related, limbic regions (nucleus accumbens, amygdala) and insula (interoceptive saliency network) in initial game stages. Upon game completion differences emerged in relation to error monitoring (anterior cingulate cortex [ACC]) and inhibitory control (inferior frontal gyrus). Importantly, activity in the saliency network (ACC and insula), which monitors interoceptive states, was related with metabolic trajectories, which was also found for limbic/reward networks. Parietal and posterior cingulate regions activated both in controls and patients with adaptive decision-making, and positively associated with metabolic trajectories.
Conclusion
We found triple converging evidence when comparing metabolic trajectories, patients versus controls or risk averse (non-learners) versus patients who learned by trial and error. Dopaminergic reward and saliency (interoceptive and error monitoring) circuits show a tight link with impaired metabolic trajectories and cognitive impulsivity in T1DM. Activity in parietal and posterior cingulate are associated with adaptive trajectories. This link between reward-saliency-inhibition circuits suggests novel strategies for patient management.

Citations

Citations to this article as recorded by  
  • Symptom perception in adults with chronic physical disease: A systematic review of insular impairments
    Giulia Locatelli, Austin Matus, Chin-Yen Lin, Ercole Vellone, Barbara Riegel
    Heart & Lung.2025; 70: 122.     CrossRef
  • Editorial: Translational neuroeconomic approach: from economic decision making to neuropsychological disorders
    Mrinalini Srivastava, S. Senthil Kumaran, Achal Kumar Srivastava, Sanjay Singh
    Frontiers in Neurology.2025;[Epub]     CrossRef
  • Neuroeconomically dissociable forms of mental accounting are altered in a mouse model of diabetes
    Chinonso A. Nwakama, Romain Durand-de Cuttoli, Zainab M. Oketokoun, Samantha O. Brown, Jillian E. Haller, Adriana Méndez, Mohammad Jodeiri Farshbaf, Y. Zoe Cho, Sanjana Ahmed, Sophia Leng, Jessica L. Ables, Brian M. Sweis
    Communications Biology.2025;[Epub]     CrossRef
  • Trust‐Based Decision‐Making in the Health and Economic Domains Shows Similar Neural Correlates
    Isabel Catarina Duarte, Bruno Ribeiro, Helena Jorge, Bruno Direito, Miguel Castelo‐Branco
    Annals of the New York Academy of Sciences.2025; 1553(1): 300.     CrossRef
  • Glycated hemoglobin, type 2 diabetes, and poor diabetes control are positively associated with impulsivity changes in aged individuals with overweight or obesity and metabolic syndrome
    Carlos Gómez‐Martínez, Nancy Babio, Lucía Camacho‐Barcia, Jordi Júlvez, Stephanie K. Nishi, Zenaida Vázquez, Laura Forcano, Andrea Álvarez‐Sala, Aida Cuenca‐Royo, Rafael de la Torre, Marta Fanlo‐Maresma, Susanna Tello, Dolores Corella, Alejandro Arias Vás
    Annals of the New York Academy of Sciences.2024;[Epub]     CrossRef
  • The usefulness of an intervention with a serious video game as a complementary approach to cognitive behavioural therapy in eating disorders: A pilot randomized clinical trial for impulsivity management
    Cristina Vintró‐Alcaraz, Núria Mallorquí‐Bagué, María Lozano‐Madrid, Giulia Testa, Roser Granero, Isabel Sánchez, Janet Treasure, Susana Jiménez‐Murcia, Fernando Fernández‐Aranda
    European Eating Disorders Review.2023; 31(6): 781.     CrossRef
  • Adaptations of the balloon analog risk task for neuroimaging settings: a systematic review
    Charline Compagne, Juliana Teti Mayer, Damien Gabriel, Alexandre Comte, Eloi Magnin, Djamila Bennabi, Thomas Tannou
    Frontiers in Neuroscience.2023;[Epub]     CrossRef
  • Trust-based health decision-making recruits the neural interoceptive saliency network which relates to temporal trajectories of Hemoglobin A1C in Diabetes Type 1
    Helena Jorge, Isabel C. Duarte, Miguel Melo, Ana Paula Relvas, Miguel Castelo-Branco
    Brain Imaging and Behavior.2023; 18(1): 171.     CrossRef
Short Communication
Technology/Device
A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus
Jiyun Park, Nammi Park, Sangjin Han, You-Bin Lee, Gyuri Kim, Sang-Man Jin, Woo Je Lee, Jae Hyeon Kim
Diabetes Metab J. 2022;46(6):941-947.   Published online March 8, 2022
DOI: https://doi.org/10.4093/dmj.2021.0299
  • 8,797 View
  • 320 Download
  • 7 Web of Science
  • 7 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
This study evaluated the safety and efficacy of tubeless patch pump called EOPatch in patients with well-controlled type 1 diabetes mellitus (T1DM). This 4-week, two-center, open-label, single-arm study enrolled 10 adult patients diagnosed with T1DM with glycosylated hemoglobin less than 7.5%. The co-primary end points were patch pump usage time for one attachment and number of serious adverse events related to the patch pump. The secondary end points were total amount of insulin injected per patch and changes in glycemic parameters including continuous glucose monitoring data compared to those at study entry. The median usage time per patch was 84.00 hours (interquartile range, 64.50 to 92.50). Serious adverse events did not occur during the trial. Four weeks later, time in range 70 to 180 mg/dL was significantly improved (70.71%±17.14 % vs. 82.96%±9.14%, P=0.01). The times spent below range (<54 mg/dL) and above range (>180 mg/dL) also improved (All P<0.05). Four-week treatment with a tubeless patch pump was safe and led to clinical improvement in glycemic control.

Citations

Citations to this article as recorded by  
  • Exploring biosensors: Distinctive features and emerging applications
    Shweta Mishra, Ashlesha J. Chauhan, Jayaveersinh Mahida
    Analytical Biochemistry.2026; 709: 115993.     CrossRef
  • Efficacy and Safety of Stage 5 Connected Insulin Pens in Type 1 or Type 2 Diabetes: Randomized Controlled Trial Protocol
    Ji Yoon Kim, Nam Hoon Kim, Soo Heon Kwak, Chang Hee Jung, Eun Seok Kang, Jun Sung Moon, Sun Joon Moon, So Yoon Kwon, Jee Hee Yoo, Younghoon Kim, Tae-min Lee, Chung-il Yang, Jae Hyeon Kim, Sang-Man Jin
    Endocrinology and Metabolism.2025;[Epub]     CrossRef
  • Multilayer track‐etched membrane‐based electroosmotic pump for drug delivery
    Qian Yang, Zebo Zhang, Junshu Lin, Boyu Zhu, Rongying Yu, Xinru Li, Bin Su, Bo Zhao
    ELECTROPHORESIS.2024; 45(5-6): 433.     CrossRef
  • Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae, Sunghwan Suh, Sun Joon Moon, Sun Ok Song, Suk Chon, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1235.     CrossRef
  • Approaches of wearable and implantable biosensor towards of developing in precision medicine
    Elham Ghazizadeh, Zahra Naseri, Hans-Peter Deigner, Hossein Rahimi, Zeynep Altintas
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Advancements in Insulin Pumps: A Comprehensive Exploration of Insulin Pump Systems, Technologies, and Future Directions
    Mohammad Towhidul Islam Rimon, Md Wasif Hasan, Mohammad Fuad Hassan, Sevki Cesmeci
    Pharmaceutics.2024; 16(7): 944.     CrossRef
  • A true continuous healthcare system for type 1 diabetes
    Jiyong Kim, Salman Khan, Eun Kyu Kim, Hye-Jun Kil, Bo Min Kang, Hyo Geon Lee, Jin-Woo Park, Jun Young Yoon, Woochul Kim
    Nano Energy.2023; 113: 108553.     CrossRef
Original Articles
Drug/Regimen
Article image
Effects of Teneligliptin on HbA1c levels, Continuous Glucose Monitoring-Derived Time in Range and Glycemic Variability in Elderly Patients with T2DM (TEDDY Study)
Ji Cheol Bae, Soo Heon Kwak, Hyun Jin Kim, Sang-Yong Kim, You-Cheol Hwang, Sunghwan Suh, Bok Jin Hyun, Ji Eun Cha, Jong Chul Won, Jae Hyeon Kim
Diabetes Metab J. 2022;46(1):81-92.   Published online June 16, 2021
DOI: https://doi.org/10.4093/dmj.2021.0016
  • 13,174 View
  • 502 Download
  • 7 Web of Science
  • 8 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
To evaluate the effects of teneligliptin on glycosylated hemoglobin (HbA1c) levels, continuous glucose monitoring (CGM)-derived time in range, and glycemic variability in elderly type 2 diabetes mellitus patients.
Methods
This randomized, double-blinded, placebo-controlled study was conducted in eight centers in Korea (clinical trial registration number: NCT03508323). Sixty-five participants aged ≥65 years, who were treatment-naïve or had been treated with stable doses of metformin, were randomized at a 1:1 ratio to receive 20 mg of teneligliptin (n=35) or placebo (n=30) for 12 weeks. The main endpoints were the changes in HbA1c levels from baseline to week 12, CGM metrics-derived time in range, and glycemic variability.
Results
After 12 weeks, a significant reduction (by 0.84%) in HbA1c levels was observed in the teneligliptin group compared to that in the placebo group (by 0.08%), with a between-group least squares mean difference of –0.76% (95% confidence interval [CI], –1.08 to –0.44). The coefficient of variation, standard deviation, and mean amplitude of glycemic excursion significantly decreased in participants treated with teneligliptin as compared to those in the placebo group. Teneligliptin treatment significantly decreased the time spent above 180 or 250 mg/dL, respectively, without increasing the time spent below 70 mg/dL. The mean percentage of time for which glucose levels remained in the 70 to 180 mg/dL time in range (TIR70–180) at week 12 was 82.0%±16.0% in the teneligliptin group, and placebo-adjusted change in TIR70–180 from baseline was 13.3% (95% CI, 6.0 to 20.6).
Conclusion
Teneligliptin effectively reduced HbA1c levels, time spent above the target range, and glycemic variability, without increasing hypoglycemia in our study population.

Citations

Citations to this article as recorded by  
  • Time in range—A new gold standard in type 2 diabetes research?
    Ashni Goshrani, Rose Lin, David O'Neal, Elif I. Ekinci
    Diabetes, Obesity and Metabolism.2025; 27(5): 2342.     CrossRef
  • Analysis glycemic variability in pregnant women with various type of hyperglycemia
    Xuexin Zhou, Ru Zhang, Shiwei Jiang, Decui Cheng, Hao Wu
    BMC Pregnancy and Childbirth.2025;[Epub]     CrossRef
  • Triple arm, prospective, real-world study comparing the efficacy of FDC teneligliptin + dapagliflozin to FDC sitagliptin + dapagliflozin, and FDC linagliptin + empagliflozin in Indian type 2 diabetes mellitus patients using CGM device: the Amplify-TIR stu
    Suhas Erande, Mayur Agrawal, Sanjeev Gulati, Namdev Jagtap, N. S. Praveen Kumar, Vinod Kumar Kapoor, Sumit Bhushan, Rujuta Gadkari, Mayur Jadhav, Sanjay Choudhari, Saiprasad Patil, Hanmant Barkate
    Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub]     CrossRef
  • Comparison of teneligliptin and other gliptin-based regimens in addressing insulin resistance and glycemic control in type 2 diabetic patients: a cross-sectional study
    Harmanjit Singh, Ravi Rohilla, Shivani Jaswal, Mandeep Singla
    Expert Review of Endocrinology & Metabolism.2024; 19(1): 81.     CrossRef
  • Potential approaches using teneligliptin for the treatment of type 2 diabetes mellitus: current status and future prospects
    Harmanjit Singh, Jasbir Singh, Ravneet Kaur Bhangu, Mandeep Singla, Jagjit Singh, Farideh Javid
    Expert Review of Clinical Pharmacology.2023; 16(1): 49.     CrossRef
  • Mechanism of molecular interaction of sitagliptin with human DPP4 enzyme - New Insights
    Michelangelo Bauwelz Gonzatti, José Edvar Monteiro Júnior, Antônio José Rocha, Jonathas Sales de Oliveira, Antônio José de Jesus Evangelista, Fátima Morgana Pio Fonseca, Vânia Marilande Ceccatto, Ariclécio Cunha de Oliveira, José Ednésio da Cruz Freire
    Advances in Medical Sciences.2023; 68(2): 402.     CrossRef
  • A prospective multicentre open label study to assess effect of Teneligliptin on glycemic control through parameters of time in range (TIR) Metric using continuous glucose monitoring (TOP-TIR study)
    Banshi Saboo, Suhas Erande, A.G. Unnikrishnan
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2022; 16(2): 102394.     CrossRef
  • Association between Variability of Metabolic Risk Factors and Cardiometabolic Outcomes
    Min Jeong Park, Kyung Mook Choi
    Diabetes & Metabolism Journal.2022; 46(1): 49.     CrossRef
Drug/Regimen
Article image
Increasing Age Associated with Higher Dipeptidyl Peptidase-4 Inhibition Rate Is a Predictive Factor for Efficacy of Dipeptidyl Peptidase-4 Inhibitors
Sangmo Hong, Chang Hee Jung, Song Han, Cheol-Young Park
Diabetes Metab J. 2022;46(1):63-70.   Published online April 19, 2021
DOI: https://doi.org/10.4093/dmj.2020.0253
  • 65,535 View
  • 319 Download
  • 3 Web of Science
  • 3 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
It is not known which type 2 diabetes mellitus (T2DM) patients would most benefit from dipeptidyl peptidase-4 (DPP-4) inhibitor treatment. We aimed to investigate the predictors of response to DPP-4 inhibitors considering degree of DPP-4 inhibition.
Methods
This study is a post hoc analysis of a 24-week, randomized, double-blind, phase III trial that compared the efficacy and safety of a DPP-4 inhibitor (gemigliptin vs. sitagliptin) in patients with T2DM. Subjects were classified into tertiles of T1 <65.26%, T2=65.26%–76.35%, and T3 ≥76.35% by DPP-4 inhibition. We analyzed the change from baseline in glycosylated hemoglobin (HbA1c) according to DPP-4 inhibition with multiple linear regression adjusting for age, ethnicity, body mass index, baseline HbA1c, and DPP-4 activity at baseline.
Results
The mean age was greater in the high tertile group compared with the low tertile group (T1: 49.8±8.3 vs. T2: 53.1±10.5 vs. T3: 55.3±9.5, P<0.001) of DPP-4 inhibition. Although HbA1c at baseline was not different among tertiles of DPP-4 inhibition (P=0.398), HbA1c after 24-week treatment was lower in the higher tertile compares to the lower tertile (T1: 7.30%±0.88% vs. T2: 7.12%±0.78% vs. T3: 7.00%±0.78%, P=0.021). In multiple regression analysis, DPP-4 enzyme inhibition rate was not a significant determent for HbA1c reduction due to age. In subgroup analysis by tertile of DPP-4 inhibition, age was the only significant predictor and only in the highest tertile (R2=0.281, B=–0.014, P=0.024).
Conclusion
This study showed that HbA1c reduction by DPP-4 inhibitor was associated with increasing age, and this association was linked with higher DPP-4 inhibition.

Citations

Citations to this article as recorded by  
  • Comparative efficacy and safety of sitagliptin or gliclazide combined with metformin in treatment-naive patients with type 2 diabetes: A single-center, prospective, randomized, controlled, noninferiority study with genetic polymorphism analysis
    Min Qin, Lingxi Chao, Shiqun Liu
    Medicine.2025; 104(2): e41061.     CrossRef
  • Safety and efficacy of prusogliptin in type-2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
    Abdul Moeed, Muhammad Ahmed Ali Fahim, Afia Salman, Tooba Saqib, Laiba Zafar, Hoorain Jamil, Alishba Adnan Janjua, Syed Muhammad Muneeb Akhtar, Hamna Ahmed Khan, Hajra Zainab Chaudry, Ayesha Ali, Laiba Sanober, Muqaddas Parvez, Hala Najeeb, Abdul Hannan S
    Irish Journal of Medical Science (1971 -).2025; 194(3): 887.     CrossRef
  • Neurological Sequelae of Post-COVID-19 Fatigue: A Narrative Review of Dipeptidyl Peptidase IV-Mediated Cerebrovascular Complications
    Che Mohd Nasril Che Mohd Nassir, Muhammad Danial Che Ramli, Usman Jaffer, Hafizah Abdul Hamid, Muhammad Zulfadli Mehat, Mazira Mohamad Ghazali, Ebrahim Nangarath Kottakal Cheriya
    Current Issues in Molecular Biology.2024; 46(12): 13565.     CrossRef
Review
Type 1 Diabetes
Article image
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
Jee Hee Yoo, Jae Hyeon Kim
Diabetes Metab J. 2020;44(6):828-839.   Published online December 23, 2020
DOI: https://doi.org/10.4093/dmj.2020.0257
Correction in: Diabetes Metab J 2021;45(5):795
  • 21,623 View
  • 626 Download
  • 59 Web of Science
  • 61 Crossref
AbstractAbstract PDFPubReader   ePub   
Glycosylated hemoglobin (HbA1c) has been the sole surrogate marker for assessing diabetic complications. However, consistently reported limitations of HbA1c are that it lacks detailed information on short-term glycemic control and can be easily interfered with by various clinical conditions such as anemia, pregnancy, or liver disease. Thus, HbA1c alone may not represent the real glycemic status of a patient. The advancement of continuous glucose monitoring (CGM) has enabled both patients and healthcare providers to monitor glucose trends for a whole single day, which is not possible with HbA1c. This has allowed for the development of core metrics such as time spent in time in range (TIR), hyperglycemia, or hypoglycemia, and glycemic variability. Among the 10 core metrics, TIR is reported to represent overall glycemic control better than HbA1c alone. Moreover, various evidence supports TIR as a predictive marker of diabetes complications as well as HbA1c, as the inverse relationship between HbA1c and TIR reveals. However, there are more complex relationships between HbA1c, TIR, and other CGM metrics. This article provides information about 10 core metrics with particular focus on TIR and the relationships between the CGM metrics for comprehensive understanding of glycemic status using CGM.

Citations

Citations to this article as recorded by  
  • Differences Between Glycated Hemoglobin and Glucose Management Indicator in Real-Time and Intermittent Scanning Continuous Glucose Monitoring in Adults With Type 1 Diabetes
    Jee Hee Yoo, Sun Joon Moon, Cheol-Young Park, Jae Hyeon Kim
    Journal of Diabetes Science and Technology.2026; 20(1): 103.     CrossRef
  • Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naïve type 2 diabetes: The EMPA-FIT study
    Soo Lim, Cheol Young Park, In Kyung Jeong, Ji Sung Yoon, Sang Yong Kim, Eun Seok Kang, Junghyun Noh, Kyu Yeon Hur, Sungrae Kim
    Journal of Diabetes and its Complications.2026; 40(1): 109214.     CrossRef
  • A Study of the Relationship Between Serum Albumin–Corrected Fructosamine and Type 2 Diabetic Retinopathy
    Zejiang Liu, Qiyun Long, Xuhui Song, Qin Guo, Tao Li, Huaguo Wang, Xing Qi, Sheng Lin, Hannah Wesley
    Journal of Diabetes Research.2026;[Epub]     CrossRef
  • A Review of Third-Trimester Complications in Pregnancies Complicated by Diabetes Mellitus
    Shaun R. Welsey, Jessica Day, Scott Sullivan, Sarah D. Crimmins
    American Journal of Perinatology.2025; 42(09): 1119.     CrossRef
  • Improved Glycemic Control in Insulin-Treated Individuals With Poorly Controlled Type 2 Diabetes Through Combined Structured Education With Real-Time Continuous Glucose Monitoring
    Jee Hee Yoo, Ji Eun Jun, Soo Heon Kwak, Jae Hyeon Kim
    Journal of Diabetes Science and Technology.2025;[Epub]     CrossRef
  • Quantification of the relation between continuous glucose monitoring observation period and the estimation error in assessing long-term glucose regulation
    Stennie Zoet, Thomas Urgert, Anouk Veldhuis, Bert-Jan van Beijnum, Gozewijn D Laverman
    BMJ Open Diabetes Research & Care.2025; 13(1): e004768.     CrossRef
  • How to take action beyond ambulatory glucose profile: Latin American expert recommendations on CGM data interpretation
    Luis Eduardo Calliari, Álvaro Contreras Sepúlveda, Nicolás Coronel-Restrepo, Laura Kabakian, Rodrigo N. Lamounier, Emma Picasso, Adrian Proietti, Alex Ramírez-Rincón, Alicia E. Yépez-Rodriguez
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Comparison of Real-Time and Intermittently-Scanned Continuous Glucose Monitoring for Glycemic Control in Type 1 Diabetes Mellitus: Nationwide Cohort Study
    Ji Yoon Kim, Seohyun Kim, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2025; 49(3): 436.     CrossRef
  • Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy
    Seung Eun Lee, Ju-Hyun Park, Dalyong Kim, Hyun-A Lee, Yun Seong Kang, Young Soon Yoon, Yun Jeong Jeong, Han Seok Choi, Kyoung-Ah Kim
    Biomedicines.2025; 13(5): 1101.     CrossRef
  • Relation of time in range to severity of coronary artery disease in patients with type 2 diabetes: A cross-sectional study
    Weiguo Ma, Jinfeng Li, Xiaojuan Shao, Xiaohong Yin, Chuanqing Xie, Fenfen Wang, Ya Li
    Open Medicine.2025;[Epub]     CrossRef
  • Associations of time in tight range, time in range, and glycated hemoglobin with albuminuria in type 1 diabetes: A cross-sectional study
    Ji Yoon Kim, Seohyun Kim, Sang Ho Park, Jin A Lee, So Hyun Cho, Rosa Oh, Myunghwa Jang, You-Bin Lee, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
    Diabetes Research and Clinical Practice.2025; 226: 112325.     CrossRef
  • Effect of Ebenatide on glycemic metabolism and body fat in patients with type 2 diabetes mellitus
    Cheng-lan Xu, Xiao-cen Kong, Xiao-mei Liu, Xiao-hua Xu, Bing-li Liu, Jian-hua Ma
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • The effect of exercise with augmented reality glasses on metabolic parameters, anthropometric measurement values and quality of life in children aged 10–12 with type 1 diabetes: A randomized controlled trial
    Harun Özbey, Meral Bayat
    Journal of Pediatric Nursing.2025; 85: 239.     CrossRef
  • Achievement of time in range goals among patients with diabetes using continuous glucose monitoring
    Faezeh Azizi, Katherine Diehl, Lauren Enser, Samantha Heacock
    Journal of the American Pharmacists Association.2025; 65(6): 102924.     CrossRef
  • Impact of Carbohydrate Intake Fluctuations on Glucose Profiles: Insights from Continuous Glucose Monitoring-Based Patient Clustering
    Hyun Ah Kim, Kyung Hee Kim, Young Lee, Yoon-Ju Song, Joon Ho Moon, Sung Hee Choi, Tae Jung Oh
    Endocrinology and Metabolism.2025;[Epub]     CrossRef
  • Comment on “Relationship Between Glycemic Indices and eGFR Values Among Type 2 Diabetes Mellitus Individuals With Chronic Kidney Disease Across Various Progression Stages”
    Shyam Sundar Sah, Abhishek Kumbhalwar
    Clinical Medicine Insights: Endocrinology and Diabetes.2025;[Epub]     CrossRef
  • Two-week continuous glucose monitoring-derived metrics and degree of hepatic steatosis: a cross-sectional study among Chinese middle-aged and elderly participants
    Haili Zhong, Ke Zhang, Lishan Lin, Yan Yan, Luqi Shen, Hanzu Chen, Xinxiu Liang, Jingnan Chen, Zelei Miao, Ju-Sheng Zheng, Yu-ming Chen
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Acute and Chronic Adverse Outcomes of Type 1 Diabetes
    Rachel Longendyke, Jody B. Grundman, Shideh Majidi
    Endocrinology and Metabolism Clinics of North America.2024; 53(1): 123.     CrossRef
  • La plongée sous-marine en scaphandre autonome avec un diabète de type 1. Une belle histoire du dernier millénaire
    Lise Dufaitre Patouraux, Agnès Sola-Gazagnes, Boris Lormeau, Corinne Lormeau
    Médecine des Maladies Métaboliques.2024; 18(1): 67.     CrossRef
  • S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects
    Gloria Ursino, Giulia Lucibello, Pryscila D. S. Teixeira, Anna Höfler, Christelle Veyrat-Durebex, Soline Odouard, Florian Visentin, Luca Galgano, Emmanuel Somm, Claudia R. Vianna, Ariane Widmer, François R. Jornayvaz, Andreas Boland, Giorgio Ramadori, Rob
    Science Advances.2024;[Epub]     CrossRef
  • Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index
    Melissa H. Lee, Sara Vogrin, Timothy W. Jones, David N. O’Neal
    Journal of Diabetes Science and Technology.2024; 18(4): 764.     CrossRef
  • Clinically relevant stratification of patients with type 2 diabetes by using continuous glucose monitoring data
    Xiaopeng Shao, Jingyi Lu, Rui Tao, Liang Wu, Yaxin Wang, Wei Lu, Hongru Li, Jian Zhou, Xia Yu
    Diabetes, Obesity and Metabolism.2024; 26(6): 2082.     CrossRef
  • Effects of a 2-Week Kinect-Based Mixed-Reality Exercise Program on Prediabetes: A Pilot Trial during COVID-19
    So Young Ahn, Si Woo Lee, Hye Jung Shin, Won Jae Lee, Jun Hyeok Kim, Hyun-Jun Kim, Wook Song
    Journal of Obesity & Metabolic Syndrome.2024; 33(1): 54.     CrossRef
  • Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Kang Hee Sim, Bo-Yeon Kim, Jae Hyoung Cho, Jun Sung Moon, Soo Lim, Eun Seok Kang, Cheol-Young Park, Sin Gon Kim, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1223.     CrossRef
  • Comparison between a tubeless, on-body automated insulin delivery system and a tubeless, on-body sensor-augmented pump in type 1 diabetes: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Eun Seok Kang, Soo Heon Kwak, Yeoree Yang, Jee Hee Yoo, Jae Hyun Bae, Jun Sung Moon, Chang Hee Jung, Ji Cheol Bae, Sunghwan Suh, Sun Joon Moon, Sun Ok Song, Suk Chon, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1235.     CrossRef
  • Psychometric Properties of the Automated Insulin Delivery: Benefits and Burdens Scale for Adults with Type 1 Diabetes
    Jenna B. Shapiro, Anthony T. Vesco, Michael S. Carroll, Jill Weissberg-Benchell
    Diabetes Technology & Therapeutics.2024; 26(11): 842.     CrossRef
  • Expert Consensus on Dipeptidyl Peptidase-4 Inhibitor-Based Therapies in the Modern Era of Type 2 Diabetes Mellitus Management in India
    Sanjay Kalra, Saptarshi Bhattacharya, A Dhingra, Sambit Das, Nitin Kapoor, Shehla Shaikh, Vivek Kolapkar, R V Lokesh Kumar, Kamlesh Patel, Rahul Kotwal
    Cureus.2024;[Epub]     CrossRef
  • Optimal hyperglycemia thresholds in patients undergoing chemotherapy: a cross sectional study of oncologists’ practices
    Teresa M. Salgado, Poorva B. Birari, Mona Alshahawey, Erin Hickey Zacholski, Emily Mackler, Tonya M. Buffington, Kerri T. Musselman, William J. Irvin, Jennifer M. Perkins, Trang N. Le, Dave L. Dixon, Karen B. Farris, Vanessa B. Sheppard, Resa M. Jones
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • Glycemic Risk Index in a Cohort of Patients with Type 1 Diabetes Mellitus Stratified by the Coefficient of Variation: A Real-Life Study
    Sandra Herranz-Antolín, Clara Coton-Batres, María Covadonga López-Virgos, Verónica Esteban-Monge, Visitación Álvarez-de Frutos, Leonel Pekarek, Miguel Torralba
    Diabetes Technology & Therapeutics.2024; 26(12): 960.     CrossRef
  • Diabetes Management in Transition: Market Insights and Technological Advancements in CGM and Insulin Delivery
    Tae Sang Yu, Soojeong Song, Junwoo Yea, Kyung‐In Jang
    Advanced Sensor Research.2024;[Epub]     CrossRef
  • Association between glucose levels of children with type 1 diabetes and parental economic status in mobile health application
    Wen-Hao Zhang, Chao-Fan Wang, Hao Wang, Jie Tang, Hong-Qiang Zhang, Jiang-Yu Zhu, Xue-Ying Zheng, Si-Hui Luo, Yu Ding
    World Journal of Diabetes.2024; 15(7): 1477.     CrossRef
  • Impact of diverse aerobic exercise plans on glycemic control, lipid levels, and functional activity in stroke patients with type 2 diabetes mellitus
    Kangcheng Chen, Yulong Wang, Dongxia Li, Jun Li, Yong Huang, Meiling Huang, Haifeng Ma
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Reinforcement Learning: A Paradigm Shift in Personalized Blood Glucose Management for Diabetes
    Lehel Dénes-Fazakas, László Szilágyi, Levente Kovács, Andrea De Gaetano, György Eigner
    Biomedicines.2024; 12(9): 2143.     CrossRef
  • Anagliptin twice‐daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double‐blind, randomized controlled trial
    Yong‐ho Lee, Doo‐Man Kim, Jae Myung Yu, Kyung Mook Choi, Sin Gon Kim, Kang Seo Park, Hyun‐Shik Son, Choon Hee Chung, Kyu Jeung Ahn, Soon Hee Lee, Ki‐Ho Song, Su Kyoung Kwon, Hyeong Kyu Park, Kyu Chang Won, Hak Chul Jang
    Diabetes, Obesity and Metabolism.2023; 25(5): 1174.     CrossRef
  • Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
    Jee Hee Yoo, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2023; 47(1): 27.     CrossRef
  • Status of continuous glucose monitoring use and management in tertiary hospitals of China: a cross-sectional study
    Liping Chen, Xiaoqin Liu, Qin Lin, Hongmei Dai, Yong Zhao, Zumin Shi, Liping Wu
    BMJ Open.2023; 13(2): e066801.     CrossRef
  • Real-world outcomes of continuous glucose monitoring in adults with diabetes mellitus attending an Irish tertiary hospital
    Aoife Courtney, Diarmuid Smith, Hannah Forde
    Irish Journal of Medical Science (1971 -).2023; 192(6): 2763.     CrossRef
  • Insight into continuous glucose monitoring: from medical basics to commercialized devices
    Ayman Chmayssem, Małgorzata Nadolska, Emily Tubbs, Kamila Sadowska, Pankaj Vadgma, Isao Shitanda, Seiya Tsujimura, Youssef Lattach, Martin Peacock, Sophie Tingry, Stéphane Marinesco, Pascal Mailley, Sandrine Lablanche, Pierre Yves Benhamou, Abdelkader Zeb
    Microchimica Acta.2023;[Epub]     CrossRef
  • Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
    Shuo Zhang, Chuanyan Zhang, Jingxian Chen, Feiying Deng, Zezhen Wu, Dan Zhu, Fengwu Chen, Yale Duan, Yue Zhao, Kaijian Hou
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Impact of continuous glucose monitoring on glycemic control and its derived metrics in type 1 diabetes: a longitudinal study
    So Hyun Cho, Seohyun Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes
    Jee Hee Yoo, Ji Yoon Kim, Jae Hyeon Kim
    Diabetes Technology & Therapeutics.2023; 25(10): 726.     CrossRef
  • Acute Glycemic Variability and Early Outcomes After Cardiac Surgery: A Meta-Analysis
    Shuo Chang, Mian Xu, Yu Wang, Yanbo Zhang
    Hormone and Metabolic Research.2023; 55(11): 771.     CrossRef
  • Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality
    Ji Yoon Kim, Jee Hee Yoo, Jae Hyeon Kim
    Diabetes Technology & Therapeutics.2023; 25(12): 883.     CrossRef
  • Correlação entre tempo no alvo e hemoglobina glicada de pessoas com diabetes mellitus: revisão sistemática
    Rafael Aparecido Dias Lima, Daiane Rubinato Fernandes, Rute Aparecida Casas Garcia, Lucas Ariel da Rocha Carvalho, Renata Cristina de Campos Pereira Silveira, Carla Regina de Souza Teixeira
    Revista Latino-Americana de Enfermagem.2023;[Epub]     CrossRef
  • Correlación entre tiempo en rango y hemoglobina glicosilada en personas con diabetes mellitus: revisión sistemática
    Rafael Aparecido Dias Lima, Daiane Rubinato Fernandes, Rute Aparecida Casas Garcia, Lucas Ariel da Rocha Carvalho, Renata Cristina de Campos Pereira Silveira, Carla Regina de Souza Teixeira
    Revista Latino-Americana de Enfermagem.2023;[Epub]     CrossRef
  • Correlation between time on target and glycated hemoglobin in people with diabetes mellitus: systematic review
    Rafael Aparecido Dias Lima, Daiane Rubinato Fernandes, Rute Aparecida Casas Garcia, Lucas Ariel da Rocha Carvalho, Renata Cristina de Campos Pereira Silveira, Carla Regina de Souza Teixeira
    Revista Latino-Americana de Enfermagem.2023;[Epub]     CrossRef
  • Smart Insulin Pen: Managing Insulin Therapy for People with Diabetes in the Digital Era
    Jee Hee Yoo, Jae Hyeon Kim
    The Journal of Korean Diabetes.2023; 24(4): 190.     CrossRef
  • Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
    Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Hypoglycemic agents and glycemic variability in individuals with type 2 diabetes: A systematic review and network meta-analysis
    SuA Oh, Sujata Purja, Hocheol Shin, Minji Kim, Eunyoung Kim
    Diabetes and Vascular Disease Research.2022;[Epub]     CrossRef
  • Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus
    Jeongmin Lee, Jae-Seung Yun, Seung-Hyun Ko
    Nutrients.2022; 14(15): 3086.     CrossRef
  • Influence of dipeptidyl peptidase-4 inhibitors on glycemic variability in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Shangyu Chai, Ruya Zhang, Ye Zhang, Richard David Carr, Yiman Zheng, Swapnil Rajpathak, Miao Yu
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Glucose Profiles Assessed by Intermittently Scanned Continuous Glucose Monitoring System during the Perioperative Period of Metabolic Surgery
    Kyuho Kim, Sung Hee Choi, Hak Chul Jang, Young Suk Park, Tae Jung Oh
    Diabetes & Metabolism Journal.2022; 46(5): 713.     CrossRef
  • Deterioration in glycemic control on schooldays among children and adolescents with type 1 diabetes: A continuous glucose monitoring-based study
    Yu Ding, Wenhao Zhang, Xiumei Wu, Tian Wei, Xulin Wang, Xueying Zheng, Sihui Luo
    Frontiers in Pediatrics.2022;[Epub]     CrossRef
  • Effect of repeated bolus and continuous glucose infusion on a panel of circulating biomarkers in healthy volunteers
    Roland Feldbauer, Matthias Wolfgang Heinzl, Carmen Klammer, Michael Resl, Johannes Pohlhammer, Klemens Rosenberger, Verena Almesberger, Florian Obendorf, Lukas Schinagl, Thomas Wagner, Margot Egger, Benjamin Dieplinger, Martin Clodi, Stephen L. Atkin
    PLOS ONE.2022; 17(12): e0279308.     CrossRef
  • Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study
    Akemi Tokutsu, Yosuke Okada, Keiichi Torimoto, Yoshiya Tanaka
    Diabetology & Metabolic Syndrome.2021;[Epub]     CrossRef
  • Time-in-range for monitoring glucose control: Is it time for a change?
    Virginia Bellido, Pedro José Pinés-Corrales, Rocío Villar-Taibo, Francisco Javier Ampudia-Blasco
    Diabetes Research and Clinical Practice.2021; 177: 108917.     CrossRef
  • Glucose Management Indicator for People with Type 1 Asian Diabetes Is Different from That of the Published Equation: Differences by Glycated Hemoglobin Distribution
    Jee Hee Yoo, Seung Hee Yang, Gyuri Kim, Jae Hyeon Kim
    Diabetes Technology & Therapeutics.2021;[Epub]     CrossRef
  • Health-Related Quality of Life, Family Conflicts and Fear of Injecting: Perception Differences between Preadolescents and Adolescents with Type 1 Diabetes and Their Mothers
    Marta Tremolada, Maria Cusinato, Sabrina Bonichini, Arianna Fabris, Claudia Gabrielli, Carlo Moretti
    Behavioral Sciences.2021; 11(7): 98.     CrossRef
  • Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
    Seung Min Chung, Yun Hee Lee, Chang Oh Kim, Ji Yeon Lee, Sang-Man Jin, Seung-Hyun Yoo, Jun Sung Moon, Kwang Joon Kim
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study §
    Yannis Préau, Sébastien Galie, Pauline Schaepelynck, Martine Armand, Denis Raccah
    Sensors.2021; 21(18): 6131.     CrossRef
  • Recent Advances of Integrative Bio-Omics Technologies to Improve Type 1 Diabetes (T1D) Care
    Nisha Karwal, Megan Rodrigues, David D. Williams, Ryan J. McDonough, Diana Ferro
    Applied Sciences.2021; 11(24): 11602.     CrossRef
Brief Report
Drug/Regimen
Article image
Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Soon-Jib Yoo, Sang-Ah Chang, Tae Seo Sohn, Hyuk-Sang Kwon, Jong Min Lee, Sungdae Moon, Pieter Proot, Päivi M Paldánius, Kun Ho Yoon
Diabetes Metab J. 2021;45(6):954-959.   Published online November 12, 2020
DOI: https://doi.org/10.4093/dmj.2020.0173
  • 59,920 View
  • 452 Download
  • 5 Web of Science
  • 3 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
We assessed the glycaemic durability with early combination (EC; vildagliptin+metformin [MET], n=22) versus MET monotherapy (n=17), among newly-diagnosed type 2 diabetes mellitus (T2DM) enrolled (between 2012 and 2014) in the VERIFY study from Korea (n=39). Primary endpoint was time to initial treatment failure (TF) (glycosylated hemoglobin [HbA1c] ≥7.0% at two consecutive scheduled visits after randomization [end of period 1]). Time to second TF was assessed when both groups were receiving and failing on the combination (end of period 2). With EC the risk of initial TF significantly reduced by 78% compared to MET (n=3 [15%] vs. n=10 [58.7%], P=0.0228). No secondary TF occurred in EC group versus five patients (29.4%) in MET. Patients receiving EC treatment achieved consistently lower HbA1c levels. Both treatment approaches were well tolerated with no hypoglycaemic events. In Korean patients with newly diagnosed T2DM, EC treatment significantly and consistently improved the long-term glycaemic durability as compared with MET.

Citations

Citations to this article as recorded by  
  • Efficacy and Safety of Alogliptin-Pioglitazone Combination for Type 2 Diabetes Mellitus Poorly Controlled with Metformin: A Multicenter, Double-Blind Randomized Trial
    Ji-Yeon Park, Joonyub Lee, Yoon-Hee Choi, Kyung Wan Min, Kyung Ah Han, Kyu Jeung Ahn, Soo Lim, Young-Hyun Kim, Chul Woo Ahn, Kyung Mook Choi, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2024; 48(5): 915.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
    Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Nan Hee Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, YoonJu Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae J
    Diabetes & Metabolism Journal.2023; 47(5): 575.     CrossRef
  • 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
    Kyu Yeon Hur, Min Kyong Moon, Jong Suk Park, Soo-Kyung Kim, Seung-Hwan Lee, Jae-Seung Yun, Jong Ha Baek, Junghyun Noh, Byung-Wan Lee, Tae Jung Oh, Suk Chon, Ye Seul Yang, Jang Won Son, Jong Han Choi, Kee Ho Song, Nam Hoon Kim, Sang Yong Kim, Jin Wha Kim,
    Diabetes & Metabolism Journal.2021; 45(4): 461.     CrossRef
Original Articles
Complications
Article image
Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study
Kyoung Jin Kim, Jimi Choi, Jae Hyun Bae, Kyeong Jin Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
Diabetes Metab J. 2021;45(3):368-378.   Published online October 20, 2020
DOI: https://doi.org/10.4093/dmj.2020.0046
  • 16,086 View
  • 452 Download
  • 36 Web of Science
  • 33 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
To evaluate the association of time to reach the target glycosylated hemoglobin (HbA1c) level with long-term durable glycemic control and risk of diabetic complications in patients with newly diagnosed type 2 diabetes mellitus (T2DM).
Methods
In a longitudinal observational cohort, 194 patients with T2DM newly diagnosed between January 2011 and March 2013 were followed up over 6 years. Patients were classified according to the time needed to reach the target HbA1c (<7.0%): <3, 3 to 6 (early achievement group), and ≥6 months (late achievement group). Risks of microvascular complications including diabetic retinopathy, nephropathy, and neuropathy as well as macrovascular events including ischemic heart disease, ischemic stroke, and peripheral arterial disease were assessed by multivariable Cox proportional hazards analysis.
Results
During a median follow-up of 6.53 years, 66 microvascular and 14 macrovascular events occurred. Maintenance of durable glycemic control over 6 years was more likely in the early achievement groups than in the late achievement group (34.5%, 30.0%, and 16.1% in <3, 3 to 6, and ≥6 months, respectively, P=0.039). Early target HbA1c achievement was associated with lower risk of composite diabetic complications (adjusted hazard ratio [HR, 0.47; 95% confidence interval [CI], 0.26 to 0.86 in <3 months group) (adjusted HR, 0.50; 95% CI, 0.23 to 1.10 in 3 to 6 months group, in reference to ≥6 months group). Similar trends were maintained for risks of microvascular and macrovascular complications, although statistical significance was not reached for macrovascular complications.
Conclusion
Early target HbA1c achievement was associated with long-term durable glycemic control and reduced risk of diabetic complications in newly diagnosed T2DM.

Citations

Citations to this article as recorded by  
  • Long-term effectiveness on glycemic control of insulin compared to combined oral antidiabetic drugs for initial intensive treatment in newly diagnosed type 2 diabetes: A duplicated target trial
    Tae Hyeon Kim, Yerin Hwang, Selin Woo, Kyeongmin Lee, Yejun Son, Seoyoung Park, Hyunjee Kim, Ju-Young Shin, YongHyun Cho, Dahye Shin, Dosang Cho, Kyung-Jae Lee, Sang Youl Rhee, Dong Keon Yon
    Medicine.2026; 105(5): e47235.     CrossRef
  • The dual challenge of diabesity: pathophysiology, management, and future directions
    Ritika Sindhwani, Kundan Singh Bora, Subhajit Hazra
    Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(5): 4891.     CrossRef
  • Comparison Between the Impact of Diabetes Mellitus on Liver Diseases and Vice Versa Among Saudi and Egyptian Patients
    Madiha R. Mahmoud, Somia Ibrahim, Mona M. Shahien, Amal Daher Alshammari, Fahaad S. Alenazi, Fayez Alreshidi, Ahmed Aljadani, Ashraf Abdel Khalik, Abeer H. Elhaj, Amany M. Khalifa, Hend Faleh Alreshidi, Hemat El-Sayed El-Horany, Kamaleldin B. Said, Marwa
    Healthcare.2025; 13(4): 376.     CrossRef
  • Association between continuous glucose monitoring derived metrics and clinical parameters in Indian people living with type 2 diabetes
    Purvi Chawla, Alpana Sowani, Rakesh Parikh, Amit Gupta, Jothydev Kesavadev, Rutul Gokalani, Banshi Saboo, Manoj Chawla
    Primary Care Diabetes.2025; 19(5): 453.     CrossRef
  • Time to first optimal glycaemic control and associated factors among adult patients with diabetes at the University of Gondar Comprehensive Specialized Hospital, northwest Ethiopia: a retrospective cohort study
    Adane Desta Getahun, Emneteab Mesfin Ayele, Tilahun Degu Tsega, Sisay Sitotaw Anberbr, Gebremariam Wulie Geremew, Alemneh Ayu Biyazin, Basazinew Mekuria Taye, Gizework Alemnew Mekonnen
    BMJ Open.2025; 15(9): e096615.     CrossRef
  • Efficacy of Community-based Interventions in Reducing HbA1c Levels Among Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Recent Studies Conducted in Developing Countries
    Lutfian Lutfian, Izdihar Javier Wardika, Muhammad Amirul Mukminin, Ibnu Syarifudin Hidayat, Riki Wartakusumah, Hatifah Ihsanda Tien Melati, Dinar Perwitasari, Fahmi Wildana, Nur Widayati, Fulgence Niyibitegeka, Jonathan Hasian Haposan
    Journal of Primary Care & Community Health.2025;[Epub]     CrossRef
  • A Study of Lipoprotein(a) in Newly Diagnosed Type 2 Diabetes Mellitus and Its Correlation with Glycosylated Hemoglobin
    Vaibhav Shukla, S. Priya, Princika Chauhan
    Indian Journal of Medical Specialities.2025; 16(4): 248.     CrossRef
  • Association of Helicobacter pylori infection with complications of diabetes: a single-center retrospective study
    Zhuoya Li, Jie Zhang, Yizhou Jiang, Kai Ma, Cheng Cui, Xiaoyong Wang
    BMC Endocrine Disorders.2024;[Epub]     CrossRef
  • HbA1c As Diabetes Mellitus Biomarker and Its Methods Evolution
    Liong Boy Kurniawan
    INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY.2024; 30(2): 191.     CrossRef
  • Efficacy and safety of enavogliflozin vs. dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus based on renal function: a pooled analysis of two randomized controlled trials
    Young Sang Lyu, Sangmo Hong, Si Eun Lee, Bo Young Cho, Cheol-Young Park
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • The effect of health quotient and time management skills on self-management behavior and glycemic control among individuals with type 2 diabetes mellitus
    Mengjie Chen, Man Liu, Ying Pu, Juan Wu, Mingjiao Zhang, Hongxia Tang, Laixi Kong, Maoting Guo, Kexue Zhu, Yuxiu Xie, Zhe Li, Bei Deng, Zhenzhen Xiong
    Frontiers in Public Health.2024;[Epub]     CrossRef
  • Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add‐on therapy in drug‐naïve patients with type 2 diabetes (TRIPLE‐AXEL study): A multicentre, randomized, 104‐week, open‐
    Nam Hoon Kim, Jun Sung Moon, Yong‐ho Lee, Ho Chan Cho, Soo Heon Kwak, Soo Lim, Min Kyong Moon, Dong‐Lim Kim, Tae Ho Kim, Eunvin Ko, Juneyoung Lee, Sin Gon Kim
    Diabetes, Obesity and Metabolism.2024; 26(9): 3642.     CrossRef
  • A study of the relationship between social support, depression, alexithymia and glycemic control in patients with type 2 diabetes mellitus: a structural equation modeling approach
    Yuqin Gan, Fengxiang Tian, Xinxin Fan, Hui Wang, Jian Zhou, Naihui Yang, Hong Qi
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Prediction factors and models for chronic kidney disease in type 2 diabetes mellitus: A review of the literature
    Yan Yang, Bixia Yang, Bin Wang, Hua Zhou, Min Yang, Bicheng Liu
    Clinical and Translational Discovery.2024;[Epub]     CrossRef
  • Cost‐effectiveness of the tandem t: Slim X2 with control‐IQ technology automated insulin delivery system in children and adolescents with type 1 diabetes in Sweden
    Peter Adolfsson, Alina Heringhaus, Karin Sjunnesson, Laila Mehkri, Kristian Bolin
    Diabetic Medicine.2024;[Epub]     CrossRef
  • The Association Between Triglyceride Glucose-Body Mass Index and Kidney Impairment in Patients with Type 2 Diabetes Mellitus
    Nan Huang, Bing Lu, Zhuan-Zhuan Zhu, Xiang-Yun Zhu, Sheng Chen, Zhi-Yi Shu, Gai-Fang Liu, You-Fan Peng, Ling Li
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3447.     CrossRef
  • Glycated Hemoglobin and Cardiovascular Disease in Patients Without Diabetes
    Grzegorz K. Jakubiak, Artur Chwalba, Aleksandra Basek, Grzegorz Cieślar, Natalia Pawlas
    Journal of Clinical Medicine.2024; 14(1): 53.     CrossRef
  • Glycemic control and cardiovascular complications of type 2 diabetes mellitus
    I. V. Druk, S. S. Safronova
    Meditsinskiy sovet = Medical Council.2023; (13): 130.     CrossRef
  • Effect of viscous soluble dietary fiber on glucose and lipid metabolism in patients with type 2 diabetes mellitus: a systematic review and meta-analysis on randomized clinical trials
    Kun Lu, Tingqing Yu, Xinyi Cao, Hui Xia, Shaokang Wang, Guiju Sun, Liang Chen, Wang Liao
    Frontiers in Nutrition.2023;[Epub]     CrossRef
  • Construction and validation of a clinical prediction model for asymptomatic obstructive coronary stenosis in patients with carotid stenosis
    Cuijie Qin, Chuang Li, Yunpeng Luo, Zhen Li, Hui Cao
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Risk assessment of rectal anastomotic leakage (RAREAL) after DIXON in non-emergency patients with rectal cancer
    Xue-Cong Zheng, Jin-Bo Su, Jin-Jie Zheng
    BMC Gastroenterology.2023;[Epub]     CrossRef
  • Evaluation of Left Ventricular Function in Diabetes Patients with Microvascular Disease by Three-Dimensional Speckle Tracking Imaging
    青 周
    Advances in Clinical Medicine.2023; 13(12): 18908.     CrossRef
  • Validity of the diagnosis of diabetic microvascular complications in Korean national health insurance claim data
    Hyung Jun Kim, Moo-Seok Park, Jee-Eun Kim, Tae-Jin Song
    Annals of Clinical Neurophysiology.2022; 24(1): 7.     CrossRef
  • Metformin plus a low hypoglycemic risk antidiabetic drug vs. metformin monotherapy for untreated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Wei-Tse Hung, Yuan-Jung Chen, Chun-Yu Cheng, Bruce Ovbiagele, Meng Lee, Chia-Yu Hsu
    Diabetes Research and Clinical Practice.2022; 189: 109937.     CrossRef
  • Peripheral arterial disease progression and ankle brachial index: a cohort study with newly diagnosed patients with type 2 diabetes
    João Soares Felício, Franciane Trindade Cunha de Melo, Giovana Miranda Vieira, Vitória Teixeira de Aquino, Fernanda de Souza Parente, Wanderson Maia da Silva, Nivin Mazen Said, Emanuele Rocha da Silva, Ana Carolina Contente Braga de Souza, Maria Clara Ner
    BMC Cardiovascular Disorders.2022;[Epub]     CrossRef
  • Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus
    Chen Long, Yaling Tang, Jiangsheng Huang, Suo Liu, Zhenhua Xing
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The Degree of Glycemic Control for the First Three Months Determines the Next Seven Years
    Nami Lee, Dae Jung Kim
    Journal of Korean Medical Science.2022;[Epub]     CrossRef
  • Inhibition of advanced glycation end products and protein oxidation by leaf extracts and phenolics from Chilean bean landraces
    Felipe Ávila, Nadia Cruz, Jazmin Alarcon-Espósito, Nélida Nina, Hernán Paillan, Katherine Márquez, Denis Fuentealba, Alberto Burgos-Edwards, Cristina Theoduloz, Carmina Vejar-Vivar, Guillermo Schmeda-Hirschmann
    Journal of Functional Foods.2022; 98: 105270.     CrossRef
  • Mediation Effect of Self-Efficacy Between Health Beliefs and Glycated Haemoglobin Levels in Elderly Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
    Anqi Zhang, Jinsong Wang, Xiaojuan Wan, Jing Zhang, Zihe Guo, Yamin Miao, Shuhan Zhao, Shuo Bai, Ziyi Zhang, Weiwei Yang
    Patient Preference and Adherence.2022; Volume 16: 3015.     CrossRef
  • Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
    Joonyub Lee, Jae Hyoung Cho
    Diabetes & Metabolism Journal.2021; 45(3): 337.     CrossRef
  • Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
    Ja Young Jeon
    Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef
  • Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
    Kyoung Jin Kim, Jimi Choi, Jae Hyun Bae, Kyeong Jin Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
    Diabetes & Metabolism Journal.2021; 45(4): 617.     CrossRef
  • Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient
    Dandan Xu, Yue Yu, Yayun Xu, Jinfang Ge
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 3555.     CrossRef
Lifestyle
Article image
Reducing Carbohydrate from Individual Sources Has Differential Effects on Glycosylated Hemoglobin in Type 2 Diabetes Mellitus Patients on Moderate Low-Carbohydrate Diets
Hajime Haimoto, Shiho Watanabe, Keiko Maeda, Takashi Murase, Kenji Wakai
Diabetes Metab J. 2021;45(3):390-403.   Published online July 21, 2020
DOI: https://doi.org/10.4093/dmj.2020.0033
  • 9,591 View
  • 195 Download
  • 4 Web of Science
  • 4 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

We evaluated decreases in glycosylated hemoglobin (HbA1c) achieved by reducing carbohydrate from various sources in type 2 diabetes mellitus patients.

Methods

We followed up 138 male and 107 female outpatients on a moderate low-carbohydrate diet without diabetic medication for 6 months. Changes in carbohydrate sources (Δcarbohydrate) were assessed from 3-day dietary records at baseline and 6 months, and associations with changes in HbA1c (ΔHbA1c) were examined with Spearman's correlation coefficients (rs) and multiple regression analysis.

Results

ΔHbA1c was −1.5%±1.6% in men and −0.9%±1.3% in women, while Δtotal carbohydrate was −115.3±103.7 g/day in men and −63.6±71.1 g/day in women. Positive associations with ΔHbA1c were found for Δtotal carbohydrate (rs=0.584), Δcarbohydrate from soft drinks (0.368), confectionery (0.361), rice (0.325), bread (0.221), Chinese soup noodles (0.199) in men, and Δtotal carbohydrate (0.547) and Δcarbohydrate from rice (0.376) and confectionery (0.195) in women. Reducing carbohydrate sources by 50 g achieved decreases in HbA1c of 0.43% for total carbohydrate, 1.33% for soft drinks, 0.88% for confectionery, 0.63% for bread, 0.82% for Chinese soup noodles and 0.34% for rice in men and 0.45% for total carbohydrate, 0.67% for confectionery and 0.34% for rice in women, although mean reductions in carbohydrate from these sources were much smaller than that from rice.

Conclusion

Decreases in HbA1c achieved by reducing carbohydrate from soft drinks, confectionery, bread and Chinese soup noodles were 2- to 4-fold greater than that for rice. Our results will enable patients to decrease HbA1c efficiently (UMIN000009866).

Citations

Citations to this article as recorded by  
  • Letter: Post‐HCV Cure, Precision Assessment of Liver Stiffness and Diabetes Risk in Maternal Populations—A Critical Research Need
    Zihe Guan, Yang Liu, Xinming Chen, Xiwei Yang
    Alimentary Pharmacology & Therapeutics.2025; 62(1): 93.     CrossRef
  • Exploring diet associations with Covid-19 and other diseases: a Network Analysis–based approach
    Rashmeet Toor, Inderveer Chana
    Medical & Biological Engineering & Computing.2022; 60(4): 991.     CrossRef
  • Comprehensive Understanding for Application in Korean Patients with Type 2 Diabetes Mellitus of the Consensus Statement on Carbohydrate-Restricted Diets by Korean Diabetes Association, Korean Society for the Study of Obesity, and Korean Society of Hyperte
    Jong Han Choi, Jee-Hyun Kang, Suk Chon
    Diabetes & Metabolism Journal.2022; 46(3): 377.     CrossRef
  • Associations of Dietary Salt and Its Sources with Hemoglobin A1c in Patients with Type 2 Diabetes Not Taking Anti-Diabetic Medications: Analysis Based on 6-Month Intervention with a Moderate Low-Carbohydrate Diet
    Hajime Haimoto, Takashi Murase, Shiho Watanabe, Keiko Maeda, Kenji Wakai
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4569.     CrossRef
Complications
Article image
Deterioration of Sleep Quality According to Glycemic Status
Myung Haeng Hur, Mi-Kyoung Lee, Kayeon Seong, Jun Hwa Hong
Diabetes Metab J. 2020;44(5):679-686.   Published online April 17, 2020
DOI: https://doi.org/10.4093/dmj.2019.0125
  • 11,719 View
  • 162 Download
  • 12 Web of Science
  • 18 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Type 2 diabetes mellitus (T2DM) is a progressive disease with multiple complications. The present study aimed to determine the effects of glycemic status on sleep quality in individuals with T2DM, prediabetes, and normal glucose tolerance (NGT).

Methods

A total of 90 participants were categorized into three groups, T2DM (n=30), prediabetes (n=30), and NGT (n=30). Objective sleep quality was measured with the actigraph wrist-worn device over 3 nights and subjective sleep quality was evaluated with a questionnaire.

Results

The duration of diabetes in the T2DM group was 2.23 years and the glycosylated hemoglobin (HbA1c) levels in the T2DM, prediabetes, and NGT groups were 7.83%, 5.80%, and 5.31%, respectively. Sleep efficiency decreased across the T2DM, prediabetes, and NGT groups (86.25%, 87.99%, and 90.22%, respectively; P=0.047). Additionally, HbA1c levels revealed a significant negative correlation with sleep efficiency (r=−0.348, P=0.001). The sleep quality questionnaire results were similar among the three groups.

Conclusion

Although the participants in the present study were not necessarily conscious of their sleep disturbances, deterioration in sleep quality progressed according to glycemic status.

Citations

Citations to this article as recorded by  
  • The interface of depression and diabetes: treatment considerations
    Giuseppe Fanelli, Emanuel Raschi, Gaye Hafez, Silke Matura, Carmen Schiweck, Elisabetta Poluzzi, Carlotta Lunghi
    Translational Psychiatry.2025;[Epub]     CrossRef
  • The association between insomnia (related symptoms) and glycaemic control: a systematic review and meta-analysis
    Yiming Chen, Enyu Tong, Yufeng Rao, Evan YW Yu, Maurice Zeegers, Anke Wesselius
    Journal of Global Health.2025;[Epub]     CrossRef
  • The potential impact of habitual sleep quality on glycaemic control and inflammation: A study on geriatric patients recently diagnosed with type 2 diabetes mellitus (T2DM)
    Nadia Hussain, Amal Hussain Ibrahim Al Haddad, Saima Abbass, Zina Alfahl
    Sleep Medicine: X.2025; 9: 100139.     CrossRef
  • Diyabet Tiplerine Göre Yaşam Kalitesi, Fiziksel Aktivite ve Uyku Düzeylerinin Karşılaştırılması
    Abdurrahim Yıldız, Salih Buğra Özdemir, Emircan Kökcü, Fevziye Türkoğlu Genç
    Journal of Innovative Healthcare Practices.2025; 6(1): 19.     CrossRef
  • Association Between Non-adherence to Diabetes Management and Poor Sleep Quality Based on the Korean Community Health Survey
    Horim A. Hwang, Hyunsuk Jeong, Hyeon Woo Yim
    Journal of Preventive Medicine and Public Health.2025; 58(3): 260.     CrossRef
  • Diabetic kidney disease in rural Australia: prevention, management, treatment and way forward
    Allen G. Ross, Utpal K. Mondal, Anayochukwu E. Anyasodor, Shakeel Mahmood, Feleke H. Astawesegn, M. Mamun Huda, Subash Thapa, Setognal B. Aychiluhm, Santosh Giri, Md. Ferdous Rahman, Muhammad J. A. Shiddiky, Mohammad A. Moni, Kedir Y. Ahmed
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Insulin resistance, depression, and type 2 diabetes
    A.A. Serhiyenko, O.M. Chemerys, V.I. Pankiv, V.A. Serhiyenko
    INTERNATIONAL NEUROLOGICAL JOURNAL.2025; 21(6): 431.     CrossRef
  • Risk factors of non communicable diseases among recently diagnosed diabetic patients in a tertiary care Hospital
    Yusra Amin, Sonia Mushtaq, Rukhsana Farooq
    Indian Journal of Clinical Anatomy and Physiology.2024; 10(4): 205.     CrossRef
  • Metabolic health tracking using Ultrahuman M1 continuous glucose monitoring platform in non- and pre-diabetic Indians: a multi-armed observational study
    Monik Chaudhry, Mohit Kumar, Vatsal Singhal, Bhuvan Srinivasan
    Scientific Reports.2024;[Epub]     CrossRef
  • Influence of sleep quality and other associated factors on glycemic control among diabetic patients: A hospital-based study
    Sonia Mushtaq, Yusra Amin, Rukhsana Taj, Umara Giyas, Sunil Sachadev
    Indian Journal of Clinical Anatomy and Physiology.2024; 11(1): 32.     CrossRef
  • Interventional effects of Pueraria oral liquid on T2DM rats and metabolomics analysis
    Hong-Bo Yang, Jie-Yu Song, Chan Xu, Jin Li, Chan Zhang, Sun Xie, Chun-li Teng
    Biomedicine & Pharmacotherapy.2024; 175: 116780.     CrossRef
  • Replacing sedentary time with sleep and physical activity: associations with physical function and wellbeing in Type 2 diabetes
    Alix Covenant, Thomas Yates, Alex V. Rowlands, Paddy C. Dempsey, Charlotte L. Edwardson, Andrew P. Hall, Melanie J. Davies, Joseph Henson
    Diabetes Research and Clinical Practice.2024; 217: 111886.     CrossRef
  • Relation between sleep quality and glycemic control among type 2 diabetic patients
    Asmaa Ali Elsayed Ali
    Frontiers of Nursing.2023; 10(1): 115.     CrossRef
  • Heart rate variability in different sleep stages is associated with metabolic function and glycemic control in type 2 diabetes mellitus
    Wenquan Cheng, Hongsen Chen, Leirong Tian, Zhimin Ma, Xingran Cui
    Frontiers in Physiology.2023;[Epub]     CrossRef
  • Association Between Diabetic Retinopathy and Insomnia Risk: A Nationwide Population-Based Study
    Yoo Hyun Um, Tae-Won Kim, Jong-Hyun Jeong, Seung-Chul Hong, Ho-Jun Seo, Kyung-Do Han
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Nutritional Biomarkers and Factors Correlated with Poor Sleep Status among Young Females: A Case-Control Study
    Sara AL-Musharaf, Lama AlAjllan, Ghadeer Aljuraiban, Munirah AlSuhaibani, Noura Alafif, Syed Danish Hussain
    Nutrients.2022; 14(14): 2898.     CrossRef
  • The impact of sleep disorders on microvascular complications in patients with type 2 diabetes (SLEEP T2D): the protocol of a cohort study and feasibility randomised control trial
    Christina Antza, Ryan Ottridge, Smitaa Patel, Gemma Slinn, Sarah Tearne, Matthew Nicholls, Brendan Cooper, Asad Ali, Abd A. Tahrani
    Pilot and Feasibility Studies.2021;[Epub]     CrossRef
  • Early Development of Bidirectional Associations between Sleep Disturbance and Diabetes
    Yongin Cho
    Diabetes & Metabolism Journal.2020; 44(5): 668.     CrossRef
Short Communication
Epidemiology
Low-Normal Free Thyroxine Levels in Euthyroid Male Are Associated with Prediabetes
Sung Woo Kim, Jae-Han Jeon, Jun Sung Moon, Eon Ju Jeon, Mi-Kyung Kim, In-Kyu Lee, Jung Beom Seo, Keun-Gyu Park
Diabetes Metab J. 2019;43(5):718-726.   Published online March 19, 2019
DOI: https://doi.org/10.4093/dmj.2018.0222
  • 6,989 View
  • 64 Download
  • 5 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   

Abnormal thyroid function is associated with impaired glucose homeostasis. This study aimed to determine whether free thyroxine (FT4) influences the prevalence of prediabetes in euthyroid subjects using a cross-sectional survey derived from the Korea National Health and Nutrition Examination Survey, conducted between 2013 and 2015. We studied 2,399 male participants of >20 years of age who were euthyroid and non-diabetic. Prediabetic participants had lower FT4 concentrations than those without prediabetes, but their thyrotropin concentrations were similar. We stratified the population into tertiles according to FT4 concentration. After adjusting for multiple confounding factors, glycosylated hemoglobin (HbA1c) levels significantly decreased with increasing FT4 tertile, whereas fasting plasma glucose (FPG) levels were not associated with FT4 tertiles (HbA1c, P<0.01 in T3 vs. T1; FPG, P=0.489 in T3 vs. T1). The prevalence of prediabetes was significantly higher in T1 (odds ratio, 1.426; 95% confidence interval, 1.126 to 1.806; P<0.01) than in T3. In conclusion, subjects with low-normal serum FT4 had high HbA1c and were more likely to have prediabetes. These results suggest that low FT4 concentration is a risk factor for prediabetes in male, even when thyroid function is within the normal range.

Citations

Citations to this article as recorded by  
  • Hypothyroidism: playing the cardiometabolic risk concerto
    George J. Kahaly, Youshuo Liu, Luca Persani
    Thyroid Research.2025;[Epub]     CrossRef
  • Correlation between thyroid hormone values and anemia in elderly patients with diabetic nephropathy.
    Jingjing Yu, Keke Tang, Yan Song
    Investigación Clínica.2025; 66(2): 157.     CrossRef
Original Article
Clinical Diabetes & Therapeutics
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
Ji-Yeon Lee, Yongin Cho, Minyoung Lee, You Jin Kim, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
Diabetes Metab J. 2019;43(2):158-173.   Published online January 25, 2019
DOI: https://doi.org/10.4093/dmj.2018.0057
  • 10,025 View
  • 204 Download
  • 17 Web of Science
  • 16 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

We investigated the predictive markers for the therapeutic efficacy and the best combination of sodium-glucose co-transporter 2 (SGLT2) inhibitors (empagliflozin, dapagliflozin, and ipragliflozin) therapy in patients with type 2 diabetes mellitus (T2DM).

Methods

A total of 804 patients with T2DM who had taken SGLT2 inhibitor as monotherapy or an add-on therapy were analyzed. Multivariate regression analyses were performed to identify the predictors of SGLT2 inhibitor response including the classes of baseline anti-diabetic medications.

Results

After adjusting for age, sex, baseline body mass index (BMI), diabetes duration, duration of SGLT2 inhibitor use, initial glycosylated hemoglobin (HbA1c) level, estimated glomerular filtration rate (eGFR), and other anti-diabetic agent usage, multivariate analysis revealed that shorter diabetes duration, higher initial HbA1c and eGFR were associated with better glycemic response. However, baseline BMI was inversely correlated with glycemic status; lean subjects with well-controlled diabetes and obese subjects with inadequately controlled diabetes received more benefit from SGLT2 inhibitor treatment. In addition, dipeptidyl peptidase 4 (DPP4) inhibitor use was related to a greater reduction in HbA1c in patients with higher baseline HbA1c ≥7%. Sulfonylurea users experienced a larger change from baseline HbA1c but the significance was lost after adjustment for covariates and metformin and thiazolidinedione use did not affect the glycemic outcome.

Conclusion

A better response to SGLT2 inhibitors is expected in Korean T2DM patients who have higher baseline HbA1c and eGFR with a shorter diabetes duration. Moreover, the add-on of an SGLT2 inhibitor to a DPP4 inhibitor is likely to show the greatest glycemic response.

Citations

Citations to this article as recorded by  
  • Exploring the value of ChatGPT in selecting antidiabetic agents for type 2 diabetes
    Seol A. Jang, Su Jin Kwon, Chul Sik Kim, Seok Won Park, Kyoung Min Kim
    Diabetes, Obesity and Metabolism.2025; 27(10): 5761.     CrossRef
  • Predictors of efficacy of Sodium‐GLucose Transporter‐2 inhibitors and Glucagon‐Like Peptide 1 receptor agonists: A retrospective cohort study
    Daniele Scoccimarro, Giacomo Cipani, Ilaria Dicembrini, Edoardo Mannucci
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study
    M. L. Morieri, I. Raz, A. Consoli, M. Rigato, A. Lapolla, F. Broglio, E. Bonora, A. Avogaro, G. P. Fadini, Federica Ginestra, Gloria Formoso, Agostino Consoli, Francesco Andreozzi, Giorgio Sesti, Salvatore Turco, Luigi Lucibelli, Adriano Gatti, Raffaella
    Journal of Endocrinological Investigation.2023; 46(7): 1429.     CrossRef
  • Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
    Katherine G. Young, Eram Haider McInnes, Robert J. Massey, Anna R. Kahkoska, Scott J. Pilla, Sridharan Raghavan, Maggie A. Stanislawski, Deirdre K. Tobias, Andrew P. McGovern, Adem Y. Dawed, Angus G. Jones, Ewan R. Pearson, John M. Dennis, Deirdre K. Tobi
    Communications Medicine.2023;[Epub]     CrossRef
  • Predictors of HbA1c treatment response to add-on medication following metformin monotherapy: a population-based cohort study
    Wei Ying Tan, Wynne Hsu, Mong Li Lee, Ngiap Chuan Tan
    Scientific Reports.2023;[Epub]     CrossRef
  • Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extensio
    Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2023; 47(6): 808.     CrossRef
  • Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
    Seung-Hwan Lee, Kyung-Wan Min, Byung-Wan Lee, In-Kyung Jeong, Soon-Jib Yoo, Hyuk-Sang Kwon, Yoon-Hee Choi, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2021; 45(3): 339.     CrossRef
  • Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice
    Kana N. Miyata, Chao-Sheng Lo, Shuiling Zhao, Min-Chun Liao, Yuchao Pang, Shiao-Ying Chang, Junzheng Peng, Matthias Kretzler, Janos G. Filep, Julie R. Ingelfinger, Shao-Ling Zhang, John S.D. Chan
    Clinical Science.2021; 135(7): 943.     CrossRef
  • Sodium-Glucose Cotransporter-2 Inhibitor for Renal Function Preservation in Patients with Type 2 Diabetes Mellitus: A Korean Diabetes Association and Korean Society of Nephrology Consensus Statement
    Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon
    Diabetes & Metabolism Journal.2020; 44(4): 489.     CrossRef
  • Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure
    Francesco Giorgino, Irene Caruso, Julia Moellmann, Michael Lehrke
    Metabolism.2020; 104: 154045.     CrossRef
  • Clinical Predictors of the Hypoglycemic Effect of Sodium–Glucose Co-transporter-2 Inhibitors in Hyperuricemic Patients: A Retrospective Descriptive Observational Study
    Toshinori Hirai, Yuya Kawagoe, Motoki Kei, Ryuichi Ogawa, Toshimasa Itoh
    Biological and Pharmaceutical Bulletin.2020; 43(5): 782.     CrossRef
  • Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: A Korean Diabetes Association and Korean Society of Nephrology consensus statement
    Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon
    Kidney Research and Clinical Practice.2020; 39(3): 269.     CrossRef
  • Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysis
    Ildiko Lingvay, Matthew S Capehorn, Andrei-Mircea Catarig, Pierre Johansen, Jack Lawson, Anna Sandberg, Robert Shaw, Abby Paine
    The Journal of Clinical Endocrinology & Metabolism.2020; 105(12): e4593.     CrossRef
  • Letter: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73)
    Kyung-Soo Kim
    Diabetes & Metabolism Journal.2019; 43(3): 377.     CrossRef
  • Response: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158–73)
    Ji-Yeon Lee, Eun Seok Kang
    Diabetes & Metabolism Journal.2019; 43(3): 379.     CrossRef
  • An Age of Sodium-Glucose Cotransporter-2 Inhibitor Priority: Are We Ready?
    Ji A Seo
    Diabetes & Metabolism Journal.2019; 43(5): 578.     CrossRef
Short Communication
Complications
Glycosylated Hemoglobin in Subjects Affected by Iron-Deficiency Anemia
Jari Intra, Giuseppe Limonta, Fabrizio Cappellini, Maria Bertona, Paolo Brambilla
Diabetes Metab J. 2019;43(4):539-544.   Published online November 28, 2018
DOI: https://doi.org/10.4093/dmj.2018.0072
  • 14,211 View
  • 185 Download
  • 12 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   

Previous studies have suggested that iron-deficiency anemia affects glycosylated hemoglobin (HbA1c) measurements, but the results were contradictory. We conducted a retrospective case-control study to determine the effects of iron deficiency on HbA1c levels. Starting with the large computerized database of the Italian Hospital of Desio, including data from 2000 to 2016, all non-pregnant individuals older than 12 years of age with at least one measurement of HbA1c, cell blood count, ferritin, and fasting blood glucose on the same date of blood collection were enrolled. A total of 2,831 patients met the study criteria. Eighty-six individuals were diagnosed with iron-deficiency anemia, while 2,745 had a normal iron state. The adjusted means of HbA1c were significantly higher in anemic subjects (5.59% [37.37 mmol/mol]), than those measured in individuals without anemia (5.34% [34.81 mmol/mol]) (P<0.0001). These results suggest that clinicians should be cautious about diagnosing prediabetes and diabetes in individuals with anemia.

Citations

Citations to this article as recorded by  
  • Management of diabetes in people with advanced chronic kidney disease
    Tahseen A. Chowdhury, Dorcas Mukuba, Mahalia Casabar, Conor Byrne, M. Magdi Yaqoob
    Diabetic Medicine.2025;[Epub]     CrossRef
  • A cross-sectional study of glycosylated hemoglobin characteristics among Jeddah city population: Saudi Arabia
    Almonther A. Hershan, Moufag M. S. Tayeb
    Journal of Family Medicine and Primary Care.2025; 14(5): 1933.     CrossRef
  • Iron deficiency anemia and glycated hemoglobin among adolescents: A case‑control study
    Ahmed Mohamedain
    World Academy of Sciences Journal.2025; 7(5): 1.     CrossRef
  • Fingerprinting hyperglycemia using predictive modelling approach based on low-cost routine CBC and CRP diagnostics
    Amna Tahir, Kashif Asghar, Waqas Shafiq, Hijab Batool, Dilawar Khan, Omar Chughtai, Safee Ullah Chaudhary
    Scientific Reports.2024;[Epub]     CrossRef
  • Unlocking Optimal Glycemic Interpretation: Redefining HbA1c Analysis in Female Patients With Diabetes and Iron‐Deficiency Anemia Using Machine Learning Algorithms
    Kadra Mohamed Abdillahi, Fatma Ceyla Eraldemir, Irfan Kösesoy
    Journal of Clinical Laboratory Analysis.2024;[Epub]     CrossRef
  • Effect of Iron Deficiency Anemia on HbA1c Levels Among Diabetic and Nondiabetic Patients
    Kenkere Marulaiah Srinath, N. Akash, Adarsh Lakkur Siddappa, Basave Gowda Madhu, K. C. Shashidhara, Prasanna Kumar Hassan Ramaswamy
    D Y Patil Journal of Health Sciences.2024; 12(2): 51.     CrossRef
  • SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
    Hae Kyung Kim, Geert Jan Biessels, Min Heui Yu, Namki Hong, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Minyoung Lee
    Neurology.2024;[Epub]     CrossRef
  • Implications of Iron Deficiency Anaemia on Glycemic Dynamics in Diabetes Mellitus: A Critical Risk Factor in Cardiovascular Disease
    Eman Elsheikh, Sereen S Aljohani , Munirah M Alshaikhmubarak, Meshari A Alhawl, Alhanouf W Alsubaie, Norah Alsultan, Asmaa F Sharif, Sayed Ibrahim Ali
    Cureus.2023;[Epub]     CrossRef
  • Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps
    Yi Lu, Qian Zhang, Xiangyu Wang, Ya Jiang, Yaoming Xue
    Journal of Diabetes and its Complications.2023; 37(11): 108613.     CrossRef
  • Serum Iron Profile in Type 2 Diabetes, A Role Beyond Anemic Marker!
    Happy Chutia, Sungdirenla Jamir, Md Yasir, Gautam Handique
    The Journal of Medical Research.2023; 9(5): 129.     CrossRef
  • Association between Anemia and Myopia in Korean Adults
    Minyi Seo, Sangshin Park
    Journal of Health Informatics and Statistics.2023; 48(4): 314.     CrossRef
  • Large-scale retrospective analyses of the effect of iron deficiency anemia on hemoglobin A1c concentrations
    Lokinendi V. Rao, George W. Pratt, Caixia Bi, Martin H. Kroll
    Clinica Chimica Acta.2022; 529: 21.     CrossRef
  • Integrity loss of glycosylated hemoglobin with deepening anemia
    Bünyamin AYDIN, Aysun GÖNDEREN
    Journal of Health Sciences and Medicine.2022; 5(3): 839.     CrossRef
  • Association between hemoglobin within the normal range and hemoglobin A1c among Chinese non-diabetes adults
    Yi Lai, Zhihong Lin, Zhongxin Zhu
    BMC Endocrine Disorders.2021;[Epub]     CrossRef
  • The Association between Daily Total Dietary Nutrient Intake and Recent Glycemic Control States of Non-Pregnant Adults 20+ Years Old from NHANES 1999–2018 (Except for 2003–2004)
    Yin Bai, Hao Zhang, Jie Yang, Lei Peng
    Nutrients.2021; 13(11): 4168.     CrossRef
Original Articles
Clinical Diabetes & Therapeutics
Effectiveness of Exercise Intervention in Reducing Body Weight and Glycosylated Hemoglobin Levels in Patients with Type 2 Diabetes Mellitus in Korea: A Systematic Review and Meta-Analysis
Ji-Eun Jang, Yongin Cho, Byung Wan Lee, Ein-Soon Shin, Sun Hee Lee
Diabetes Metab J. 2019;43(3):302-318.   Published online November 19, 2018
DOI: https://doi.org/10.4093/dmj.2018.0062
  • 11,367 View
  • 138 Download
  • 16 Web of Science
  • 19 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

This study aimed to assess the effectiveness of exercise intervention in reducing body weight and glycosylated hemoglobin (HbA1c) level in patients with type 2 diabetes mellitus (T2DM) in Korea.

Methods

Cochrane, PubMed, Embase, KoreaMed, KMbase, NDSL, KCI, RISS, and DBpia databases were used to search randomized controlled trials and controlled clinical trials that compared exercise with non-exercise intervention among patients with non-insulin-treated T2DM in Korea. The effectiveness of exercise intervention was estimated by the mean difference in body weight changes and HbA1c level. Weighted mean difference (WMD) with its corresponding 95% confidence interval (CI) was used as the effect size. The pooled mean differences of outcomes were calculated using a random-effects model.

Results

We identified 7,692 studies through literature search and selected 23 articles (723 participants). Compared with the control group, exercise intervention (17 studies) was associated with a significant decline in HbA1c level (WMD, −0.58%; 95% CI, −0.89 to −0.27; I2=73%). Although no significant effectiveness on body weight was observed, eight aerobic training studies showed a significant reduction in body weight (WMD, −2.25 kg; 95% CI, −4.36 to −0.13; I2=17%) in the subgroup analysis.

Conclusion

Exercise significantly improves glycemic control; however, it does not significantly reduce body weight. Aerobic training can be beneficial for patients with non-insulin-treated T2DM in Korea.

Citations

Citations to this article as recorded by  
  • A Feasibility Study of a Web Application Intervention for Persons With Uncontrolled Diabetes
    Atchara Meenasantirak, Chalee Siripitakchai, Natthawut Suriya
    Health Promotion Journal of Australia.2025;[Epub]     CrossRef
  • Surface electromyography for characterizing neuromuscular changes in diabetic peripheral neuropathy
    I. Junquera-Godoy, J.L. Martinez-De-Juan, G. González Lorente, J.M. Carot-Sierra, J. Gomis-Tena, J. Saiz, R. López Mateu, G.C. Mas Penalva, S.Garcia Blasco, E. Boix Carreño, E. Soler Climent, G. Prats-Boluda
    Journal of Electromyography and Kinesiology.2025; 82: 102991.     CrossRef
  • 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
    Shinae Kang, Seon Mee Kang, Jong Han Choi, Seung-Hyun Ko, Bo Kyung Koo, Hyuk-Sang Kwon, Mi Kyung Kim, Sang Yong Kim, Soo-Kyung Kim, Young-eun Kim, Eun Sook Kim, Jae Hyeon Kim, Chong Hwa Kim, Ji Min Kim, Hae Jin Kim, Min Kyong Moon, Sun Joon Moon, Jun Sung
    Diabetes & Metabolism Journal.2025; 49(4): 582.     CrossRef
  • Lifestyle Management of Hypertension and Type 2 Diabetes
    JungHwan Kim
    Korean Journal of Family Practice.2025; 15(3): 120.     CrossRef
  • Effect of low-volume combined aerobic and resistance high-intensity interval training on vascular health in people with type 2 diabetes: a randomised controlled trial
    Emily R. Cox, Trishan Gajanand, Shelley E. Keating, Matthew D. Hordern, Nicola W. Burton, Daniel J. Green, Joyce S. Ramos, Maximiano V. Ramos, Robert G. Fassett, Stephen V. Cox, Jeff S. Coombes, Tom G. Bailey
    European Journal of Applied Physiology.2024; 124(9): 2819.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
    Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, Yoon Ju Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang
    Diabetes & Metabolism Journal.2024; 48(4): 546.     CrossRef
  • Exercise as a Therapeutic Intervention for Chronic Disease Management: A Comprehensive Review
    Maryam Fairag, Saif A Alzahrani, Naif Alshehri, Arjwan O Alamoudi, Yazeed Alkheriji, Omar A Alzahrani, Abdulrahman M Alomari, Yahya A Alzahrani, Shahad Mohammed Alghamdi, Amer Fayraq
    Cureus.2024;[Epub]     CrossRef
  • The anti-inflammatory effects of aerobic exercise training in patients with type 2 diabetes: A systematic review and meta-analysis
    Georgia Papagianni, Chrystalla Panayiotou, Michail Vardas, Nikolaos Balaskas, Constantinos Antonopoulos, Dimitrios Tachmatzidis, Triantafyllos Didangelos, Vaia Lambadiari, Nikolaos P.E. Kadoglou
    Cytokine.2023; 164: 156157.     CrossRef
  • Glucose Control in Korean Patients with Type 2 Diabetes Mellitus according to Body Mass Index
    Ye-lim Shin, Heesoh Yoo, Joo Young Hong, Jooeun Kim, Kyung-do Han, Kyu-Na Lee, Yang-Hyun Kim
    Journal of Obesity & Metabolic Syndrome.2023; 32(1): 55.     CrossRef
  • Exercise therapy for diabetes mellitus
    Chaiho Jeong, Tae-Seo Sohn
    Journal of the Korean Medical Association.2023; 66(7): 427.     CrossRef
  • Effects of an evidence‐based nursing intervention on prevention of anxiety and depression in the postpartum period
    Jun Meng, Junying Du, Xiaoli Diao, Yingxia Zou
    Stress and Health.2022; 38(3): 435.     CrossRef
  • Effect of exercise intervention dosage on reducing visceral adipose tissue: a systematic review and network meta-analysis of randomized controlled trials
    Yu-Hsuan Chang, Hui-Ying Yang, Shiow-Ching Shun
    International Journal of Obesity.2021; 45(5): 982.     CrossRef
  • Development and validation of the type 2 diabetes mellitus 10-year risk score prediction models from survey data
    Gregor Stiglic, Fei Wang, Aziz Sheikh, Leona Cilar
    Primary Care Diabetes.2021; 15(4): 699.     CrossRef
  • Pioglitazone for NAFLD Patients With Prediabetes or Type 2 Diabetes Mellitus: A Meta-Analysis
    Jingxuan Lian, Jianfang Fu
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Exercise Training: The Holistic Approach in Cardiovascular Prevention
    Francesco Giallauria, Teresa Strisciuglio, Gianluigi Cuomo, Anna Di Lorenzo, Andrea D’Angelo, Mario Volpicelli, Raffaele Izzo, Maria Virginia Manzi, Emanuele Barbato, Carmine Morisco
    High Blood Pressure & Cardiovascular Prevention.2021; 28(6): 561.     CrossRef
  • Effect of chronic High Intensity Interval Training on glycosylated haemoglobin in people with type 2 diabetes: a meta-analysis
    María Cristina Arrieta-Leandro, Jessenia Hernández-Elizondo, Judith Jiménez-Díaz
    Human Movement.2021; 24(1): 32.     CrossRef
  • Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
    Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
  • Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
    Kyung-Soo Kim, Byung-Wan Lee
    Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef
  • Factors Influencing Glycemic Control among Type 2 Diabetes Mellitus Patients: The Sixth Korea National Health and Nutrition Examination Survey (2013~2015)
    Mee Ock Gu
    Korean Journal of Adult Nursing.2019; 31(3): 235.     CrossRef
Epidemiology
Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults
Jieun Lee, Young Ah Lee, Jae Hyun Kim, Seong Yong Lee, Choong Ho Shin, Sei Won Yang
Diabetes Metab J. 2019;43(2):174-182.   Published online November 2, 2018
DOI: https://doi.org/10.4093/dmj.2018.0046
  • 11,158 View
  • 95 Download
  • 13 Web of Science
  • 15 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Glycosylated hemoglobin (HbA1c) has been recommended as a diagnostic test for prediabetes and diabetes. Here, we evaluated the level of agreement between diagnoses based on fasting plasma glucose (FPG) versus HbA1c levels and determined optimal HbA1c cutoff values for these diseases in youth and young adults.

Methods

The study included 7,332 subjects (n=4,129, aged 10 to 19 years in youth group; and n=3,203 aged 20 to 29 years in young adult group) from the 2011 to 2016 Korea National Health and Nutrition Examination Survey. Prediabetes and diabetes were defined as 100 to 125 mg/dL (impaired fasting glucose [IFG]) and ≥126 mg/dL for FPG (diabetes mellitus [DM] by FPG [DMFPG]), and 5.7% to 6.4% and ≥6.5% for HbA1c, respectively.

Results

In the youth group, 32.5% with IFG had an HbA1c level of 5.7% to 6.4%, and 72.2% with DMFPG had an HbA1c ≥6.5%. In the young adult group, 27.5% with IFG had an HbA1c level of 5.7% to 6.4%, and 66.6% with DMFPG had an HbA1c ≥6.5%. Kappa coefficients for agreement between the FPG and HbA1c results were 0.12 for the youth group and 0.19 for the young adult group. In receiver operating characteristic curve analysis, the optimal HbA1c cutoff for IFG and DMFPG were 5.6% and 5.9% in youths and 5.5% and 5.8% in young adults, respectively.

Conclusion

Usefulness of HbA1c for diagnosis of IFG and DMFPG in Koreans aged <30 years remains to be determined due to discrepancies between the results of glucose- and HbA1c-based tests. Additional testing might be warranted at lower HbA1c levels to detect IFG and DMFPG in this age group.

Citations

Citations to this article as recorded by  
  • Validity of hemoglobin A1C for screening prediabetes and diabetes in the Iranian population: analysis of National surveillance data
    Mona Talaschian, Samaneh Asgari, Maryam Tohidi, Fereidoun Azizi, Korosh Etemad, Farzad Hadaegh, Davood Khalili
    Scientific Reports.2026;[Epub]     CrossRef
  • Clinical utility of glycated albumin and 1,5-anhydroglucitol in the screening and prediction of diabetes: A multi-center study
    Kam-Ching Ku, Junda Zhong, Erfei Song, Carol Ho-Yi Fong, Karen Siu-Ling Lam, Aimin Xu, Chi-Ho Lee, Chloe Yu-Yan Cheung
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Artificial intelligence-based multiclass diabetes risk stratification for big data embedded with explainability: From machine learning to attention models
    Ekta Tiwari, Siddharth Gupta, Anudeep Pavulla, Mustafa Al-Maini, Rajesh Singh, Esma R. Isenovic, Sumit Chaudhary, John L. Laird, Laura Mantella, Amer M. Johri, Luca Saba, Jasjit S. Suri
    Biomedical Signal Processing and Control.2025; 106: 107672.     CrossRef
  • Lower Dietary Magnesium Is Associated with a Higher Hemoglobin Glycation Index in the National Health and Nutrition Examination Survey
    Juan Chen, Song Lin, Xingzhou Wang, Xiwei Wang, Pengxia Gao
    Biological Trace Element Research.2024; 202(3): 878.     CrossRef
  • Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis
    So Yon Jun, Sooyoung Cho, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Seung Yong Jeong, Kyu Joo Park, Aesun Shin
    Cancer Medicine.2024;[Epub]     CrossRef
  • Prevalence and clinical correlates of impaired fasting blood glucose in children and adolescents with depressive disorder and relationship with triglyceride and high-density lipoprotein ratio
    Zhiwei Liu, Liang Sun, Feng Sun, Shu Cui, Yulong Zhang, Juan Wang, Zhaokun Zhang, Longlong Sun, Rongchun Yang, Gaofeng Yao, Yun Liu
    Scientific Reports.2024;[Epub]     CrossRef
  • Associations between HbA1c-derived estimated average glucose and fasting plasma glucose in patients with normal and abnormal hemoglobin patterns
    Wilaiwan Sriwimol, Phattanapong Choosongsang, Pensiri Choosongsang, Warakorn Petkliang, Pittaya Treerut
    Scandinavian Journal of Clinical and Laboratory Investigation.2022; 82(3): 192.     CrossRef
  • Increasing prevalence of fasting hyperglycemia in adolescents aged 10–18 years and its relationship with metabolic indicators: the Korea National Health and Nutrition Examination Study (KNHANES), 2007–2018
    Seung Eun Yoo, Ji Hyen Lee, Jung Won Lee, Hye Sook Park, Hye Ah Lee, Hae Soon Kim
    Annals of Pediatric Endocrinology & Metabolism.2022; 27(1): 60.     CrossRef
  • Differences in Clinical Indicators of Diabetes, Hypertension, and Dyslipidemia Among Workers Who Worked Long Hours and Shift Work
    EunKyo Kang
    Workplace Health & Safety.2021; 69(6): 268.     CrossRef
  • Practice Patterns in the Acceptance of Medically Complex Living Kidney Donors with Obesity, Hypertension, Family History of Kidney Disease, or Donor-Recipient Age Discrepancy
    Ziad Arabi, Muhammad Bukhari, Abdullah Hamad, Abdulrahman Altheaby, Saleh Kaysi
    Avicenna Journal of Medicine.2021; 11(04): 172.     CrossRef
  • Endocrine comorbidities of pediatric obesity
    Jieun Lee, Jae Hyun Kim
    Clinical and Experimental Pediatrics.2021; 64(12): 619.     CrossRef
  • Association between handgrip strength and cardiovascular risk factors among Korean adolescents
    Kyoung Kon Kim, Kyu Rae Lee, In Cheol Hwang
    Journal of Pediatric Endocrinology and Metabolism.2020; 33(9): 1213.     CrossRef
  • Hypertriglyceridemia is associated with long-term risk of cardiovascular events and specific comorbidity in very high-risk hypertensive patients
    O. Ya. Korolyuk, O. M. Radchenko
    The Ukrainian Biochemical Journal.2020; 92(2): 8.     CrossRef
  • The Effect of Bariatric Surgery on Weight Loss and Metabolic Changes in Adults with Obesity
    Stanisław Głuszek, Arkadiusz Bociek, Edyta Suliga, Jarosław Matykiewicz, Magdalena Kołomańska, Piotr Bryk, Przemysław Znamirowski, Łukasz Nawacki, Martyna Głuszek-Osuch, Iwona Wawrzycka, Dorota Kozieł
    International Journal of Environmental Research and Public Health.2020; 17(15): 5342.     CrossRef
  • Peculiarities of Clinical Presentations and Long–Term Complications in Patients with Coronary Artery Disease and Metabolic Syndrome, depending on their Serum Triglyceride Levels
    O. Ya. Korolyuk
    Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2020; 5(1): 125.     CrossRef
Complications
Cardiovascular Autonomic Neuropathy Predicts Higher HbA1c Variability in Subjects with Type 2 Diabetes Mellitus
Yeoree Yang, Eun-Young Lee, Jae-Hyoung Cho, Yong-Moon Park, Seung-Hyun Ko, Kun-Ho Yoon, Moo-Il Kang, Bong-Yun Cha, Seung-Hwan Lee
Diabetes Metab J. 2018;42(6):496-512.   Published online September 28, 2018
DOI: https://doi.org/10.4093/dmj.2018.0026
  • 7,848 View
  • 54 Download
  • 11 Web of Science
  • 10 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

This study aimed to investigate the association between the presence and severity of cardiovascular autonomic neuropathy (CAN) and development of long-term glucose fluctuation in subjects with type 2 diabetes mellitus.

Methods

In this retrospective cohort study, subjects with type 2 diabetes mellitus who received cardiovascular autonomic reflex tests (CARTs) at baseline and at least 4-year of follow-up with ≥6 measures of glycosylated hemoglobin (HbA1c) were included. The severity of CAN was categorized as normal, early, or severe CAN according to the CARTs score. HbA1c variability was measured as the standard deviation (SD), coefficient of variation, and adjusted SD of serial HbA1c measurements.

Results

A total of 681 subjects were analyzed (294 normal, 318 early, and 69 severe CAN). The HbA1c variability index values showed a positive relationship with the severity of CAN. Multivariable logistic regression analysis showed that CAN was significantly associated with the risk of developing higher HbA1c variability (SD) after adjusting for age, sex, body mass index, diabetes duration, mean HbA1c, heart rate, glomerular filtration rate, diabetic retinopathy, coronary artery disease, insulin use, and anti-hypertensive medication (early CAN: odds ratio [OR], 1.65; 95% confidence interval [CI], 1.12 to 2.43) (severe CAN: OR, 2.86; 95% CI, 1.47 to 5.56). This association was more prominent in subjects who had a longer duration of diabetes (>10 years) and lower mean HbA1c (<7%).

Conclusion

CAN is an independent risk factor for future higher HbA1c variability in subjects with type 2 diabetes mellitus. Tailored therapy for stabilizing glucose fluctuation should be emphasized in subjects with CAN.

Citations

Citations to this article as recorded by  
  • Healthcare workers’ knowledge, attitudes, and practices regarding diabetic cardiovascular autonomic neuropathy
    Hong Zhu, Yanzhe Wu, Yalong Jiang, Li Wu, Wen Wang, Guang Zhu, Changchun Cao, Ji Wu
    Scientific Reports.2025;[Epub]     CrossRef
  • Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions
    Jingyang Chen, Dong Yin, Kefei Dou
    Cardiovascular Diabetology.2023;[Epub]     CrossRef
  • Long-Term Risk of Cardiovascular Disease Among Type 2 Diabetes Patients According to Average and Visit-to-Visit Variations of HbA1c Levels During the First 3 Years of Diabetes Diagnosis
    Hyunah Kim, Da Young Jung, Seung-Hwan Lee, Jae-Hyoung Cho, Hyeon Woo Yim, Hun-Sung Kim
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
  • Factors Associated with Diabetic Complication Index among Type 2 Diabetes Patients: Focusing on Regular Outpatient Follow-up and HbA1c Variability
    Haejung Lee, Gaeun Park, Ah Reum Khang
    Asian Nursing Research.2023; 17(5): 259.     CrossRef
  • The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study
    Natsumi Matsuoka-Uchiyama, Haruhito A. Uchida, Shugo Okamoto, Yasuhiro Onishi, Katsuyoshi Katayama, Mariko Tsuchida-Nishiwaki, Hidemi Takeuchi, Rika Takemoto, Yoshiko Hada, Ryoko Umebayashi, Naoko Kurooka, Kenji Tsuji, Jun Eguchi, Hirofumi Nakajima, Kenic
    Journal of Diabetes Research.2022; 2022: 1.     CrossRef
  • Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review
    Xiaochun Zhang, Xue Yang, Bao Sun, Chunsheng Zhu
    Communications Biology.2021;[Epub]     CrossRef
  • Assessment of Functions of the Autonomic Nervous System in the Elderly with Different Comorbid Factors
    Sushma S., Medha Y. Rao, Shaikh Mohammed Aslam
    Journal of Neurosciences in Rural Practice.2020; 12: 80.     CrossRef
  • Prognostic irrelevance of plaque vulnerability following plaque sealing in high-risk patients with type 2 diabetes: an optical coherence tomography study
    Rosalia Dettori, Andrea Milzi, Kathrin Burgmaier, Mohammad Almalla, Martin Hellmich, Nikolaus Marx, Sebastian Reith, Mathias Burgmaier
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • HbA1C Variability Is Strongly Associated With the Severity of Cardiovascular Autonomic Neuropathy in Patients With Type 2 Diabetes After Longer Diabetes Duration
    Yun-Ru Lai, Chih-Cheng Huang, Wen-Chan Chiu, Rue-Tsuan Liu, Nai-Wen Tsai, Hung-Chen Wang, Wei-Che Lin, Ben-Chung Cheng, Yu-Jih Su, Chih-Min Su, Sheng-Yuan Hsiao, Pei-Wen Wang, Jung-Fu Chen, Cheng-Hsien Lu
    Frontiers in Neuroscience.2019;[Epub]     CrossRef
  • Polyscore of Non-invasive Cardiac Risk Factors
    Alexander Steger, Alexander Müller, Petra Barthel, Michael Dommasch, Katharina Maria Huster, Katerina Hnatkova, Daniel Sinnecker, Alexander Hapfelmeier, Marek Malik, Georg Schmidt
    Frontiers in Physiology.2019;[Epub]     CrossRef
Epidemiology
Article image
Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
Jong Chul Won, Jae Hyuk Lee, Jae Hyeon Kim, Eun Seok Kang, Kyu Chang Won, Dae Jung Kim, Moon-Kyu Lee
Diabetes Metab J. 2018;42(5):415-424.   Published online August 9, 2018
DOI: https://doi.org/10.4093/dmj.2018.0017
  • 17,714 View
  • 107 Download
  • 78 Web of Science
  • 81 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

This report presents the recent prevalence and comorbidities related to diabetes in Korea by analyzing the nationally representative data.

Methods

Using data from the Korea National Health and Nutrition Examination Survey for 2013 to 2014, the percentages and the total number of subjects over the age of 30 years with diabetes and prediabetes were estimated and applied to the National Population Census in 2014. Diagnosis of diabetes was based on fasting plasma glucose (≥126 mg/dL), current taking of antidiabetic medication, history of previous diabetes, or glycosylated hemoglobin (HbA1c) ≥6.5%. Impaired fasting glucose (IFG) was defined by fasting plasma glucose in the range of 100 to 125 mg/dL among those without diabetes.

Results

About 4.8 million (13.7%) Korean adults (≥30 years old) had diabetes, and about 8.3 million (24.8%) Korean adults had IFG. However, 29.3% of the subjects with diabetes are not aware of their condition. Of the subjects with diabetes, 48.6% and 54.7% were obese and hypertensive, respectively, and 31.6% had hypercholesterolemia. Although most subjects with diabetes (89.1%) were under medical treatment, and mostly being treated with oral hypoglycemic agents (80.2%), 10.8% have remained untreated. With respect to overall glycemic control, 43.5% reached the target of HbA1c <7%, whereas 23.3% reached the target when the standard was set to HbA1c <6.5%, according to the Korean Diabetes Association guideline.

Conclusion

Diabetes is a major public health threat in Korea, but a significant proportion of adults were not controlling their illness. We need comprehensive approaches to overcome the upcoming diabetes-related disease burden in Korea.

Citations

Citations to this article as recorded by  
  • Low socioeconomic status as a major risk factor for early-onset type 2 diabetes with limited lifestyle mediation: Cross-Sectional evidence from US and South Korean populations
    Siying Liu, Tingting Liu, Yanli Cao, Cihang Lu, Jiahui Guo, Jie Li, Qiqiang Guo, Jing Zhang, Yongze Li
    Social Science & Medicine.2026; 391: 118939.     CrossRef
  • Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia
    Joonyub Lee, Kun-Ho Yoon
    Endocrinology and Metabolism.2025; 40(1): 57.     CrossRef
  • Association of Systolic and Diastolic Blood Pressure with the Risk of End-Stage Renal Disease in Older Type 2 Diabetes Mellitus Patients without Cardiovascular Disease: A Nationwide Population-Based Study
    Sangmo Hong, Kyungdo Han, Kye-Yeung Park, Chang Beom Lee, Dong Sun Kim, Jung Hwan Park, Sung Hoon Yu
    Diabetes & Metabolism Journal.2025; 49(6): 1308.     CrossRef
  • Associations between diabetes mellitus and drinking patterns in Korean adults by sex: insights from the Korea National health and nutrition examination survey 2013–2018
    Hyunsoo Yoo, Yoon-Seok Choi, Young-Mo Yang
    Diabetology & Metabolic Syndrome.2025;[Epub]     CrossRef
  • Impact of anaerobic zone on biodegradation of micropollutants: Comparison of micropollutants’ removal efficiencies in lab-scale anaerobic bioreactor and in full-scale anaerobic zone
    Jingyeong Shin, Sungman Lee, Jihea Lee, Heejong Son, Yunho Lee, Young Mo Kim
    Chemical Engineering Journal.2024; 481: 148356.     CrossRef
  • The Risk of the Aggravation of Diabetic Foot According to Air Quality Factors in the Republic of Korea: A Nationwide Population-Based Study
    Saintpee Kim, Sungho Won, Young Yi
    International Journal of Environmental Research and Public Health.2024; 21(6): 775.     CrossRef
  • Methionine sulfoxide reductase B2 protects against cardiac complications in diabetes mellitus
    Seung Hee Lee, Suyeon Cho, Jong Youl Lee, Ji Yeon Kim, Suji Kim, Myoungho Jeong, Jung Yeon Hong, Geun-Young Kim, Seung Woo Lee, Eunmi Kim, Jihwa Kim, Jee Woong Kim, John Hwa, Won-Ho Kim
    Diabetology & Metabolic Syndrome.2024;[Epub]     CrossRef
  • Association of early-onset diabetes with socioeconomic, and health factors: a matched case-control study controlling for age, gender, and BMI
    Jun-Hao Shen, In-Whi Hwang, Ju-Pil Choe, Soo-Ji Hwang, Joon-Young Kim, Jung-Min Lee
    Journal of Diabetes & Metabolic Disorders.2024;[Epub]     CrossRef
  • Clinical traits and systemic risks of familial diabetes mellitus according to age of onset and quantity: an analysis of data from the community-based KoGES cohort study
    Ju-Yeun Lee, Kyungsik Kim, Sangjun Lee, Woo Ju An, Sue K. Park
    Epidemiology and Health.2023; 45: e2023029.     CrossRef
  • Diabetes self-management education
    Ibironke Cecilia OJO, Elizabeth Olufunmilayo OJO, Simeo Kayode OLUBIYI
    Journal of Integrative Nursing.2023; 5(2): 93.     CrossRef
  • The prevalence and predictors of pre-diabetes and diabetes among adults 40–70 years in Kharameh cohort study: A population-based study in Fars province, south of Iran
    Masoumeh Ghoddusi Johari, Kimia Jokari, Alireza Mirahmadizadeh, Mozhgan Seif, Abbas Rezaianzadeh
    Journal of Diabetes & Metabolic Disorders.2022; 21(1): 85.     CrossRef
  • Concept and Proof of the Lifelog Bigdata Platform for Digital Healthcare and Precision Medicine on the Cloud
    Kyu Hee Lee, Erdenebayar Urtnasan, Sangwon Hwang, Hee Young Lee, Jung Hun Lee, Sang Baek Koh, Hyun Youk
    Yonsei Medical Journal.2022; 63(Suppl): S84.     CrossRef
  • The Impact of Diabetes on Vascular Disease: Progress from the Perspective of Epidemics and Treatments
    Runyang Liu, Lihua Li, Chen Shao, Honghua Cai, Zhongqun Wang, Pawel Kleczynski
    Journal of Diabetes Research.2022; 2022: 1.     CrossRef
  • Incidence and Predisposing Factors of Postoperative Infection after Rhinoplasty: A Single Surgeon’s 16-Year Experience with 2630 Cases in an East Asian Population
    Khanh Ngoc Tran, Yong Ju Jang
    Plastic & Reconstructive Surgery.2022; 150(1): 51e.     CrossRef
  • Predictors for successful weight reduction during treatment with Dapagliflozin among patients with type 2 diabetes mellitus in primary care
    Youn Huh, Young Sik Kim
    BMC Primary Care.2022;[Epub]     CrossRef
  • Skin accumulation of advanced glycation end products and cardiovascular risk in Korean patients with type 2 diabetes mellitus
    Lee-Seoul Choi, Kainat Ahmed, Young-Seol Kim, Jung-Eun Yim
    Heliyon.2022; 8(6): e09571.     CrossRef
  • Health-related Quality of Life Instrument With 8 Items for Use in Patients With Type 2 Diabetes Mellitus: A Validation Study in Korea
    Juyoung Kim, Hyeon-Jeong Lee, Min-Woo Jo
    Journal of Preventive Medicine and Public Health.2022; 55(3): 234.     CrossRef
  • Factors Influencing the Utilization of Diabetes Complication Tests Under the COVID-19 Pandemic: Machine Learning Approach
    Haewon Byeon
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus
    Yongin Cho, Hye-Sun Park, Byung Wook Huh, Seong Ha Seo, Da Hea Seo, Seong Hee Ahn, Seongbin Hong, Young Ju Suh, So Hun Kim
    Diabetes & Metabolism.2022; 48(6): 101389.     CrossRef
  • Prevalence and Early Prediction of Diabetes Using Machine Learning in North Kashmir: A Case Study of District Bandipora
    Salliah Shafi Bhat, Venkatesan Selvam, Gufran Ahmad Ansari, Mohd Dilshad Ansari, Md Habibur Rahman, Mamoon Rashid
    Computational Intelligence and Neuroscience.2022; 2022: 1.     CrossRef
  • Association between Nighttime Work and HbA1c Levels in South Korea
    Yeon-Suk Lee, Jae Hong Joo, Eun-Cheol Park
    Healthcare.2022; 10(10): 1977.     CrossRef
  • Differences in health behavior and nutrient intake status between diabetes-aware and unaware Korean adults based on the Korea national health and nutrition examination survey 2016–18 data: A cross-sectional study
    Anshul Sharma, Chen Lulu, Kee-Ho Song, Hae-Jeung Lee
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Screening for Prediabetes and Diabetes in Korean Nonpregnant Adults: A Position Statement of the Korean Diabetes Association, 2022
    Kyung Ae Lee, Dae Jung Kim, Kyungdo Han, Suk Chon, Min Kyong Moon
    Diabetes & Metabolism Journal.2022; 46(6): 819.     CrossRef
  • Sex differences in sarcopenia and frailty among community‐dwelling Korean older adults with diabetes: The Korean Frailty and Aging Cohort Study
    Sunyoung Kang, Tae Jung Oh, Be Long Cho, Yong Soon Park, Eun Roh, Hyeon Ju Kim, Sam‐Gyu Lee, Bong Jo Kim, Miji Kim, Chang Won Won, Hak Chul Jang
    Journal of Diabetes Investigation.2021; 12(2): 155.     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10-year longitudinal cohort study
    Wonjin Kim, Taehwa Go, Dae Ryong Kang, Eun Jig Lee, Ji Hye Huh
    Journal of Diabetes and its Complications.2021; 35(1): 107760.     CrossRef
  • East Asian diet‐mimicking diet plan based on the Mediterranean diet and the Dietary Approaches to Stop Hypertension diet in adults with type 2 diabetes: A randomized controlled trial
    Sang‐Man Jin, Jiyeon Ahn, Jiyun Park, Kyu Yeon Hur, Jae Hyeon Kim, Moon‐Kyu Lee
    Journal of Diabetes Investigation.2021; 12(3): 357.     CrossRef
  • Status of Diabetic Neuropathy in Korea: A National Health Insurance Service-National Sample Cohort Analysis (2006 to 2015)
    Seong-Su Moon, Chong Hwa Kim, Seon Mee Kang, Eun Sook Kim, Tae Jung Oh, Jae-Seung Yun, Ho Chan Cho, Dae Jung Kim, Tae Sun Park
    Diabetes & Metabolism Journal.2021; 45(1): 115.     CrossRef
  • Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
    Chan-Hee Jung, Jang Won Son, Shinae Kang, Won Jun Kim, Hun-Sung Kim, Hae Soon Kim, Mihae Seo, Hye-Jung Shin, Seong-Su Lee, Su Jin Jeong, Yongin Cho, Seung Jin Han, Hyang Mi Jang, Mira Rho, Shinbi Lee, Mihyun Koo, Been Yoo, Jung-Wha Moon, Hye Young Lee, Ja
    Diabetes & Metabolism Journal.2021; 45(1): 1.     CrossRef
  • Considering serum alanine aminotransferase and gamma-glutamyltransferase levels together strengthen the prediction of impaired fasting glucose risk: a cross-sectional and longitudinal study
    Ji Hye Jeong, Susie Jung, Kyu-Nam Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • The Associations Between Vitamin D Receptor BsmI and ApaI Polymorphisms and Obesity in Korean Patients with Type 2 Diabetes Mellitus
    Sang Won Nam, Jinwoo Choi, Hyun Jeong Jeon, Tae Keun Oh, Dong-Hwa Lee
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 557.     CrossRef
  • Association between living alone and incident type 2 diabetes among middle-aged individuals in Korea: a nationwide cohort study
    Ga Eun Nam, Wonsock Kim, Kyungdo Han, Jin-Hyung Jung, Byoungduck Han, Jinwook Kim, Nan Hee Kim, Kyung Mook Choi, Kyung Hwan Cho, Yong Gyu Park, Seon Mee Kim
    Scientific Reports.2021;[Epub]     CrossRef
  • Retracted: Western pacific consensus proposals for management of prediabetes

    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Blood glucose levels and bodyweight change after dapagliflozin administration
    Hyunah Kim, Seung‐Hwan Lee, Hyunyong Lee, Hyeon Woo Yim, Jae‐Hyoung Cho, Kun‐Ho Yoon, Hun‐Sung Kim
    Journal of Diabetes Investigation.2021; 12(9): 1594.     CrossRef
  • Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data
    Sung-Hee Oh, Hyemin Ku, Kang Seo Park
    BMC Public Health.2021;[Epub]     CrossRef
  • Prediction of Type 2 Diabetes Based on Machine Learning Algorithm
    Henock M. Deberneh, Intaek Kim
    International Journal of Environmental Research and Public Health.2021; 18(6): 3317.     CrossRef
  • Development of a clinical risk score for incident diabetes: A 10‐year prospective cohort study
    Tae Jung Oh, Jae Hoon Moon, Sung Hee Choi, Young Min Cho, Kyong Soo Park, Nam H Cho, Hak Chul Jang
    Journal of Diabetes Investigation.2021; 12(4): 610.     CrossRef
  • New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors
    Chan-Hee Jung
    Endocrinology and Metabolism.2021; 36(2): 339.     CrossRef
  • Treatment Patterns of Type 2 Diabetes Assessed Using a Common Data Model Based on Electronic Health Records of 2000–2019
    Kyung Ae Lee, Heung Yong Jin, Yu Ji Kim, Yong-Jin Im, Eun-Young Kim, Tae Sun Park
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • No influence of hepatic steatosis on the 3‐year outcomes of patients with quiescent chronic hepatitis B
    Jin Won Chang, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
    Journal of Viral Hepatitis.2021; 28(11): 1545.     CrossRef
  • Occupational Noise Exposure and Incidence of High Fasting Blood Glucose: A 3-Year, Multicenter, Retrospective Study
    Seunghan Kim, Byungyoon Yun, Seunghyun Lee, Changyoung Kim, Juho Sim, Ara Cho, Yeonsuh Oh, Jiho Lee, Jinha Yoon
    International Journal of Environmental Research and Public Health.2021; 18(17): 9388.     CrossRef
  • Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need
    Ye Seul Yang, Kyungdo Han, Tae Seo Sohn, Nam Hoon Kim
    The Korean Journal of Internal Medicine.2021; 36(5): 1049.     CrossRef
  • Blood Pressure and Cardiovascular Disease in Older Patients With Diabetes: Retrospective Cohort Study
    Sangmo Hong, Jung Hwan Park, Kyungdo Han, Chang Beom Lee, Dong Sun Kim, Sung Hoon Yu
    Journal of the American Heart Association.2021;[Epub]     CrossRef
  • Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check‐up clinic population
    Kyung A Kang, Dae Won Jun, Mi Sung Kim, Heon‐Ju Kwon, Mindie H. Nguyen
    Alimentary Pharmacology & Therapeutics.2020; 51(3): 388.     CrossRef
  • The Effects of Bariatric Surgery on Type 2 Diabetes in Asian Populations: a Meta-analysis of Randomized Controlled Trials
    Jin Hwa Kim, Jung-Soo Pyo, Won Jin Cho, Sang Yong Kim
    Obesity Surgery.2020; 30(3): 910.     CrossRef
  • Opposite Effects of Work-Related Physical Activity and Leisure-Time Physical Activity on the Risk of Diabetes in Korean Adults
    Hyun Sook Oh
    International Journal of Environmental Research and Public Health.2020; 17(16): 5812.     CrossRef
  • Middle-aged men with type 2 diabetes as potential candidates for pancreatic cancer screening: a 10-year nationwide population-based cohort study
    Dong-Hoe Koo, Kyung-Do Han, Hong Joo Kim, Cheol-Young Park
    Acta Diabetologica.2020; 57(2): 197.     CrossRef
  • Efficacy and safety of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in Asia Pacific insulin‐naïve people with type 2 diabetes: The EDITION AP randomized controlled trial
    Linong Ji, Eun Seok Kang, XiaoLin Dong, Ling Li, GuoYue Yuan, Shuhua Shang, Elisabeth Niemoeller
    Diabetes, Obesity and Metabolism.2020; 22(4): 612.     CrossRef
  • Non-Exercise Based Estimation of Cardiorespiratory Fitness Mediates Associations between Comorbidities and Health-Related Quality of Life in Older Korean Adults with Diabetes
    Inhwan Lee, Shinuk Kim, Hyunsik Kang
    International Journal of Environmental Research and Public Health.2020; 17(4): 1164.     CrossRef
  • γ-Linolenic Acid versus α-Lipoic Acid for Treating Painful Diabetic Neuropathy in Adults: A 12-Week, Double-Placebo, Randomized, Noninferiority Trial
    Jong Chul Won, Hyuk-Sang Kwon, Seong-Su Moon, Sung Wan Chun, Chong Hwa Kim, Ie Byung Park, In Joo Kim, Jihyun Lee, Bong Yun Cha, Tae Sun Park
    Diabetes & Metabolism Journal.2020; 44(4): 542.     CrossRef
  • Circulating myokine levels in different stages of glucose intolerance
    Kahui Park, Chul Woo Ahn, Jong Suk Park, YuSik Kim, Ji Sun Nam
    Medicine.2020; 99(8): e19235.     CrossRef
  • Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults
    Eun-Jung Rhee, Hyemi Kwon, Se Eun Park, Kyung-Do Han, Yong-Gyu Park, Yang-Hyun Kim, Won-Young Lee
    Diabetes & Metabolism Journal.2020; 44(4): 592.     CrossRef
  • The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
    Ji Hyun Lee, Kyungdo Han, Ji Hye Huh
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Glucose-Lowering Effect of Home-Delivered Therapeutic Meals in Patients with Type 2 Diabetes
    Jong Han Choi, Se Hee Min, Kyeong Hye Lim, Uoon Jeong Shin, Min-Seon Kim
    The Journal of Korean Diabetes.2020; 21(1): 46.     CrossRef
  • Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study
    Min Cheol Chang, Jong-Moon Hwang, Jae-Han Jeon, Sang Gyu Kwak, Donghwi Park, Jun Sung Moon
    Endocrinology and Metabolism.2020; 35(3): 595.     CrossRef
  • Gender differences in adverse event reports associated with antidiabetic drugs
    Kyung-In Joung, Gyu-Won Jung, Han-Heui Park, Hyesung Lee, So-Hee Park, Ju-Young Shin
    Scientific Reports.2020;[Epub]     CrossRef
  • Relative fat mass at baseline and its early change may be a predictor of incident nonalcoholic fatty liver disease
    Hwi Young Kim, Su Jung Baik, Hye Ah Lee, Byoung Kwon Lee, Hye Sun Lee, Tae Hun Kim, Kwon Yoo
    Scientific Reports.2020;[Epub]     CrossRef
  • Peripheral Arterial Stiffness Increases the Risk of Progression of Renal Disease in Type 2 Diabetic Patients
    Tae Hoon Lim, Seung Min Chung, Dong Sung Lee, Se Ra Choi, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Frontiers in Medicine.2020;[Epub]     CrossRef
  • Association of Urinary Polycyclic Aromatic Hydrocarbons and Diabetes in Korean Adults: Data from the Korean National Environmental Health Survey Cycle 2 (2012–2014)


    Yon Ju Nam, Shin-Hye Kim
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 3993.     CrossRef
  • Present and Future of Digital Health in Diabetes and Metabolic Disease
    Sang Youl Rhee, Chiweon Kim, Dong Wook Shin, Steven R. Steinhubl
    Diabetes & Metabolism Journal.2020; 44(6): 819.     CrossRef
  • Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea
    Min-Jeong Lee, Kyoung Hwa Ha, Dae Jung Kim, Inwhee Park
    Diabetes & Metabolism Journal.2020; 44(6): 933.     CrossRef
  • An evaluation of the impact of aggressive diabetes and hypertension management on chronic kidney diseases at the population level: a simulation analysis
    John Pastor Ansah, Shawn Tan Yi Wei, Tessa Lui Shi Min
    System Dynamics Review.2020; 36(4): 497.     CrossRef
  • Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors
    Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung Mo Nam, Eun Seok Kang
    Diabetes Care.2019; 42(11): 2057.     CrossRef
  • Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study
    Jee Hee Yoo, Yun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, Yu Mi Kang, Chang Hee Jung, Joong-Yeol Park, Woo Je Lee
    Diabetes Therapy.2019; 10(4): 1453.     CrossRef
  • Diabetes and the Risk of Infection: A National Cohort Study
    Eun Jin Kim, Kyoung Hwa Ha, Dae Jung Kim, Young Hwa Choi
    Diabetes & Metabolism Journal.2019; 43(6): 804.     CrossRef
  • Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
    Da Hea Seo, Shinae Kang, Yong-ho Lee, Jung Yoon Ha, Jong Suk Park, Byoung-Wan Lee, Eun Seok Kang, Chul Woo Ahn, Bong-Soo Cha
    Endocrinology and Metabolism.2019; 34(3): 282.     CrossRef
  • Effects of Blood Pressure and Glucose Levels on Visual Acuity
    Dae-Jong Kim
    Journal of Korean Ophthalmic Optics Society.2019; 24(2): 181.     CrossRef
  • An evaluation of the impact of aggressive hypertension, diabetes and smoking cessation management on CVD outcomes at the population level: a dynamic simulation analysis
    John Pastor Ansah, Ryan Leung Hoe Inn, Salman Ahmad
    BMC Public Health.2019;[Epub]     CrossRef
  • Retracted : Angelica polysaccharide alleviates TNF‐α‐induced MIN6 cell damage a through the up‐regulation microRNA‐143
    Yingying Zhao, Chuanqian Liu, Xueting Zhang, Xipeng Yan
    BioFactors.2019;[Epub]     CrossRef
  • Poor Control of Blood Glucose, Lifestyle, and Cardiometabolic Parameters in Younger Adult Patients with Type 2 Diabetes Mellitus
    Ga Eun Nam, Byoungduck Han, Chae Lin Joo, Seo Young Kang, Jisun Lim, Yang-Hyun Kim, Hye Soon Park
    Journal of Clinical Medicine.2019; 8(9): 1405.     CrossRef
  • Frailty and Disability in Diabetes
    Sol-Ji Yoon, Kwang-il Kim
    Annals of Geriatric Medicine and Research.2019; 23(4): 165.     CrossRef
  • A Case Report of Increased Blood Sugar in a Diabetic Patient Treated with Socheongryong-tang
    Youngji Kim, Juyeon Song, Seungcheol Hong, Song-won Park, Hakkyeom Kim, Lib Ahn, Dong-jun Choi
    The Journal of Internal Korean Medicine.2019; 40(5): 929.     CrossRef
  • A comparison of sotagliflozin therapy for diabetes mellitus between week 24 with week 52
    Nie Zhang, Zhi-Qun Gu, Yun-Long Ding, Liu Yang, Mao-Bing Chen, Qi-Han Zheng
    Medicine.2019; 98(47): e17976.     CrossRef
  • 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
    Mee Kyoung Kim, Seung-Hyun Ko, Bo-Yeon Kim, Eun Seok Kang, Junghyun Noh, Soo-Kyung Kim, Seok-O Park, Kyu Yeon Hur, Suk Chon, Min Kyong Moon, Nan-Hee Kim, Sang Yong Kim, Sang Youl Rhee, Kang-Woo Lee, Jae Hyeon Kim, Eun-Jung Rhee, SungWan Chun, Sung Hoon Yu
    Diabetes & Metabolism Journal.2019; 43(4): 398.     CrossRef
  • Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2019;43:582–9)
    Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(6): 909.     CrossRef
  • The Need to Improve the Quality of Diabetes Care in Korea
    Seung Jin Han, Dae Jung Kim
    Journal of Korean Medical Science.2019;[Epub]     CrossRef
  • Letter: Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90–6)
    Bo Kyung Koo
    Diabetes & Metabolism Journal.2019; 43(2): 242.     CrossRef
  • Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
    Hannah Seok, Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
  • Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double‐blind, non‐inferiority trial
    Yonghyun Kim, Eun Seok Kang, Hak Chul Jang, Dong Jun Kim, Taekeun Oh, Eun Sook Kim, Nan‐Hee Kim, Kyung Mook Choi, Sung‐Rae Kim, JiYoung You, Se‐Jin Kim, Moon‐Kyu Lee
    Diabetes, Obesity and Metabolism.2019; 21(3): 631.     CrossRef
  • Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period
    Cheng-Wei Lin, David G Armstrong, Chia-Hung Lin, Pi-Hua Liu, Shih-Yuan Hung, Shu-Ru Lee, Chung-Huei Huang, Yu-Yao Huang
    BMJ Open Diabetes Research & Care.2019; 7(1): e000795.     CrossRef
  • Fifty Years of Compassionate Care and Harmonious Collaboration of the Korean Diabetes Association: The 50th Anniversary of Korean Diabetes Association
    Jong Chul Won, Eun-Jung Rhee, Hyung Joon Yoo
    Diabetes & Metabolism Journal.2018; 42(6): 475.     CrossRef
Complications
Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease
Ji Hye Huh, Minyoung Lee, So Young Park, Jae Hyeon Kim, Byung-Wan Lee
Diabetes Metab J. 2018;42(3):215-223.   Published online May 2, 2018
DOI: https://doi.org/10.4093/dmj.2017.0091
  • 8,391 View
  • 69 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The aim of this study was to investigate which glycemic parameters better reflect urinary N-acetyl-β-D-glucosaminidase (uNAG) abnormality, a marker for renal tubulopathy, in subjects with type 2 diabetes mellitus (T2DM) subjects with normoalbuminuria and a normal estimated glomerular filtration rate (eGFR).

Methods

We classified 1,061 participants with T2DM into two groups according to uNAG level—normal vs. high (>5.8 U/g creatinine)—and measured their biochemical parameters.

Results

Subjects with high uNAG level had significantly higher levels of fasting and stimulated glucose, glycated albumin (GA), and glycosylated hemoglobin (HbA1c) and lower levels of homeostasis model assessment of β-cell compared with subjects with normal uNAG level. Multiple linear regression analyses showed that uNAG was significantly associated with GA (standardized β coefficient [β]=0.213, P=0.016), but not with HbA1c (β=−0.137, P=0.096) or stimulated glucose (β=0.095, P=0.140) after adjusting confounding factors. In receiver operating characteristic analysis, the value of the area under the curve (AUC) for renal tubular injury of GA was significantly higher (AUC=0.634; 95% confidence interval [CI], 0.646 to 0.899) than those for HbA1c (AUC=0.598; 95% CI, 0.553 to 0.640), stimulated glucose (AUC=0.594; 95% CI, 0.552 to 0.636), or fasting glucose (AUC=0.558; 95% CI, 0.515 to 0.600). The optimal GA cutoff point for renal tubular damage was 17.55% (sensitivity 59%, specificity 62%).

Conclusion

GA is a more useful glycation index than HbA1c for reflecting renal tubulopathy in subjects with T2DM with normoalbuminuria and normal eGFR.

Citations

Citations to this article as recorded by  
  • Diagnostic and therapeutic potential of PCSK9 in diabetic tubulopathy: Evidence from observational and experimental studies
    JingJing Quan, Si Li, Bin Yi, Zhijun Huang
    International Immunopharmacology.2026; 168: 115907.     CrossRef
  • Albumin does not induce IL-6 release and toll-like receptor activation in vitro: Role of endotoxin contamination and biochemical modifications
    Margret Paar, Vera H. Fengler, Martina Schweiger, Christine Rossmann, Christoph Nusshold, Martina Mairold, Doris Payerl, Gerhard Cvirn, Karl Oettl
    BBA Advances.2025; 8: 100174.     CrossRef
  • Glucagon-Like Peptide 1 Receptor Agonist Improves Renal Tubular Damage in Mice with Diabetic Kidney Disease
    Ran Li, Dunmin She, Zhengqin Ye, Ping Fang, Guannan Zong, Yong Zhao, Kerong Hu, Liya Zhang, Sha Lei, Keqin Zhang, Ying Xue
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 1331.     CrossRef
  • Use of glycated albumin for the identification of diabetes in subjects from northeast China
    Guo-Yan Li, Hao-Yu Li, Qiang Li
    World Journal of Diabetes.2021; 12(2): 149.     CrossRef
  • Diabetic Kidney Disease, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease: A New Triumvirate?
    Carolina M. Perdomo, Nuria Garcia-Fernandez, Javier Escalada
    Journal of Clinical Medicine.2021; 10(9): 2040.     CrossRef
  • Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transition
    Nitin A. Das, Andrea J. Carpenter, Anthony Belenchia, Annayya R. Aroor, Makoto Noda, Ulrich Siebenlist, Bysani Chandrasekar, Vincent G. DeMarco
    Cellular Signalling.2020; 68: 109506.     CrossRef
  • Glycated Plasma Proteins as More Sensitive Markers for Glycemic Control in Type 1 Diabetes
    Lina Zhang, Qibin Zhang
    PROTEOMICS – Clinical Applications.2020;[Epub]     CrossRef
  • Glycated albumin and its variability: Clinical significance, research progress and overall review
    Dongjun Dai, Yifei Mo, Jian Zhou
    Obesity Medicine.2020; 19: 100256.     CrossRef
  • Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
    Eugene Han, Yongin Cho, Kyung-won Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-wan Lee
    Medicine.2020; 99(33): e21038.     CrossRef
  • Increasing waist circumference is associated with decreased levels of glycated albumin
    Yiting Xu, Xiaojing Ma, Yun Shen, Yufei Wang, Jian Zhou, Yuqian Bao
    Clinica Chimica Acta.2019; 495: 118.     CrossRef
  • Glucometabolic characteristics and higher vascular complication risk in Korean patients with type 2 diabetes with non-albumin proteinuria
    Yongin Cho, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-wan Lee
    Journal of Diabetes and its Complications.2019; 33(8): 585.     CrossRef
  • Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes
    Huanhuan Zhu, Xi Liu, Chengning Zhang, Qing Li, Xiaofei An, Simeng Liu, Lin Wu, Bo Zhang, Yanggang Yuan, Changying Xing
    Journal of Diabetes and its Complications.2019; 33(11): 107419.     CrossRef
Clinical Care/Education
Improvement of Glycosylated Hemoglobin in Patients with Type 2 Diabetes Mellitus under Insulin Treatment by Reimbursement for Self-Monitoring of Blood Glucose
Young Shin Song, Bo Kyung Koo, Sang Wan Kim, Ka Hee Yi, Kichul Shin, Min Kyong Moon
Diabetes Metab J. 2018;42(1):28-42.   Published online September 28, 2017
DOI: https://doi.org/10.4093/dmj.2018.42.1.28
  • 7,980 View
  • 56 Download
  • 7 Web of Science
  • 5 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

In Korea, the costs associated with self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes mellitus (T2DM) under insulin treatment have been reimbursed since November 2015. We investigated whether this new reimbursement program for SMBG has improved the glycemic control in the beneficiaries of this policy.

Methods

Among all adult T2DM patients with ≥3 months of reimbursement (n=854), subjects without any changes in anti-hyperglycemic agents during the study period were selected. The improvement of glycosylated hemoglobin (HbA1c) was defined as an absolute reduction in HbA1c ≥0.6% or an HbA1c level at follow-up <7%.

Results

HbA1c levels significantly decreased from 8.5%±1.3% to 8.2%±1.2% during the follow-up (P<0.001) in all the study subjects (n=409). Among them, 35.5% (n=145) showed a significant improvement in HbA1c. Subjects covered under the Medical Aid system showed a higher prevalence of improvement in HbA1c than those with medical insurance (52.2% vs. 33.3%, respectively, P=0.012). In the improvement group, the baseline HbA1c (P<0.001), fasting C-peptide (P=0.016), and daily dose of insulin/body weight (P=0.024) showed significant negative correlations with the degree of HbA1c change. Multivariate analysis showed that subjects in the Medical Aid system were about 2.5-fold more likely to improve in HbA1c compared to those with medical insurance (odds ratio, 2.459; 95% confidence interval, 1.138 to 5.314; P=0.022).

Conclusion

The reimbursement for SMBG resulted in a significant improvement in HbA1c in T2DM subjects using insulin, which was more prominent in subjects with poor glucose control at baseline or covered under the Medical Aid system.

Citations

Citations to this article as recorded by  
  • Conundrum and chances of diabetes management in the Western Pacific Region: A narrative review
    Yerin Hwang, Hyunmin Lee, Moon‐Kyu Lee
    Journal of Diabetes Investigation.2025; 16(8): 1357.     CrossRef
  • The status of blood glucose monitoring and its influencing factors in Chinese patients with type 2 diabetes initiating premixed insulin: A prospective real-world study
    Si Chen, Jingyi Lu, Danfeng Peng, Fengjing Liu, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou, Weiping Jia
    Diabetes Research and Clinical Practice.2024; 218: 111895.     CrossRef
  • Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
    Tri Juli Edi Tarigan, Adisti Dwijayanti, Susie Setyowati, Melva Louisa
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 107.     CrossRef
  • Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study
    Luca Degli Esposti, Valentina Perrone, Stefania Saragoni, Valerio Blini, Stefano Buda, Rosella D’avella, Gina Gasperini, Fabio Lena, Francesca Fanelli, Luca Gazzi, Francesco Giorgino
    Journal of Diabetes Research.2019; 2019: 1.     CrossRef
  • Self-Monitoring of Blood Glucose in Patients with Insulin-Treated Type 2 Diabetes Mellitus
    Kyung-Soo Kim
    Diabetes & Metabolism Journal.2018; 42(1): 26.     CrossRef
Clinical Care/Education
Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes
Hun-Sung Kim, Hyunah Kim, Hae-Kyung Yang, Eun Young Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Hyeon Woo Yim, Bong-Yun Cha
Diabetes Metab J. 2017;41(3):187-194.   Published online May 12, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.3.187
  • 7,080 View
  • 41 Download
  • 1 Web of Science
  • 3 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

When patients with diabetes mellitus (DM) are first referred to a hospital from primary health care clinics, physicians have to decide whether to administer an oral hypoglycemic agent (OHA) immediately or postpone a medication change in favor of diabetes education regarding diet or exercise. The aim of this study was to determine the effect of diabetes education alone (without alterations in diabetes medication) on blood glucose levels.

Methods

The study was conducted between January 2009 and December 2013 and included patients with DM. The glycosylated hemoglobin (HbA1c) levels were evaluated at the first visit and after 3 months. During the first medical examination, a designated doctor also conducted a diabetes education session that mainly covered dietary management.

Results

Patients were divided into those who received no diabetic medications (n=66) and those who received an OHA (n=124). Education resulted in a marked decrease in HbA1c levels in the OHA group among patients who had DM for <1 year (from 7.0%±1.3% to 6.6%±0.9%, P=0.0092) and for 1 to 5 years (from 7.5%±1.8% to 6.9%±1.1%, P=0.0091). Those with DM >10 years showed a slightly lower HbA1c target achievement rate of <6.5% (odds ratio, 0.089; P=0.0024).

Conclusion

For patients who had DM for more than 5 years, higher doses or changes in medication were more effective than intensive active education. Therefore, individualized and customized education are needed for these patients. For patients with a shorter duration of DM, it may be more effective to provide initial intensive education for diabetes before prescribing medicines, such as OHAs.

Citations

Citations to this article as recorded by  
  • Management Status of Patients with Type 2 Diabetes Mellitus at General Hospitals in Korea: A 5-Year Follow-Up Study
    Jin Hee Jung, Jung Hwa Lee, Hyang Mi Jang, Young Na, Hee Sun Choi, Yeon Hee Lee, Yang Gyo Kang, Na Rae Kim, Jeong Rim Lee, Bok Rye Song, Kang Hee Sim
    The Journal of Korean Diabetes.2022; 23(1): 64.     CrossRef
  • Effect of Voluntary Participation on Mobile Health Care in Diabetes Management: Randomized Controlled Open-Label Trial
    Da Young Lee, Seung-Hyun Yoo, Kyong Pil Min, Cheol-Young Park
    JMIR mHealth and uHealth.2020; 8(9): e19153.     CrossRef
  • Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
    Hun-Sung Kim, Sue Hyun Lee, Tong Min Kim, Ju Han Kim
    Clinical Hypertension.2018;[Epub]     CrossRef
Clinical Care/Education
Diabetes Camp as Continuing Education for Diabetes Self-Management in Middle-Aged and Elderly People with Type 2 Diabetes Mellitus
So Young Park, Sun Young Kim, Hye Mi Lee, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee, Kang-Hee Sim, Sang-Man Jin
Diabetes Metab J. 2017;41(2):99-112.   Published online March 3, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.2.99
  • 7,145 View
  • 52 Download
  • 4 Web of Science
  • 3 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

Despite the established benefits of diabetes camps for the continuing education of children with type 1 diabetes mellitus, little is known about the long-term metabolic benefits of diabetes camps for middle-aged and elderly people with type 2 diabetes mellitus (T2DM), especially in terms of glycosylated hemoglobin (HbA1c) variability.

Methods

The 1-year mean and variability of HbA1c before and after the diabetes camp was compared between the participants of the diabetes camp (n=57; median age 65 years [range, 50 to 86 years]; median diabetes duration 14 years [range, 1 to 48 years]). Additional case-control analysis compared the metabolic outcomes of the participants of the diabetes camp and their propensity score-matched controls who underwent conventional diabetes education (n=93).

Results

The levels of HbA1c during the first year after the diabetes camp were comparable to those of the matched controls (P=0.341). In an analysis of all participants of the diabetes camp, the 1-year mean±standard deviation (SD) of HbA1c decreased (P=0.010 and P=0.041) after the diabetes camp, whereas the adjusted SD and coefficient of variance (CV) of HbA1c did not decrease. The adjusted SD and CV significantly decreased after the diabetes camp in participants whose 1-year mean HbA1c was ≥6.5% before the diabetes camp (n=40) and those with a duration of diabetes less than 15 years (n=32).

Conclusion

The 1-year mean and SD of HbA1c decreased after the diabetes camp, with significant reduction in the adjusted SD and CV in those with higher baseline HbA1c and a shorter duration of diabetes.

Citations

Citations to this article as recorded by  
  • Camp-style lifestyle modification program (CAMP) for diabetes prevention among rural women with prior GDM: study protocol for a three-arm cluster hybrid type 2 randomized controlled trial
    Yao Chen, Qinyi Zhong, Wencong Lv, Qing Long, Man Ping Wang, Jyu-Lin Chen, James Allen Willey, Robin Whittemore, Jia Guo
    BMC Public Health.2024;[Epub]     CrossRef
  • Older adults’ experiences of being at a senior summer camp—A phenomenographic study
    Veronika Wallroth, Kjerstin Larsson, Agneta Schröder
    Qualitative Social Work.2022; 21(5): 956.     CrossRef
  • Pushing for miracles, pulling away from risk: An ethnographic analysis of the force dynamics at Senior Summer Camps in Sweden
    Gabriella Nilsson, Lisa Ekstam, Janicke Andersson
    Journal of Aging Studies.2018; 47: 96.     CrossRef
Clinical Care/Education
Practical Focus on American Diabetes Association/European Association for the Study of Diabetes Consensus Algorithm in Patients with Type 2 Diabetes Mellitus: Timely Insulin Initiation and Titration (Iran-AFECT)
Mohammad Ebrahim Khamseh, Gholamreza Yousefzadeh, Zahra Banazadeh, Sahar Ghareh
Diabetes Metab J. 2017;41(1):31-37.   Published online October 25, 2016
DOI: https://doi.org/10.4093/dmj.2017.41.1.31
  • 5,275 View
  • 44 Download
AbstractAbstract PDFPubReader   ePub   
Background

The aim of this study was to evaluate the safety and effectiveness of insulin glargine in a large population from a variety of clinical care in Iranian people with type 2 diabetes mellitus (T2DM) and to measure the percentage of patients achieving glycosylated hemoglobin (HbA1c) <7% by the end of 24 weeks of treatment in routine clinical practice.

Methods

This study was a 24 week, observational study of patients with T2DM, for whom the physician had decided to initiate or to switch to insulin glargine. The safety and efficacy of glargine were assessed at baseline and at week 24.

Results

Seven hundred and twenty-five people with T2DM (63% female) including both insulin naïve and prior insulin users were recruited in this study. The mean age of the participants was 54.2±11.2 years, and the mean HbA1c level was 8.88%±0.93% at baseline. By the end of the study, 27% of the entire participants reached to HbA1c target of less than 7% and 52% had HbA1c ≤7.5%. No serious adverse event was reported in this study. Furthermore, overall hypoglycemia did not increase in prior insulin users and the entire cohort. In addition, body weight did not change in participants while lipid profile improved significantly.

Conclusion

Treatment with insulin glargine could improve glycemic control without increasing the risk of hypoglycemic events in people with T2DM. In addition, a significant clinical improvement was observed in lipid profile.

Complications
Risk Factors for the Development and Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Advanced Diabetic Retinopathy
Kyung-Jin Yun, Hye Ji Kim, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Hyun Baek, Young Jung Roh, Ki-Ho Song
Diabetes Metab J. 2016;40(6):473-481.   Published online September 20, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.6.473
  • 8,192 View
  • 60 Download
  • 32 Web of Science
  • 31 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Some patients with type 2 diabetes mellitus (T2DM) do not develop diabetic kidney disease (DKD) despite the presence of advanced diabetic retinopathy (DR). We aimed to investigate the presence of DKD and its risk factors in patients with T2DM and advanced DR.

Methods

We conducted a cross-sectional study in 317 patients with T2DM and advanced DR. The phenotypes of DKD were divided into three groups according to the urine albumin/creatinine ratio (uACR, mg/g) and estimated glomerular filtration rate (eGFR, mL/min/1.73 m2): no DKD (uACR <30 and eGFR ≥60), non-severe DKD (uACR ≥30 or eGFR <60), and severe DKD (uACR ≥30 and eGFR <60). Mean systolic and diastolic blood pressure, mean glycosylated hemoglobin (HbA1c) level, and HbA1c variability (standard deviation [SD] of serial HbA1c values or HbA1c-SD) were calculated for the preceding 2 years.

Results

The prevalence of no DKD, non-severe DKD, and severe DKD was 37.2% (n=118), 37.0% (n=117), and 25.8% (n=82), respectively. HbA1c-SD and the triglyceride/high density lipoprotein cholesterol (TG/HDL-C) ratio correlated positively with uACR and negatively with eGFR. Multiple linear regression analyses showed that the HbA1c-SD and TG/HDL-C ratio were significantly related with eGFR. Multiple logistic regression analyses after adjusting for several risk factors showed that HbA1c-SD and the TG/HDL-C ratio were significant risk factors for severe DKD.

Conclusion

The prevalence of DKD was about 60% in patients with T2DM and advanced DR. HbA1c variability and TG/HDL-C ratio may affect the development and progression of DKD in these patients.

Citations

Citations to this article as recorded by  
  • Causal associations between HbA1c and multiple diseases unveiled through a Mendelian randomization phenome-wide association study in East Asian populations
    Li Han, Shuling Xu, Rumeng Chen, Zhiwei Zheng, Yining Ding, Zhu Wu, Sen Li, Binsheng He, Meihua Bao
    Medicine.2025; 104(11): e41861.     CrossRef
  • Lipid abnormality in diabetic kidney disease and potential treatment advancements
    Qian Ming Tu, Hui Min Jin, Xiu Hong Yang
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Causal relationship between obstructive sleep apnea and diabetic nephropathy: bidirectional and multivariable Mendelian randomization study
    Li Zhao, Zerui Liu, Rundong Zhang, Yanan Li, Xi Zhang
    Renal Failure.2025;[Epub]     CrossRef
  • The effect of HbA1C variability on the development and progression of diabetic nephropathy
    Alper Coskun, Aslihan Calim, Emre Sedar Saygili, Tamer Sakaci, Feyza Yener Ozturk, Yener Koc, Fatih Borlu, Yuksel Altuntas, Taner Basturk
    Frontiers in Clinical Diabetes and Healthcare.2025;[Epub]     CrossRef
  • Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR
    Charles C. Wykoff, Diana V. Do, Roger A. Goldberg, Dilsher S. Dhoot, Jennifer I. Lim, Weiming Du, Fabiana Q. Silva, Rutvi Desai, Hadi Moini, Kimberly Reed, Alyson J. Berliner, Robert Vitti, W. Lloyd Clark
    Ophthalmology Retina.2024; 8(4): 399.     CrossRef
  • Developing screening tools to estimate the risk of diabetic kidney disease in patients with type 2 diabetes mellitus
    Xu Cao, Xiaomei Pei
    Technology and Health Care.2024; 32(3): 1807.     CrossRef
  • Interpretable prediction model for assessing diabetes complication risks in Chinese sufferers
    Ye Shiren, Ye Jiangnan, Ye Xinhua, Ni Xinye
    Diabetes Research and Clinical Practice.2024; 209: 111560.     CrossRef
  • Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Jianbo Guo, Chen Liu, Yifan Wang, Baoyi Shao, Tung Leong Fong, Ngai Chung Lau, Hui Zhang, Haidi Li, Jianan Wang, Xinyu Lu, Anqi Wang, Cheuk Lung Leung, Xin Wei Chia, Fei Li, Xiaoming Meng, Qingyong He, Haiyong Chen
    eClinicalMedicine.2024; 69: 102482.     CrossRef
  • Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta‐analysis
    Shihan Wang, Shuoning Song, Junxiang Gao, Yanbei Duo, Yuting Gao, Yong Fu, Yingyue Dong, Tao Yuan, Weigang Zhao
    Diabetes, Obesity and Metabolism.2024; 26(11): 5167.     CrossRef
  • Sex-Specific Computed Tomography Abdominal Fat and Skeletal Muscle Characteristics in Type 2 Diabetic Retinopathy Patients With/Without Comorbid Diabetic Kidney Disease
    Jinlei Fan, Liping Zuo, Mingyuan Hou, Bowen Wang, Yueming An, Baoli Hao, Dexin Yu
    Academic Radiology.2023; 30(11): 2686.     CrossRef
  • The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study of 26,809 patients from 5 primary hospitals in China
    Zhaoxiang Liu, Xianglan Li, Yanlei Wang, Yanxia Song, Qiang Liu, Junxia Gong, Wenshuang Fan, Chunmei Lv, Chenxiang Cao, Wenhui Zhao, Jianzhong Xiao
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy
    Luxin Li, Yucen Dai, Dan Ke, Jieting Liu, Peijian Chen, Dong Wei, Tongtong Wang, Yanjie Teng, Xiaohuan Yuan, Zhen Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study
    Xiao zhu Liu, Minjie Duan, Hao dong Huang, Yang Zhang, Tian yu Xiang, Wu ceng Niu, Bei Zhou, Hao lin Wang, Ting ting Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Association between serum complements and kidney function in patients with diabetic kidney disease
    Meng-chao Liu, Jia-lin Li, Yue-fen Wang, Yuan Meng, Gui-min Zheng, Zhen Cai, Cun Shen, Meng-di Wang, Xiang-gang Zhu, Yang-zi Chen, Yu-lin Wang, Wen-jing Zhao, Wen-quan Niu, Yao-xian Wang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Coagulation Function and Type 2 Diabetic Kidney Disease: A Real-World Observational Study
    Meng-chao Liu, Wen-quan Niu, Yue-fen Wang, Yuan Meng, Gui-min Zheng, Zhen Cai, Cun Shen, Xiang-gang Zhu, Meng-di Wang, Jia-lin Li, Wen-jing Zhao, Yao-xian Wang, Eusebio Chiefari
    Journal of Diabetes Research.2023; 2023: 1.     CrossRef
  • Punicalagin alleviates renal injury via the gut-kidney axis in high-fat diet-induced diabetic mice
    Qinglian Hua, Yaling Han, Haifeng Zhao, Haowen Zhang, Bei Yan, Shengjie Pei, Xin He, Yue Li, Xiangyuan Meng, Lei Chen, Feng Zhong, Duo Li
    Food & Function.2022; 13(2): 867.     CrossRef
  • Status and Trends of the Association Between Diabetic Nephropathy and Diabetic Retinopathy From 2000 to 2021: Bibliometric and Visual Analysis
    Wenwen Lin, Yayong Luo, Fang Liu, Hangtian Li, Qian Wang, Zheyi Dong, Xiangmei Chen
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • The Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China
    Hong Lian, Hongshi Wu, Jie Ning, Diaozhu Lin, Chulin Huang, Feng Li, Ying Liang, Yiqin Qi, Meng Ren, Li Yan, Lili You, Mingtong Xu
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Weight change and microvascular outcomes in patients with new-onset diabetes: a nationwide cohort study
    Eun Sil Koh, Kyung Do Han, Mee Kyoung Kim, Eun Sook Kim, Min-Kyung Lee, Ga Eun Nam, Hyuk-Sang Kwon
    The Korean Journal of Internal Medicine.2021; 36(4): 932.     CrossRef
  • Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Eugene Han, Mi Kyung Kim, Byoung Kuk Jang, Hye Soon Kim
    Diabetes & Metabolism Journal.2021; 45(5): 698.     CrossRef
  • Effect of Calcium Dobesilate in Preventing Contrast-Induced Nephropathy in Patients with Diabetes and Chronic Kidney Disease
    Hao Zhang, Shao-Hua Guo, Zheng-Kai Xue, Ya-Ru Zhang, Jia-Rui Wang, Jing-Jin Che, Tong Liu, Hua-Yue Tao, Guang-Ping Li, Seung-Woon Rha, Swapnil-Zaman Ashraful-Haque, Kang-Yin Chen
    Clinics.2021; 76: e2942.     CrossRef
  • Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients
    Wenkai Xia, Xiajuan Yao, Yan Chen, Jie Lin, Volker Vielhauer, Hong Hu
    BMC Nephrology.2020;[Epub]     CrossRef
  • Thermal Perception Abnormalities Can Predict Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
    Wei-Ching Fang, Kuei-Mei Chou, Chiao-Yin Sun, Chin-Chan Lee, I-Wen Wu, Yung-Chang Chen, Heng-Chih Pan
    Kidney and Blood Pressure Research.2020; 45(6): 926.     CrossRef
  • Association between nonalbumin proteinuria and renal tubular damage of N-acetyl-β-d-glucosaminidase and its clinical relevance in patients with type 2 diabetes without albuminuria
    Eugene Han, Mi-Kyung Kim, Yong-ho Lee, Hye Soon Kim, Byung-Wan Lee
    Journal of Diabetes and its Complications.2019; 33(3): 255.     CrossRef
  • Detection of Lower Albuminuria Levels and Early Development of Diabetic Kidney Disease Using an Artificial Intelligence-Based Rule Extraction Approach
    Yoichi Hayashi
    Diagnostics.2019; 9(4): 133.     CrossRef
  • Therapeutic effect of liraglutide on expression of CTGF and BMP‐7 in induced diabetic nephropathy
    Maggie M. Ramzy, Ahlam M. Abdalla, Nagwa M. Zenhom, Ahmed M. Okasha, Aya E. Abdelkafy, Rabeh K. Saleh
    Journal of Cellular Biochemistry.2019; 120(10): 17512.     CrossRef
  • Are blood lipids associated with microvascular complications among type 2 diabetes mellitus patients? A cross-sectional study in Shanghai, China
    Hua Yang, Doris Young, Jian Gao, Yuanzhi Yuan, Minqian Shen, Yuan Zhang, Xueyan Duan, Shanzhu Zhu, Xiaoming Sun
    Lipids in Health and Disease.2019;[Epub]     CrossRef
  • Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
    Ki‐Ho Song, Jee‐Sun Jeong, Mee Kyoung Kim, Hyuk‐Sang Kwon, Ki‐Hyun Baek, Seung‐Hyun Ko, Yu‐Bae Ahn
    Journal of Diabetes Investigation.2019; 10(3): 745.     CrossRef
  • Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients
    Marsida Teliti, Giulia Cogni, Lucia Sacchi, Arianna Dagliati, Simone Marini, Valentina Tibollo, Pasquale De Cata, Riccardo Bellazzi, Luca Chiovato
    Diabetes and Vascular Disease Research.2018; 15(5): 424.     CrossRef
  • Higher Prevalence and Progression Rate of Chronic Kidney Disease in Elderly Patients with Type 2 Diabetes Mellitus
    Kyung-Soo Kim, Seok Won Park, Yong-Wook Cho, Soo-Kyung Kim
    Diabetes & Metabolism Journal.2018; 42(3): 224.     CrossRef
  • Determinants of the Risk of Diabetic Kidney Disease and Diabetic Retinopathy Independent of Glucose Exposure
    Bo Kyung Koo
    Diabetes & Metabolism Journal.2016; 40(6): 444.     CrossRef
Brief Report
Epidemiology
Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey
Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Cheol-Young Park, Chang Beom Lee, Sung-Hee Ihm
Diabetes Metab J. 2016;40(2):167-170.   Published online April 5, 2016
DOI: https://doi.org/10.4093/dmj.2016.40.2.167
  • 7,693 View
  • 45 Download
  • 1 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   

We aimed to estimate the threshold level of glycosylated hemoglobin (HbA1c) for the fasting plasma glucose of 100 and 126 mg/dL in the Korean adult population, using the 2011 Korea National Health and Nutrition Examination Survey. A total of 4,481 participants over 19 years of age without diabetic medications and conditions to influence the interpretation of HbA1c levels, such as anemia, renal insufficiency, liver cirrhosis, and cancers, were analyzed. A point-wise area under the receiver operating characteristic curve was used to estimate the optimal HbA1c cutoff value. A HbA1c threshold of 6.35% was optimal for predicting diabetes with a sensitivity of 86.9% and a specificity of 99.1%. Furthermore, the threshold of HbA1c was 5.65% for prediabetes, with a sensitivity of 69.3% and a specificity of 71%. Further prospective studies are needed to evaluate the HbA1c cutoff point for diagnosing prediabetes and diabetes in the Korean population.

Citations

Citations to this article as recorded by  
  • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
  • Cutoff Point of HbA1c for Diagnosis of Diabetes Mellitus in Chinese Individuals
    Bing Wang, Ming-Chuan Liu, Xin-Yu Li, Xu-Han Liu, Qiu-Xia Feng, Lu Lu, Zhu Zhu, Ying-Shu Liu, Wei Zhao, Zheng-Nan Gao, Noel Christopher Barengo
    PLOS ONE.2016; 11(11): e0166597.     CrossRef
Original Articles
The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults
Eun Hee Sim, Hye Won Lee, Hyun Ju Choi, Dong Wook Jeong, Seok Man Son, Yang Ho Kang
Diabetes Metab J. 2016;40(1):62-69.   Published online November 27, 2015
DOI: https://doi.org/10.4093/dmj.2016.40.1.62
  • 6,609 View
  • 45 Download
  • 8 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Cystatin C has been known to be associated not only with early renal impairment but also with the incidence of diabetic conditions (prediabetes plus diabetes). However, it is not clear whether cystatin C levels are associated with the prevalence of diabetic conditions in Asian populations. We evaluated this association using glycosylated hemoglobin (HbA1c) levels as the definition of diabetes in Korean adults.

Methods

We analyzed data from 1,559 Korean adults (937 men and 622 women) with available serum cystatin C and HbA1c values.

Results

The serum cystatin C levels in subjects with prediabetes and diabetes were significantly increased (0.91±0.14 mg/L in prediabetes and 0.91±0.17 mg/L in diabetes vs. 0.88±0.13 mg/L in patients with normal glucose levels, P=0.001). At increasing cystatin C levels, the prevalence of subjects with prediabetes (30.2% vs. 14.6%, P<0.001) and those with diabetes (10.6% vs. 8.0%, P<0.001) significantly increased in the group with the highest cystatin C levels. The group with the highest cystatin C levels had a significantly increased odds ratio (OR) for the presence of diabetic conditions compared to the group with the lowest values in total subjects (OR, 2.35; 95% confidence interval [CI], 1.54 to 3.58; P<0.001) and in women (OR, 4.13; 95% CI, 1.97 to 8.65; P<0.001), though there was no significant increase after adjusting for multiple variables.

Conclusions

Higher levels of serum cystatin C are associated with an increased prevalence of diabetic conditions in Korean adults. Our findings may extend the positive association of cystatin C with diabetes incidence to an Asian population.

Citations

Citations to this article as recorded by  
  • Relationship between serum cystatin C and diabetic retinopathy in T2DM patients
    Qiuqi Gui, Kunhua Jiang, Yuxin Xu
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Prognostic significance of serum cystatin C in acute brainstem infarctions patients
    H. Li, B. Zhang, Z. Huang, H. Wu, B. Qin, L. Zhou, Z. Lu, F. Qin
    Revue Neurologique.2024; 180(7): 642.     CrossRef
  • Detection of decline in estimated glomerular filtration rate in patients with type 2 diabetes by cystatin C-based equations
    Tam Thai Thanh Tran, Tien Kim Ha, Nhut Minh Phan, Minh Van Le, Tin Hoang Nguyen
    World Journal of Nephrology.2024;[Epub]     CrossRef
  • Cardiovascular risk assessment in prediabetic patients in a hypertensive population: The role of cystatin C
    Rafael Garcia-Carretero, Luis Vigil-Medina, Inmaculada Mora-Jimenez, Cristina Soguero-Ruiz, Rebeca Goya-Esteban, Javier Ramos-Lopez, Oscar Barquero-Perez
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2018; 12(5): 625.     CrossRef
  • Characteristics of Dapagliflozin Responders: A Longitudinal, Prospective, Nationwide Dapagliflozin Surveillance Study in Korea
    Eugene Han, Ari Kim, Sung Jae Lee, Je-Yon Kim, Jae Hyeon Kim, Woo Je Lee, Byung-Wan Lee
    Diabetes Therapy.2018; 9(4): 1689.     CrossRef
  • Cystatin C as a Predictor for Diabetes according to Glycosylated Hemoglobin Levels in Korean Patients
    Eon Ju Jeon, Ji Hyun Lee
    Diabetes & Metabolism Journal.2016; 40(1): 32.     CrossRef
  • Prevalence of Reduced Kidney Function by Estimated Glomerular Filtration Rate Using an Equation Based on Creatinine and Cystatin C in Metabolic Syndrome and Its Components in Korean Adults
    Yang Ho Kang, Dong Wook Jeong, Seok Man Son
    Endocrinology and Metabolism.2016; 31(3): 446.     CrossRef
  • Letter: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)
    Kyung-Soo Kim
    Diabetes & Metabolism Journal.2016; 40(2): 171.     CrossRef
  • Response: The Association of Serum Cystatin C with Glycosylated Hemoglobin in Korean Adults (Diabetes Metab J 2016;40:62-9)
    Yang Ho Kang
    Diabetes & Metabolism Journal.2016; 40(2): 173.     CrossRef
Obesity and Metabolic Syndrome
The Usefulness of the Glycosylated Hemoglobin Level for the Diagnosis of Gestational Diabetes Mellitus in the Korean Population
Ah Jeong Ryu, Hyuk Jin Moon, Joo Ok Na, Yeo Joo Kim, Sang Jin Kim, Sang Il Mo, Jeong Ran Byun
Diabetes Metab J. 2015;39(6):507-511.   Published online November 23, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.6.507
  • 7,537 View
  • 52 Download
  • 14 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

An oral glucose tolerance test (OGTT) is the current method used for screening and diagnosis of gestational diabetes mellitus (GDM). OGTT is a relatively complicated procedure and is expensive. Thus, new strategies that do not require fasting or more than a single blood draw may improve the diagnosis of GDM and increase the rate of GDM testing. We investigated the utility of monitoring glycosylated hemoglobin (HbA1c) levels for the diagnosis of GDM.

Methods

The data from 992 pregnant women with estimated gestational ages ranging from 24 to 28 weeks were retrospectively reviewed. There were 367 women with plasma glucose levels ≥140 mg/dL 1 hour after a 50-g OGTT. GDM was diagnosed according to the Carpenter-Coustan criteria for a 3-hour 100 g OGTT. A HbA1c assessment was performed at the same time.

Results

We enrolled 343 women in this study, and there were 109 women with GDM. The area under the curve the receiver operating characteristic curve for HbA1c detection of GDM was 0.852 (95% confidence interval, 0.808 to 0.897). A HbA1c cutoff value ≥5.35% had maximal points on the Youden index (0.581). The sensitivity was 87.2% and the specificity was 70.9% for diagnosing GDM. A threshold value ≥5.35% indicated that 163 patients had GDM and that 68 (41.7%) were false positive. The positive predictive value was 58.3% at this threshold value.

Conclusion

Despite substantial progress in methodology, HbA1c values cannot replace OGTT for the diagnosis of GDM.

Citations

Citations to this article as recorded by  
  • Serum Ferritin Combined with Glycated Hemoglobin for Early Prediction of Gestational Diabetes Mellitus: A Retrospective Cohort Study
    Wei Wang, Yu-ping Wei, Yu-qi Zhang, Sheng-hu Miao, Xiang Chang
    Clinical and Investigative Medicine.2025; 48(1): 5.     CrossRef
  • Predelivery HbA1c levels and their relationship with adverse perinatal outcomes in women with normal 75-g OGTT
    Xiaoxia Tang, Jin Wei, Zifeng Jiang, Shaohua Wu
    Archives of Gynecology and Obstetrics.2023; 310(1): 293.     CrossRef
  • The diagnostic value of glycosylated hemoglobin for gestational diabetes mellitus in Asian populations: A systematic review and meta‐analysis
    Jiani Zhang, Fan Zhou, Tingting Xu, Jinfeng Xu, Yaqian Li, Li Lin, Qi Cao, Xiaodong Wang
    Journal of Obstetrics and Gynaecology Research.2022; 48(4): 902.     CrossRef
  • The role of first-trimester HbA1c in the early detection of gestational diabetes
    Mehrnaz Valadan, Zeinab Bahramnezhad, Fatemeh Golshahi, Elham Feizabad
    BMC Pregnancy and Childbirth.2022;[Epub]     CrossRef
  • Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring
    Martina Gáborová, Viera Doničová, Ivana Bačová, Mária Pallayová, Martin Bona, Igor Peregrim, Soňa Grešová, Judita Štimmelová, Barbora Dzugasová, Lenka Šalamonová Blichová, Viliam Donič
    International Journal of Environmental Research and Public Health.2021; 18(7): 3402.     CrossRef
  • A Review on Research Progress in the Application of Glycosylated Hemoglobin and Glycated Albumin in the Screening and Monitoring of Gestational Diabetes
    Xinyan Liu, Na Wu, Abdulrahman Al-Mureish
    International Journal of General Medicine.2021; Volume 14: 1155.     CrossRef
  • Evaluation of the Combination of HbA1C with Hematocrit for Early Screening of Gestational Diabetes Mellitus
    Ali Reza Norouzi, Mahsa Siavashi, Fatemeh Norouzi, Maryam Talayeh, Somayyeh Noei Teymoordash
    Journal of Obstetrics, Gynecology and Cancer Research.2021; 6(4): 217.     CrossRef
  • The accuracy of haemoglobin A1c as a screening and diagnostic test for gestational diabetes: a systematic review and meta-analysis of test accuracy studies
    Chiamaka Esther Amaefule, Archana Sasitharan, Princee Kalra, Stamatina Iliodromoti, Mohammed S.B. Huda, Ewelina Rogozinska, Javier Zamora, Shakila Thangaratinam
    Current Opinion in Obstetrics & Gynecology.2020; 32(5): 322.     CrossRef
  • Downregulation of microRNA-873 attenuates insulin resistance and myocardial injury in rats with gestational diabetes mellitus by upregulating IGFBP2
    Na Han, Hai-Yan Fang, Jie-Xuan Jiang, Qian Xu
    American Journal of Physiology-Endocrinology and Metabolism.2020; 318(5): E723.     CrossRef
  • Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus
    Duria A. Rayis, Abdel B. A. Ahmed, Manal E. Sharif, Amir ElSouli, Ishag Adam
    Journal of Clinical Laboratory Analysis.2020;[Epub]     CrossRef
  • Mid‐trimester glycosylated hemoglobin levels (HbA1c) and its correlation with oral glucose tolerance test (World Health Organization 1999)
    Devanshi Dubey, Shipra Kunwar, Uma Gupta
    Journal of Obstetrics and Gynaecology Research.2019; 45(4): 817.     CrossRef
  • The utility of HbA1c combined with haematocrit for early screening of gestational diabetes mellitus
    Kui Wu, Yan Cheng, Tingting Li, Ziwen Ma, Junxiu Liu, Qingying Zhang, Haidong Cheng
    Diabetology & Metabolic Syndrome.2018;[Epub]     CrossRef
  • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
  • Diagnosing gestational diabetes mellitus: implications of recent changes in diagnostic criteria and role of glycated haemoglobin (HbA1c)
    Fahmy W Hanna, Christopher J Duff, Ann Shelley-Hitchen, Ellen Hodgson, Anthony A Fryer
    Clinical Medicine.2017; 17(2): 108.     CrossRef
  • Utility of Glycated Haemoglobin in Gestational Diabetes Mellitus: Present and Future
    Rajesh Rajput, Deepak Jain
    EMJ Diabetes.2016; : 84.     CrossRef
Review
The Optimal Cutoff Value of Glycated Hemoglobin for Detection of Diabetic Retinopathy
Jung Min Kim, Dong-Jun Kim
Diabetes Metab J. 2015;39(1):16-26.   Published online February 16, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.1.16
  • 9,993 View
  • 67 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDFPubReader   ePub   

With standardization of measurement of glycated hemoglobin (A1C), the International Expert Committee Report in 2009 and the American Diabetes Association in 2010 recommended incorporating A1C ≥6.5% into the previous diagnostic criteria using fasting plasma glucose and/or 2-hour plasma glucose. Whereas the association of A1C with cardiovascular diseases and other diabetic microvascular complications was linear without evidence of a distinct threshold, several studies suggested a threshold value for A1C in diabetic retinopathy (DR). In studies about the optimal cutoff value for A1C in DR, the A1C values range from 5.2% to 7.8%. There are several possible reasons why these values for DR differ so widely (differences in the definition and/or methods for DR, variation in statistical methods, differences in study population, differences in exclusion criteria, and difference in methods for measuring A1C). With these wide variations in the study method, drawing a conclusive cutoff value for A1C in DR is impossible. In published studies, the cutoff values for moderate or severe DR were higher than those for any or mild DR (6.4% to 7.0% vs. 5.5% to 6.5%).

Citations

Citations to this article as recorded by  
  • What Difference Does a Diagnosis Make?
    Mattan Alalouf, Sarah Miller, Laura R. Wherry
    American Journal of Health Economics.2024; 10(1): 97.     CrossRef
  • EFFECTS OF GLYCEMIC VARIABILITY ON THE PROGRESSION OF DIABETIC RETINOPATHY AMONG PATIENTS WITH TYPE 2 DIABETES
    Jae Yong Park, Je Hyung Hwang, Min Ji Kang, Ha Eun Sim, Jae Suk Kim, Kyung Soo Ko
    Retina.2021; 41(7): 1487.     CrossRef
  • Simple diagnosis of HbA1c using the dual-plasmonic platform integrated with LSPR and SERS
    Nam Su Heo, Cheol Hwan Kwak, Hoomin Lee, Dongjoo Kim, Sunmook Lee, Gi-bum Kim, Soonjo Kwon, Woo Sik Kim, Yun Suk Huh
    Journal of Crystal Growth.2017; 469: 154.     CrossRef
  • Insulin resistance and beta-cell dysfunction in people with prediabetes according to criteria based on glycemia and glycosylated hemoglobin
    Andrea Tura, Christian Göbl, Ermanno Moro, Giovanni Pacini
    Endocrine Journal.2017; 64(1): 117.     CrossRef
  • DIABETIC RETINOPATHY-RISK FACTORS, STAGING & MANAGEMENT
    Naidu A. P. R., Satyavathidevi P
    Journal of Evidence Based Medicine and Healthcare.2016; 3(2): 94.     CrossRef
Brief Report
Glycated Hemoglobin Value for Fasting Plasma Glucose of 126 mg/dL in Korean: The 2011 Korea National Health and Nutrition Examination Survey
Jung Min Kim, Jae Won Hong, Jong Chul Won, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim
Diabetes Metab J. 2014;38(6):480-483.   Published online December 15, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.6.480
  • 8,208 View
  • 41 Download
  • 9 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   ePub   

We aimed to estimate the cutoff value of glycated hemoglobin (HbA1c, A1c) for fasting plasma glucose (FPG) of 126 mg/dL in the Korean adult population, using the 2011 Korea National Health and Nutrition Examination Survey. A total of 5,421 participants without a history of diabetes and over 19 years of age were included in the analysis. A point-wise area under the receiver operating characteristic curve was used to estimate the optimal A1c cutoff value. A1c threshold of 6.1% produced the highest sum of sensitivity (85.2%) and specificity (90.5%) for FPG of 126 mg/dL (area under the curve, 0.941, P<0.001). A1c of 6.5% produced a sensitivity of 67.7% and specificity of 98.0% for FPG of 126 mg/dL. Considering A1c as one of three criteria for the diagnosis of diabetes and the specificity of an A1c cutoff of 6.5%, the current diagnostic criteria of A1c≥6.5% might be acceptable in the Korean adult population.

Citations

Citations to this article as recorded by  
  • How Do We Diagnose Diabetes in Primary Care?
    Hyeong Jin Kim
    The Journal of Korean Diabetes.2025; 26(1): 10.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
    Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, Yoon Ju Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang
    Diabetes & Metabolism Journal.2024; 48(4): 546.     CrossRef
  • The Effect of an Empowerment Program on the Perceived Risk and Physical Health of Patients With Coronary Artery Disease
    Zeinab Ghasemzadeh Kuchi, Masoomeh Zakerimoghadam, Maryam Esmaeili, Babak Geraiely
    Holistic Nursing Practice.2020; 34(3): 163.     CrossRef
  • Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
    So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Sun Hee Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Jeong-Ho Kim, Byung-Wan Lee
    Annals of Laboratory Medicine.2017; 37(1): 9.     CrossRef
  • Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Cheol-Young Park, Chang Beom Lee, Sung-Hee Ihm
    Diabetes & Metabolism Journal.2016; 40(2): 167.     CrossRef
  • Is an Oral Glucose Tolerance Test Still Valid for Diagnosing Diabetes Mellitus?
    Dong-Lim Kim, Sun-Doo Kim, Suk Kyeong Kim, Sooyoun Park, Kee-Ho Song
    Diabetes & Metabolism Journal.2016; 40(2): 118.     CrossRef
  • Comparison of the clinical characteristics of diabetes mellitus diagnosed using fasting plasma glucose and haemoglobin A1c: The 2011 Korea National Health and Nutrition Examination Survey
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Chang Beom Lee, Sung-Hee Ihm
    Diabetes Research and Clinical Practice.2016; 113: 23.     CrossRef
  • Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants
    G Danaei, S Fahimi, Y Lu, B Zhou, K Hajifathalian, M Di Cesare, WC Lo, B Reis-Santos, MJ Cowan, JE Shaw, J Bentham, JK Lin, H Bixby, D Magliano, P Bovet, JJ Miranda, YH Khang, GA Stevens, LM Riley, MK Ali, M Ezzati, ZA Abdeen, KA Kadir, M Abu-Rmeileh, B A
    The Lancet Diabetes & Endocrinology.2015; 3(8): 624.     CrossRef
  • The Optimal Cutoff Value of Glycated Hemoglobin for Detection of Diabetic Retinopathy
    Jung Min Kim, Dong-Jun Kim
    Diabetes & Metabolism Journal.2015; 39(1): 16.     CrossRef
Original Articles
Effectiveness of 3-Day Continuous Glucose Monitoring for Improving Glucose Control in Type 2 Diabetic Patients in Clinical Practice
Soo Kyoung Kim, Hye Jeong Kim, Taehun Kim, Kyu Yeon Hur, Sun Wook Kim, Moon-Kyu Lee, Yong-Ki Min, Kwang-Won Kim, Jae Hoon Chung, Jae Hyeon Kim
Diabetes Metab J. 2014;38(6):449-455.   Published online December 15, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.6.449
  • 8,159 View
  • 47 Download
  • 21 Web of Science
  • 20 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The aim of this study was to investigate whether adjusting diabetic treatment regimens according to the information obtained from a continuous glucose monitoring system (CGMS) might lead to improved glycemic control in patients with type 2 diabetes.

Methods

We reviewed the medical charts of 172 patients who used the CGMS for 1 year starting in December 2008 and the records of 1,500 patients who visited their regular outpatient clinics during December 2008. Of these patients, a total of 65 CGMS patients and 301 regular outpatients (control group) were enrolled in the study after propensity score matching. There were no differences in baseline glycated hemoglobin (HbA1c), age, and duration of diabetes between the CGMS and the control groups after propensity score matching. The changes in the HbA1c levels from baseline to 6 months were calculated.

Results

The CGMS group showed a significant improvement in the HbA1c level compared to the control group at 3 months (7.9%±1.6% vs. 7.4%±1.2%, P=0.001) and at 6 months (7.4%±1.2% vs. 7.9%±1.6%, P=0.010). There were significant differences in the treatment modality changes between the CGMS group and the control group.

Conclusion

Using a 3-day CGMS was advantageous for improving glucose control in patients with type 2 diabetes and may help these patients to optimize glycemic control in clinical practice.

Citations

Citations to this article as recorded by  
  • Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review
    Grazia Aleppo, Anders L. Carlson, Janet B. McGill, Hamza Alshannaq, Rodolfo Galindo, Davida Kruger, Carol J. Levy, Jessica Y. Matuoka, Sabrina Ilham, Guillermo Umpierrez, Gregory J. Norman
    Diabetes Technology & Therapeutics.2026;[Epub]     CrossRef
  • Advanced Hybrid Closed‐Loop Insulin Delivery Is Associated With Improved Glycemic Indicators and Normalization of Small Nerve Fibre Structure in Adults With Type 1 Diabetes
    Hoda Gad, Einas Elgassim, Kawsar Mohamed Ayon Mohamud, Najlaa Sultan Al‐Naimi, Hamad Ali Al‐Sharshani, Ibrahim Mohammed, Mariam A. Al‐Malaheem, Dorothy J. Quadros, Alhanoof AlJalahma, Neila Lamine, Ahmad Yaser Alhaddad, Hussein Ahmed Hussein Zaky Aly, Joh
    Journal of the Peripheral Nervous System.2025;[Epub]     CrossRef
  • Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials
    Ronnie Aronson, Alexander Abitbol, Harpreet S. Bajaj, Alice Y. Y. Cheng, Stavroula Christopoulos, Stewart B. Harris, Akshay B. Jain, Ronald M. Goldenberg
    Diabetes, Obesity and Metabolism.2025; 27(11): 6220.     CrossRef
  • Effectiveness of continuous glucose monitoring in patient management of Type 2 Diabetes Mellitus: an umbrella review of systematic reviews from 2011 to 2024
    Yong Yi Tan, Enhui Suan, Gerald Choon Huat Koh, Suhana Binte Suhairi, Shilpa Tyagi
    Archives of Public Health.2024;[Epub]     CrossRef
  • Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
    Zhao Liu, Hiromitsu Hayashi, Kazuki Matsumura, Norio Uemura, Yuta Shiraishi, Hiroki Sato, Hideo Baba
    Cancers.2023; 15(2): 498.     CrossRef
  • Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta‐analysis
    Sergio Di Molfetta, Irene Caruso, Angelo Cignarelli, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino
    Diabetes, Obesity and Metabolism.2023; 25(5): 1301.     CrossRef
  • American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
    George Grunberger, Jennifer Sherr, Myriam Allende, Thomas Blevins, Bruce Bode, Yehuda Handelsman, Richard Hellman, Rosemarie Lajara, Victor Lawrence Roberts, David Rodbard, Carla Stec, Jeff Unger
    Endocrine Practice.2021; 27(6): 505.     CrossRef
  • Lack of Acceptance of Digital Healthcare in the Medical Market: Addressing Old Problems Raised by Various Clinical Professionals and Developing Possible Solutions
    Jong Il Park, Hwa Young Lee, Hyunah Kim, Jisan Lee, Jiwon Shinn, Hun-Sung Kim
    Journal of Korean Medical Science.2021;[Epub]     CrossRef
  • A head‐to‐head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot
    Othmar Moser, Marlene Pandis, Felix Aberer, Harald Kojzar, Daniel Hochfellner, Hesham Elsayed, Melanie Motschnig, Thomas Augustin, Philipp Kreuzer, Thomas R. Pieber, Harald Sourij, Julia K. Mader
    Diabetes, Obesity and Metabolism.2019; 21(4): 1043.     CrossRef
  • Glucose monitoring in diabetes: from clinical studies to real‐world practice
    Rebecca C Sagar, Afroze Abbas, Ramzi Ajjan
    Practical Diabetes.2019; 36(2): 57.     CrossRef
  • The Effectiveness of Continuous Glucose Monitoring in Patients with Type 2 Diabetes: A Systematic Review of Literature and Meta-analysis
    Cindy Park, Quang A. Le
    Diabetes Technology & Therapeutics.2018; 20(9): 613.     CrossRef
  • Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial
    Robert R. Henry, Poul Strange, Rong Zhou, Jeremy Pettus, Leon Shi, Sergey B. Zhuplatov, Traci Mansfield, David Klein, Arie Katz
    Diabetes Technology & Therapeutics.2018; 20(11): 715.     CrossRef
  • Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data
    Joseph A. Sierra, Mona Shah, Max S. Gill, Zachery Flores, Hiten Chawla, Francine R. Kaufman, Robert Vigersky
    Journal of Medical Economics.2018; 21(3): 225.     CrossRef
  • Role of continuous glucose monitoring for type 2 in diabetes management and research
    Robert Vigersky, Maneesh Shrivastav
    Journal of Diabetes and its Complications.2017; 31(1): 280.     CrossRef
  • Assessing the Therapeutic Utility of Professional Continuous Glucose Monitoring in Type 2 Diabetes Across Various Therapies: A Retrospective Evaluation
    Jothydev Kesavadev, Robert Vigersky, John Shin, Pradeep Babu Sadasivan Pillai, Arun Shankar, Geethu Sanal, Gopika Krishnan, Sunitha Jothydev
    Advances in Therapy.2017; 34(8): 1918.     CrossRef
  • Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes
    Christine L. Chan
    Current Diabetes Reports.2017;[Epub]     CrossRef
  • The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
    Gyuri Kim, Sewon Oh, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee
    Expert Opinion on Pharmacotherapy.2017; 18(12): 1179.     CrossRef
  • Morning Spot Urine Glucose-to-Creatinine Ratios Predict Overnight Urinary Glucose Excretion in Patients With Type 2 Diabetes
    So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Sun Hee Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Jeong-Ho Kim, Byung-Wan Lee
    Annals of Laboratory Medicine.2017; 37(1): 9.     CrossRef
  • The Contemporary Role of Masked Continuous Glucose Monitoring in a Real-Time World
    Ian Blumer
    Journal of Diabetes Science and Technology.2016; 10(3): 790.     CrossRef
  • Glycemic Variability: How Do We Measure It and Why Is It Important?
    Sunghwan Suh, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2015; 39(4): 273.     CrossRef
Assessment of the Association between Mean Hemoglobin A1c Levels for 5 Years and Coronary Artery Disease by Coronary Angiography in Nondiabetic Patients
Jae-Joon Kim, Ji-Hoon Kang, Ja-Jun Goo, Kyoung-Nyoun Kim, Ja-Young Lee, Mi-kyung Kim, Tae Ik Kim
Diabetes Metab J. 2014;38(1):58-63.   Published online February 19, 2014
DOI: https://doi.org/10.4093/dmj.2014.38.1.58
  • 6,709 View
  • 38 Download
  • 4 Web of Science
  • 2 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The effects of glucose on cardiovascular events or mortality in nondiabetic patients has been recently reported. However, since atherosclerosis can be formed over a long period of time, it is necessary to devote several years to unveil the relationship between the two factors. Here, we attempted to find out the relationship between the mean hemoglobin A1c (HbA1c) level and HbA1c variability for 5 years and coronary artery disease (CAD) by using coronary angiography (CAG) to assess nondiabetic patients.

Methods

We reviewed patients who performed CAG who were followed up for at least 5 years after the initial diagnosis. The fasting blood test was performed annually for glucose and HbA1c level. CAD was defined as more than 50% of luminal narrowing. The severity of CAD was divided into two groups depending on whether no vessels were involved or one more vessel were involved (CAD(-) or CAD(+), respectively).

Results

The patients in CAD(+) group had higher mean HbA1c level for 5 years than CAD(-) group (5.71±0.40 vs. 5.86±0.68; P=0.04). Mean HbA1c was a significant predictor for CAD in multiple regression (odds ratio, 2.224; P=0.028). The percentage of patients with CAD was significantly higher in patients with >6.2% of mean HbA1c levels compared to patients with <6.2% of mean HbA1c levels (P<0.019).

Conclusion

When the mean HbA1c levels were above 6.2%, the risk of CAD was higher. Also this study shows that HbA1c level can be one of the predictors for CAD even if the patients do not have diabetes.

Citations

Citations to this article as recorded by  
  • Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial
    Joyce M. Heutinck, Iris A. De Koning, Tom Vromen, Robert-Jan M. Van Geuns, Dick H.J. Thijssen, Hareld M.C. Kemps, Eddy M. Adang, Johanna M. Geleijnse, Pieter van Gorp, Arnoud W. J. van ‘t Hof, Veronica R. Janssen, Harald T. Jorstad, Roderik A. Kraaijenhag
    BMC Cardiovascular Disorders.2023;[Epub]     CrossRef
  • Evaluation of HbA1c as a prognostic biomarker of cardiovascular events and mortality in nondiabetic patients: Methodological considerations
    Denis Monneret
    Atherosclerosis.2015; 242(1): 19.     CrossRef
Prevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c
Ja Young Jeon, Seung-Hyun Ko, Hyuk-Sang Kwon, Nan Hee Kim, Jae Hyeon Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Soo Lim, Sung Hee Choi, Myoung-jin Jang, Yuna Kim, Kyungwon Oh, Dae Jung Kim, Bong-Yun Cha
Diabetes Metab J. 2013;37(5):349-357.   Published online October 17, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.5.349
  • 14,475 View
  • 116 Download
  • 128 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Due to the inconvenience of performing oral glucose tolerance tests and day to day variability in glucose level, glycated hemoglobin (HbA1c) has been recommended by the American Diabetes Association as a method to diagnose diabetes. In addition, the Korean Diabetes Association has also recommended the use of HbA1c as a diagnostic test for diabetes. In this study, we evaluated the prevalence of diabetes according to fasting plasma glucose (FPG) level only or the combination of FPG and HbA1c tests.

Methods

Data from the 2011 Korea National Health and Nutrition Examination Survey (KNHANES) were analyzed. Among 5,811 subjects aged 30 years or older, 5,020 were selected after excluding the data of fasting time <8 hours, missing values from fasting glucose or HbA1c level, previous diagnosis of diabetes made by physicians, or current use of antidiabetic medications. Diabetes was defined as FPG ≥126 mg/dL, previous diagnosis of diabetes made by a medical doctor, current use of antidiabetic medications, and/or HbA1c ≥6.5%. Prediabetes was defined as FPG of 100 to 125 mg/dL and/or HbA1c of 5.7% to 6.4%.

Results

When we used FPG only, the prevalence of diabetes and prediabetes were 10.5% (men, 12.6%; women, 8.5%) and 19.3% (men, 23.8%; women, 14.9%), respectively. When HbA1c was included as a diagnostic test, the prevalence of diabetes and prediabetes increased to 12.4% (men, 14.5%; women, 10.4%) and 38.3% (men, 41%; women, 35.7%), respectively. Participants with HbA1c ≥6.5% and fasting glucose level <126 mg/dL were older and had lower estimated glomerular filtration rate.

Conclusion

We concluded that using fasting glucose level only may result in an underestimation of diabetes and prediabetes. HbA1c is an acceptable complementary diagnostic test for diabetes in Korean patients. However, national standardization is needed to order to use HbA1c as a diagnostic method of diabetes and prediabetes.

Citations

Citations to this article as recorded by  
  • Oxidative balance scores in Korean adults are associated with periodontitis
    Jeong‐Hwa Seon, Na‐Yeong Kim, Ji‐Eun Kim, Choong‐Ho Choi, Ki‐Ho Chung
    Journal of Periodontology.2025; 96(2): 176.     CrossRef
  • Noninvasive estimation of blood glucose and HbA1c using Quantum Machine Learning technique
    Parama Sridevi, Masud Rabbani, Md Hasanul Aziz, Paramita Basak Upama, Sayed Mashroor Mamun, Rumi Ahmed Khan, Sheikh Iqbal Ahamed
    Machine Learning with Applications.2025; 19: 100626.     CrossRef
  • Optimizing the critical value of fasting plasma glucose for accurate diagnosis of diabetes mellitus in Chinese: A population study
    Ying Xu, Jinliang Cai, Jingyi Zhang, Wenjian Shi, Wenye Jiao, Xiaolu Zhang, Dongmei Wang, Lin Liu
    International Journal of Diabetes in Developing Countries.2025;[Epub]     CrossRef
  • Transfer learning prediction of type 2 diabetes with unpaired clinical and genetic data
    YounSung Jung, SeanKyo Han, EunHee Kang, SoYoung Park, MinHee Kim, NanHee Kim, TaeJin Ahn
    Scientific Reports.2025;[Epub]     CrossRef
  • Air pollution, drought, and their synergistic effects on cardiovascular disease risk in China: a nationwide study
    Chaohao Ling, Rui Li, Qian Shen, Lulu Cui, Mangen Yang, Zhou Liu, Tianzhao Xu, Wenwen Sun, Shaofu He
    Environmental Pollution.2025; 384: 126955.     CrossRef
  • Relationship between Serum Cadmium Concentration and Lung Function: A Study Using Korea National Health and Nutrition Examination Survey Data
    Oh Beom Kwon, Eun Ju Lee, Myoung-Nam Lim, Jeeyoung Kim, Woo Jin Kim
    Tuberculosis and Respiratory Diseases.2025; 88(4): 696.     CrossRef
  • Occupational and Physical Activity Factors as Predictors of Prediabetes
    Jun-hee Kim
    Journal of Occupational & Environmental Medicine.2025; 67(11): e814.     CrossRef
  • Sex differences in the associations between socioeconomic status and all-cause mortality in Chinese adults with abnormal glucose metabolism: a prospective study
    Jia-min Yan, Min-zhe Zhang, Hong-jie Yu, Qi-qiang He
    BMC Public Health.2025;[Epub]     CrossRef
  • Fracture risk by post-cessation weight change in male patients with newly diagnosed type 2 diabetes mellitus
    Jina Chung, Sangwoo Park, Sun Jae Park, Hye Jun Kim, Jaewon Kim, Hyeokjong Lee, Seogsong Jeong, Young Jun Park, Kyae Hyung Kim, Hyun-Young Shin, Minjung Han, Kiheon Lee, Sang Min Park
    The American Journal of Medicine.2025;[Epub]     CrossRef
  • Validation of the Framingham Diabetes Risk Model Using Community-Based KoGES Data
    Hye Ah Lee, Hyesook Park, Young Sun Hong
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Dietary patterns and the risk of diabetes in Korean adults: A cross-sectional and prospective cohort study
    Jiyoung Hwang, Hyesook Kim, Oran Kwon
    Nutrition.2024; 125: 112491.     CrossRef
  • Diabetes and prediabetes prevalence through a community-based screening initiative in Alqunfudah, Saudi Arabia
    Saleh Ahmed Alshaikhi, Ahmed Madini Alamri, Ibrahim Yahya Alzilai, Ageel Ahmad Alghanimi, Ali Mohammad Alrufaidi, Ahmed Mohammed Alrufaidi, Ahmed Elsayed Bader, Ahmed Abushaisha Abdelmoniem, Ayoub Ali Alshaikh, Omar Ahmed Alshaikhi, Mohammed Ahmed Alshaik
    Future Science OA.2024;[Epub]     CrossRef
  • Investigating the Effects of Diet-Induced Prediabetes on Skeletal Muscle Strength in Male Sprague Dawley Rats
    Mandlakazi Dlamini, Andile Khathi
    International Journal of Molecular Sciences.2024; 25(7): 4076.     CrossRef
  • Investigating Factors Influencing the National Cancer Screening Program among Older Individuals in Republic of Korea—Data from the Korea National Health and Nutrition Examination Survey VIII
    Seok Hwan Kim, Hyo Eun Park
    Healthcare.2024; 12(12): 1237.     CrossRef
  • Association between gingivitis, tooth loss and cardiovascular risk: Insights from a 10-year nationwide cohort study of 3.7 million Koreans
    Seung Yeon Lee, César Félix Cayo-Rojas
    PLOS ONE.2024; 19(8): e0308250.     CrossRef
  • Relationship between Marriage and Prediabetes among Healthcare Workers: Mediating Effect of Triglycerides
    Yong-Hsin Chen, Jia-June Lin, Hsiu-Mei Tang, Ching-Wen Yang, Gwo-Ping Jong, Yi-Sun Yang
    Medicina.2024; 60(9): 1418.     CrossRef
  • Establishing a Female Animal Model of Prediabetes Using a High-Carbohydrate, High-Fat Diet
    Ayanda Nkosi, Reveshni Pather, Bongeka Mshengu, Andile Khathi, Phikelelani Ngubane
    Current Issues in Molecular Biology.2024; 46(11): 12397.     CrossRef
  • Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
    Bin Zhou, Archie W Rayner, Edward W Gregg, Kate E Sheffer, Rodrigo M Carrillo-Larco, James E Bennett, Jonathan E Shaw, Christopher J Paciorek, Rosie K Singleton, Ana Barradas Pires, Gretchen A Stevens, Goodarz Danaei, Victor PF Lhoste, Nowell H Phelps, Ra
    The Lancet.2024; 404(10467): 2077.     CrossRef
  • Burden of Diabetes Mellitus and Its Determinants among Adults (≥30 Years) Residing in Urban Field Practice Area of A Tertiary Care Teaching Hospital, Uttar Dinajpur, West Bengal
    Nabarun Mandal, Debayan Podder, Nazrul Mallick, Puspendu Biswas
    Acta Medica International.2024; 11(3): 239.     CrossRef
  • Diabetes screening in South Korea: a new estimate of the number needed to screen to detect diabetes
    Kyoung Hwa Ha, Kyung Ae Lee, Kyung-Do Han, Min Kyong Moon, Dae Jung Kim
    The Korean Journal of Internal Medicine.2023; 38(1): 93.     CrossRef
  • Comparison of diagnostic accuracy for diabetes diagnosis: A systematic review and network meta-analysis
    Khanh N. C. Duong, Chia Jie Tan, Sasivimol Rattanasiri, Ammarin Thakkinstian, Thunyarat Anothaisintawee, Nathorn Chaiyakunapruk
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • Evaluation of the Association between Amount and Type of Milk Consumption and Periodontitis: Data from the Korea National Health and Nutrition Examination Survey (2016–2018)
    Eun Jeong Min, Siseong Jeong, Jun-Beom Park
    Nutrients.2023; 15(4): 914.     CrossRef
  • Association between body mass index and reversion to normoglycemia from impaired fasting glucose among Chinese adults: a 5-year cohort study
    Yong Han, Haofei Hu, Zhiqiang Huang, Dehong Liu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Evaluation of calcium/magnesium ratio in patients with type 2 diabetes mellitus
    Kamile Yücel, Ali Fuat Gürbüz
    Turkish Journal of Biochemistry.2023; 48(3): 327.     CrossRef
  • Association of dietary sodium intake with impaired fasting glucose in adult cancer survivors: A population-based cross-sectional study
    Kyuwoong Kim, Hamee Kim, Tae Joon Jun, Young-Hak Kim, Dong Keon Yon
    PLOS ONE.2023; 18(5): e0286346.     CrossRef
  • Sitagliptin: the fixed combination of the first dipeptidyl peptidase 4 inhibitor and metformin
    L. V. Egshatyan
    Meditsinskiy sovet = Medical Council.2023; (13): 116.     CrossRef
  • Reply
    Kiyoshi Tamura
    Annals of Vascular Diseases.2023; 16(3): 244.     CrossRef
  • The inverse association between DNA gaps and HbA1c levels in type 2 diabetes mellitus
    Jirapan Thongsroy, Apiwat Mutirangura
    Scientific Reports.2023;[Epub]     CrossRef
  • Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c
    Bin Zhou, Kate E. Sheffer, James E. Bennett, Edward W. Gregg, Goodarz Danaei, Rosie K. Singleton, Jonathan E. Shaw, Anu Mishra, Victor P. F. Lhoste, Rodrigo M. Carrillo-Larco, Andre P. Kengne, Nowell H. Phelps, Rachel A. Heap, Archie W. Rayner, Gretchen A
    Nature Medicine.2023; 29(11): 2885.     CrossRef
  • Lobeglitazone and Its Therapeutic Benefits: A Review
    Balamurugan M, Sarumathy S, Robinson R
    Cureus.2023;[Epub]     CrossRef
  • Position Statement on the Appropriateness and Significance of Adding the Glycated Hemoglobin Test to the National Health Examination
    Ji Hye Kim, Dae Jung Kim, Jaehyun Kim, Sangjoon Park, Kyunghoon Lee, Jun Goo Kang, Eu Jeong Ku, Su Kyoung Kwon, Won Jun Kim, Young Sang Lyu, Jang Won Son, Young Sil Eom, Kyung Ae Lee, Jeongrim Lee, Jung Min Lee, Jung Hwa Lee, Jung Hwa Jung, Hochan Cho, Da
    The Journal of Korean Diabetes.2023; 24(4): 178.     CrossRef
  • Trends in Prediabetes and Non-Alcoholic Fatty Liver Disease Associated with Abdominal Obesity among Korean Children and Adolescents: Based on the Korea National Health and Nutrition Examination Survey between 2009 and 2018
    Kyungchul Song, Goeun Park, Hye Sun Lee, Myeongseob Lee, Hae In Lee, Jungmin Ahn, Eunbyoul Lee, Han Saem Choi, Junghwan Suh, Ahreum Kwon, Ho-Seong Kim, Hyun Wook Chae
    Biomedicines.2022; 10(3): 584.     CrossRef
  • Metabolic Effects of an Oral Glucose Tolerance Test Compared to the Mixed Meal Tolerance Tests: A Narrative Review
    Marlene Lages, Renata Barros, Pedro Moreira, Maria P. Guarino
    Nutrients.2022; 14(10): 2032.     CrossRef
  • Diabetes Prevalence and Associated Risk Factors among Women in a Rural District of Nepal Using HbA1c as a Diagnostic Tool: A Population-Based Study
    Chandra Yogal, Sunila Shakya, Biraj Karmarcharya, Rajendra Koju, Astrid Kamilla Stunes, Mats Peder Mosti, Miriam K. Gustafsson, Bjørn Olav Åsvold, Berit Schei, Unni Syversen
    International Journal of Environmental Research and Public Health.2022; 19(12): 7011.     CrossRef
  • Prediabetes diagnosis is associated with the progression of coronary artery calcification: The Kangbuk Samsung Health Study
    In Young Choi, Yoosoo Chang, Yoosun Cho, Jeonggyu Kang, Hyun‐Suk Jung, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu
    Diabetes, Obesity and Metabolism.2022; 24(11): 2118.     CrossRef
  • Investigating the Effects of Diet-Induced Pre-Diabetes on the Functioning of Calcium-Regulating Organs in Male Sprague Dawley Rats: Effects on Selected Markers
    Karishma Naidoo, Phikelelani S. Ngubane, Andile Khathi
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Oncometabolic surgery in gastric cancer patients with type 2 diabetes
    Yun Suk Choi, Jin Wook Yi, Woo Young Shin, Yoonseok Heo
    Scientific Reports.2022;[Epub]     CrossRef
  • Epidemiology of prediabetes mellitus among hill tribe adults in Thailand
    Tawatchai Apidechkul, Chalitar Chomchiei, Panupong Upala, Ratipark Tamornpark, Xi Pan
    PLOS ONE.2022; 17(7): e0271900.     CrossRef
  • Ameliorative Effects of Annona muricata Leaf Ethanol Extract on Renal Morphology of Alloxan-Induced Mice
    Supri Irianti Handayani, Mutiara Intan Permata Sari, Meilania Saraswati Sardjana, Kusmardi Kusmardi, Siti Nurbaya, Rosmalena Rosmalena, Ernawati Sinaga, Vivitri Dewi Prasasty
    Applied Sciences.2022; 12(18): 9141.     CrossRef
  • ADAM17 cleaves the insulin receptor ectodomain on endothelial cells and causes vascular insulin resistance
    Thaysa Ghiarone, Jorge A. Castorena-Gonzalez, Christopher A. Foote, Francisco I. Ramirez-Perez, Larissa Ferreira-Santos, Francisco J. Cabral-Amador, Roger de la Torre, Rama R. Ganga, Andrew A. Wheeler, Camila Manrique-Acevedo, Jaume Padilla, Luis A. Marti
    American Journal of Physiology-Heart and Circulatory Physiology.2022; 323(4): H688.     CrossRef
  • A causal relationship between alcohol intake and type 2 diabetes mellitus: A two-sample Mendelian randomization study
    Meiling Liu, Sunmin Park
    Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(12): 2865.     CrossRef
  • Diabetes stabilisation during COVID-19: A case history
    Linda Nazarko
    Independent Nurse.2021; 2021(1): 16.     CrossRef
  • Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status
    Chan-Hee Jung, Jang Won Son, Shinae Kang, Won Jun Kim, Hun-Sung Kim, Hae Soon Kim, Mihae Seo, Hye-Jung Shin, Seong-Su Lee, Su Jin Jeong, Yongin Cho, Seung Jin Han, Hyang Mi Jang, Mira Rho, Shinbi Lee, Mihyun Koo, Been Yoo, Jung-Wha Moon, Hye Young Lee, Ja
    Diabetes & Metabolism Journal.2021; 45(1): 1.     CrossRef
  • Does autonomic nervous system dysfunction influence cardiovascular disease risk in young adults with intellectual disability?
    Clara C. Zwack, Rachael McDonald, Ainura Tursunalieva, Amali Cooray, Gavin W. Lambert, Elisabeth A. Lambert
    American Journal of Physiology-Heart and Circulatory Physiology.2021; 320(2): H891.     CrossRef
  • Prevalence of Prediabetes and Undiagnosed Diabetes Among Kuwaiti Adults: A Cross-Sectional Study
    Anwar Mohammad, Ali H Ziyab, Talal Mohammad
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 2167.     CrossRef
  • The prevalence of diabetes amongst young Emirati female adults in the United Arab Emirates: A cross-sectional study
    Maysm N. Mohamad, Leila Cheikh Ismail, Lily Stojanovska, Vasso Apostolopoulos, Jack Feehan, Amjad H. Jarrar, Ayesha S. Al Dhaheri, Muhammad Sajid Hamid Akash
    PLOS ONE.2021; 16(6): e0252884.     CrossRef
  • The prevalence and correlates of pre-diabetes in middle- to older-aged Irish adults using three diagnostic methods
    Kate Junker, Claire M. Buckley, Seán R. Millar, Sinéad Flynn, Janas M. Harrington, Patricia M. Kearney, Ivan J. Perry, Muhammad Sajid Hamid Akash
    PLOS ONE.2021; 16(6): e0253537.     CrossRef
  • Korea National Health and Nutrition Examination Survey, 20th anniversary: accomplishments and future directions
    Kyungwon Oh, Yoonjung Kim, Sanghui Kweon, Soyeon Kim, Sungha Yun, Suyeon Park, Yeon-Kyeng Lee, Youngtaek Kim, Ok Park, Eun Kyeong Jeong
    Epidemiology and Health.2021; 43: e2021025.     CrossRef
  • The Use of Mobile Personal Health Records for Hemoglobin A1c Regulation in Patients With Diabetes: Retrospective Observational Study
    Dongjin Seo, Yu Rang Park, Yura Lee, Ji Young Kim, Joong-Yeol Park, Jae-Ho Lee
    Journal of Medical Internet Research.2020; 22(6): e15372.     CrossRef
  • Optimal fasting plasma glucose and haemoglobin A1c levels for screening of prediabetes and diabetes according to 2‐hour plasma glucose in a high‐risk population: The Korean Diabetes Prevention Study
    Seon‐Ah Cha, Suk Chon, Jae‐Seung Yun, Sang Youl Rhee, Sun‐Young Lim, Kun‐Ho Yoon, Yu‐Bae Ahn, Seung‐Hyun Ko, Jeong‐Taek Woo, Jin‐Hee Lee
    Diabetes/Metabolism Research and Reviews.2020;[Epub]     CrossRef
  • The additive effect of type 2 diabetes on fibrinogen, von Willebrand factor, tryptophan and threonine in people living with HIV
    Michelle L. Harrison, Anthony S. Wolfe, Jonathan Fordyce, Jamie Rock, Alexandra A. García, Julie A. Zuñiga
    Amino Acids.2019; 51(5): 783.     CrossRef
  • Prevalence of Diabetes Mellitus in Adult Residents of Rural Regions of Grash Town, Fars, Iran during 2015-201
    H. Soori, M.N. Mohammadi, J. Yoosefi Lebni
    Health Education and Health Promotion.2019; 7(2): 89.     CrossRef
  • Understanding prediabetes: definition, prevalence, burden and treatment options for an emerging disease
    Kristian Rett, Ulrike Gottwald-Hostalek
    Current Medical Research and Opinion.2019; 35(9): 1529.     CrossRef
  • Does reviewing fasting plasma glucose results patterns before glycosylated hemoglobin testing in type-2 diabetic patients lead to better testing decision?
    Wichaporn Intharachuti, Jiruth Sriratanaban
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 2080.     CrossRef
  • Discrepancies between Glycosylated Hemoglobin and Fasting Plasma Glucose for Diagnosing Impaired Fasting Glucose and Diabetes Mellitus in Korean Youth and Young Adults
    Jieun Lee, Young Ah Lee, Jae Hyun Kim, Seong Yong Lee, Choong Ho Shin, Sei Won Yang
    Diabetes & Metabolism Journal.2019; 43(2): 174.     CrossRef
  • Colorectal Cancer Risks According to Sex Differences in Patients With Type II Diabetes Mellitus: A Korean Nationwide Population-Based Cohort Study
    Ji Min Lee, Kang-Moon Lee, Dae Bum Kim, Seung-Hyun Ko, Yong Gyu Park
    Clinical and Translational Gastroenterology.2019; 10(10): e00090.     CrossRef
  • Isolated HbA1c identifies a different subgroup of individuals with type 2 diabetes compared to fasting or post-challenge glucose in Asian Indians: The CARRS and MASALA studies
    U.P. Gujral, D. Prabhakaran, R. Pradeepa, N.R. Kandula, D. Kondal, M. Deepa, N.A. Zakai, R.M. Anjana, G. Rautela, V. Mohan, K.M.V. Narayan, N. Tandon, A.M. Kanaya
    Diabetes Research and Clinical Practice.2019; 153: 93.     CrossRef
  • Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status
    Bo-Yeon Kim, Jong Chul Won, Jae Hyuk Lee, Hun-Sung Kim, Jung Hwan Park, Kyoung Hwa Ha, Kyu Chang Won, Dae Jung Kim, Kyong Soo Park
    Diabetes & Metabolism Journal.2019; 43(4): 487.     CrossRef
  • Lack of association between particulate air pollution and blood glucose levels and diabetic status in peri-urban India
    Ariadna Curto, Otavio Ranzani, Carles Milà, Margaux Sanchez, Julian D. Marshall, Bharati Kulkarni, Santhi Bhogadi, Sanjay Kinra, Gregory A. Wellenius, Cathryn Tonne
    Environment International.2019; 131: 105033.     CrossRef
  • Diabetes Prevalence Survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan
    Azizul Hasan Aamir, Zia Ul-Haq, Saeed A Mahar, Faisal Masood Qureshi, Ibrar Ahmad, Ali Jawa, Aisha Sheikh, Abbas Raza, Sheraz Fazid, Zahid Jadoon, Osama Ishtiaq, Nauman Safdar, Hussain Afridi, Adrian H Heald
    BMJ Open.2019; 9(2): e025300.     CrossRef
  • Evaluation of the associations between immunoglobulin E levels and the number of natural teeth
    Kyungdo Han, Eunjoo Lee, Jun-Beom Park
    Journal of the Formosan Medical Association.2018; 117(7): 605.     CrossRef
  • Clinical implications of age and sex in the prevalence of periodontitis in Korean adults with diabetes
    Kyungdo Han, Jun‑Beom Park
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Clinical implication of fasting glucose and systolic/diastolic blood pressure on the prevalence of periodontitis in non‑diabetic and non‑hypertensive adults using nationally representative data
    Kyungdo Han, Jun‑Beom Park
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Past and Current Status of Adult Type 2 Diabetes Mellitus Management in Korea: A National Health Insurance Service Database Analysis
    Seung-Hyun Ko, Kyungdo Han, Yong-ho Lee, Junghyun Noh, Cheol-Young Park, Dae-Jung Kim, Chang Hee Jung, Ki-Up Lee, Kyung-Soo Ko
    Diabetes & Metabolism Journal.2018; 42(2): 93.     CrossRef
  • Glycated heamoglobin A1c as a tool for epidemiological studies to assess diabetes prevalence: How has it been used since its official recommendation for diabetes diagnosis?
    D. Simon
    Diabetes & Metabolism.2018; 44(3): 197.     CrossRef
  • Type 2 Diabetes Mellitus and Cognitive Function in the Elderly
    Nazila Malekian, Seyed Reza Hosseini, Sussan Moudi, Mohammad Ali Bayani, Farzan Kheirkhah, Ali Bijani, Aylar Khalilipour
    Iranian Journal of Psychiatry and Behavioral Sciences.2018;[Epub]     CrossRef
  • Evaluation of an association between long sleep duration and periodontal disease among men and women using nationally representative data
    Kyungdo Han, Yong-Moon Park, Jun-Beom Park
    Gaceta Sanitaria.2018; 32(2): 143.     CrossRef
  • Significance of prediabetes as a nosological entity
    Ladislav Stepanek, Dagmar Horakova, Marie Nakladalova, Lubica Cibickova, David Karasek, Josef Zadrazil
    Biomedical Papers.2018; 162(4): 249.     CrossRef
  • Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status
    Jong Chul Won, Jae Hyuk Lee, Jae Hyeon Kim, Eun Seok Kang, Kyu Chang Won, Dae Jung Kim, Moon-Kyu Lee
    Diabetes & Metabolism Journal.2018; 42(5): 415.     CrossRef
  • Development and Validation of the Korean Diabetes Risk Score: A 10-Year National Cohort Study
    Kyoung Hwa Ha, Yong-ho Lee, Sun Ok Song, Jae-woo Lee, Dong Wook Kim, Kyung-hee Cho, Dae Jung Kim
    Diabetes & Metabolism Journal.2018; 42(5): 402.     CrossRef
  • Evaluation of the association between sleep duration and tooth loss among Korean adults: data from the Korean National Health and Nutrition Examination Survey (KNHANES 2012–2014)
    Kyungdo Han, Jun-Beom Park
    BMJ Open.2018; 8(5): e018383.     CrossRef
  • Impact of glycated hemoglobin (HbA1c) on identifying insulin resistance among apparently healthy individuals
    Sarama Saha, Peter E. H. Schwarz
    Journal of Public Health.2017; 25(5): 505.     CrossRef
  • Trends in the pervasiveness of type 2 diabetes, impaired fasting glucose and co-morbidities during an 8-year-follow-up of nationwide Korean population
    Junghyun Noh, Kyung-Do Han, Seung-Hyun Ko, Kyung Soo Ko, Cheol-Young Park
    Scientific Reports.2017;[Epub]     CrossRef
  • Efficacy and safety of sitagliptin/metformin fixed‐dose combination compared with glimepiride in patients with type 2 diabetes: A multicenter randomized double‐blind study
    Sang Soo Kim, In Joo Kim, Kwang Jae Lee, Jeong Hyun Park, Young Il Kim, Young Sil Lee, Sung Chang Chung, Sang Jin Lee
    Journal of Diabetes.2017; 9(4): 412.     CrossRef
  • Periodontitis is associated with diabetic retinopathy in non-obese adults
    Su Jeong Song, Seong-su Lee, Kyungdo Han, Jun-Beom Park
    Endocrine.2017; 56(1): 82.     CrossRef
  • Association between oral health behavior and periodontal disease among Korean adults
    Kyungdo Han, Jun-Beom Park
    Medicine.2017; 96(7): e6176.     CrossRef
  • Prevalence and risk factors for reduced pulmonary function in diabetic patients: The Korea National Health and Nutrition Examination Survey
    Hee Yeon Kim, Tae Seo Sohn, Hannah Seok, Chang Dong Yeo, Young Soo Kim, Jae Yen Song, Young Bok Lee, Dong-Hee Lee, Jae-Im Lee, Tae-Kyu Lee, Seong Cheol Jeong, Mihee Hong, Hiun Suk Chae
    The Korean Journal of Internal Medicine.2017; 32(4): 682.     CrossRef
  • Impaired Fasting Glucose Rate by Diabetes Family History
    Eun-Hei Kim, Sang-Geun Bae, Keon-Yeop Kim, Yoon-ju Na
    Journal of Health Informatics and Statistics.2017; 42(1): 63.     CrossRef
  • Age threshold for moderate and severe periodontitis among Korean adults without diabetes mellitus, hypertension, metabolic syndrome, and/or obesity
    Kyungdo Han, Jun-Beom Park
    Medicine.2017; 96(33): e7835.     CrossRef
  • Socioeconomic status is associated with global diabetes prevalence
    Zhiye Xu, Dan Yu, Xueyao Yin, Fenping Zheng, Hong Li
    Oncotarget.2017; 8(27): 44434.     CrossRef
  • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
  • Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
    Soo Lim, Kyoung Min Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yongsoo Park, Sang Jin Kim, Hak Chul Jang, Dong Seop Choi
    Diabetes & Metabolism Journal.2017; 41(5): 377.     CrossRef
  • Association between underweight and tooth loss among Korean adults
    In-Seok Song, Kyungdo Han, Jae-Jun Ryu, Jun-Beom Park
    Scientific Reports.2017;[Epub]     CrossRef
  • Outcomes and inequalities in diabetes from 2004/2005 to 2011/2012: English longitudinal study
    Robert Fleetcroft, Miqdad Asaria, Shehzad Ali, Richard Cookson
    British Journal of General Practice.2017; 67(654): e1.     CrossRef
  • Discordance in the diagnosis of diabetes: Comparison between HbA1c and fasting plasma glucose
    Lan T. Ho-Pham, Uyen D. T. Nguyen, Truong X. Tran, Tuan V. Nguyen, Petter Bjornstad
    PLOS ONE.2017; 12(8): e0182192.     CrossRef
  • Declining Incidence of Ischemic Stroke
    Anne M. Vangen-Lønne, Tom Wilsgaard, Stein Harald Johnsen, Maja-Lisa Løchen, Inger Njølstad, Ellisiv B. Mathiesen
    Stroke.2017; 48(3): 544.     CrossRef
  • Association between temporomandibular disorders and obesity
    Eunmi Rhim, Kyungdo Han, Kyoung-In Yun
    Journal of Cranio-Maxillofacial Surgery.2016; 44(8): 1003.     CrossRef
  • Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002–2013
    Seung-Hyun Ko, Dae-Jung Kim, Jong-Heon Park, Cheol-Young Park, Chang Hee Jung, Hyuk-Sang Kwon, Joong-Yeol Park, Kee-Ho Song, Kyungdo Han, Ki-Up Lee, Kyung-Soo Ko
    Medicine.2016; 95(27): e4018.     CrossRef
  • Prevalence and risk factors of periodontitis among adults with or without diabetes mellitus
    Mihee Hong, Hee Yeon Kim, Hannah Seok, Chang Dong Yeo, Young Soo Kim, Jae Yen Song, Young Bok Lee, Dong-Hee Lee, Jae-Im Lee, Tae-Kyu Lee, Hyo-Suk Ahn, Yoon Ho Ko, Seong Cheol Jeong, Hiun Suk Chae, Tae Seo Sohn
    The Korean Journal of Internal Medicine.2016; 31(5): 910.     CrossRef
  • The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter
    Young Eun Chon, Kwang Joon Kim, Kyu Sik Jung, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Jae Bock Chung, Kyeong Hye Park, Ji Cheol Bae, Kwang-Hyub Han
    Yonsei Medical Journal.2016; 57(4): 885.     CrossRef
  • Comparative Study on Self-care Behavior Related Factors for Good, Inadequate and Poor Glycemic Control Groups: Based on Variables from Theory of Planned Behavior, Habit, and Family support*
    Jae-Kyoung Kim, Mee Ock Gu
    Journal of Korean Academy of Fundamentals of Nursing.2016; 23(3): 245.     CrossRef
  • Associations between the number of natural teeth and renal dysfunction
    Hye Min Choi, Kyungdo Han, Yong Gyu Park, Jun-Beom Park
    Medicine.2016; 95(34): e4681.     CrossRef
  • Associations between the number of natural teeth in postmenopausal women and duration of lactation: The 2010–2012 Korea National Health and Nutrition Examination Survey
    Kyungdo Han, Youngkyung Ko, Yong-Gyu Park, Jun-Beom Park
    Maturitas.2016; 85: 73.     CrossRef
  • Trends in Diabetes Incidence in the Last Decade Based on Korean National Health Insurance Claims Data
    Sun Ok Song, Yong-ho Lee, Dong Wook Kim, Young Duk Song, Joo Young Nam, Kyoung Hye Park, Dae Jung Kim, Seok Won Park, Hyun Chul Lee, Byung-Wan Lee
    Endocrinology and Metabolism.2016; 31(2): 292.     CrossRef
  • Comparison of Age of Onset and Frequency of Diabetic Complications in the Very Elderly Patients with Type 2 Diabetes
    Bong-Ki Lee, Sang-Wook Kim, Daehee Choi, Eun-Hee Cho
    Endocrinology and Metabolism.2016; 31(3): 416.     CrossRef
  • Emerging Role of Nitric Oxide and Heat Shock Proteins in Insulin Resistance
    Marisa Nile Molina, León Ferder, Walter Manucha
    Current Hypertension Reports.2016;[Epub]     CrossRef
  • Association between Consumption of Coffee and the Prevalence of Periodontitis: The 2008–2010 Korea National Health and Nutrition Examination Survey
    Kyungdo Han, Eunkyung Hwang, Jun-Beom Park, Alberto G Passi
    PLOS ONE.2016; 11(7): e0158845.     CrossRef
  • Cause-of-death statistics in the Republic of Korea, 2014
    Hyun-Young Shin, Ji-Youn Lee, Juhwa Song, Seokmin Lee, Junghun Lee, Byeongsun Lim, Heyran Kim, Sun Huh
    Journal of the Korean Medical Association.2016; 59(3): 221.     CrossRef
  • Effect of Wheat Flour Noodles with Bombyx mori Powder on Glycemic Response in Healthy Subjects
    Wanhee Suk, JiEun Kim, Do-Yeon Kim, Hyunjung Lim, Ryowon Choue
    Preventive Nutrition and Food Science.2016; 21(3): 165.     CrossRef
  • C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index
    Jong-Dai Kim, Sung Ju Kang, Min Kyung Lee, Se Eun Park, Eun Jung Rhee, Cheol-Young Park, Ki-Won Oh, Sung-Woo Park, Won-Young Lee
    Endocrinology and Metabolism.2016; 31(2): 320.     CrossRef
  • Inhibition of advanced glycation end product formation by burdock root extract
    Darye Lee, Choon Young Kim
    Journal of Nutrition and Health.2016; 49(4): 233.     CrossRef
  • Associations between the number of natural teeth in postmenopausal women and hormone replacement therapy
    Kyungdo Han, Youngkyung Ko, Yong-Gyu Park, Jun-Beom Park
    Maturitas.2016; 94: 125.     CrossRef
  • Is an Oral Glucose Tolerance Test Still Valid for Diagnosing Diabetes Mellitus?
    Dong-Lim Kim, Sun-Doo Kim, Suk Kyeong Kim, Sooyoun Park, Kee-Ho Song
    Diabetes & Metabolism Journal.2016; 40(2): 118.     CrossRef
  • Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population
    Bo Kyung Koo, Min Kyong Moon
    Diabetes & Metabolism Journal.2016; 40(3): 175.     CrossRef
  • Comparison of the clinical characteristics of diabetes mellitus diagnosed using fasting plasma glucose and haemoglobin A1c: The 2011 Korea National Health and Nutrition Examination Survey
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Chang Beom Lee, Sung-Hee Ihm
    Diabetes Research and Clinical Practice.2016; 113: 23.     CrossRef
  • Excessive Consumption of Green Tea as a Risk Factor for Periodontal Disease among Korean Adults
    Kyungdo Han, Eunkyung Hwang, Jun-Beom Park
    Nutrients.2016; 8(7): 408.     CrossRef
  • Laboratorydiagnosis of prediabetes
    Grażyna Odrowąż-Sypniewska
    Diagnostyka Laboratoryjna.2016; 52(1): 57.     CrossRef
  • TRPV1 Gene Polymorphisms Are Associated with Type 2 Diabetes by Their Interaction with Fat Consumption in the Korean Genome Epidemiology Study
    Sunmin Park, Xin Zhang, Na Ra Lee, Hyun-Seok Jin
    Lifestyle Genomics.2016; 9(1): 47.     CrossRef
  • Need for Diabetes Prevention Study
    Ja Young Jeon, Dae Jung Kim
    The Journal of Korean Diabetes.2015; 16(3): 161.     CrossRef
  • New risk factors for obesity and diabetes: Environmental chemicals
    Ja Young Jeon, Kyoung Hwa Ha, Dae Jung Kim
    Journal of Diabetes Investigation.2015; 6(2): 109.     CrossRef
  • Hospital Nurses' Pre-diabetes Knowledge, Performance and Expectation of Patient Education
    Min Jung Kim, Misoon Song
    Perspectives in Nursing Science.2015; 12(1): 33.     CrossRef
  • Secular Changes in Prediabetes Indicators Among Older-Adult Americans, 1999−2010
    Carl J. Caspersen, G. Darlene Thomas, Gloria L.A. Beckles, Kai McKeever Bullard
    American Journal of Preventive Medicine.2015; 48(3): 253.     CrossRef
  • Low transferrin saturation is associated with impaired fasting glucose and insulin resistance in the South Korean adults: the 2010 Korean National Health and Nutrition Examination Survey
    R. J. Park, J. D. Moon
    Diabetic Medicine.2015; 32(5): 673.     CrossRef
  • Role of habitual physical activity in modulating vascular actions of insulin
    Jaume Padilla, T. Dylan Olver, John P. Thyfault, Paul J. Fadel
    Experimental Physiology.2015; 100(7): 759.     CrossRef
  • Derivation and validation of an HbA1c optimal cutoff for diagnosing prediabetes in a South African mixed ancestry population
    Annalise E. Zemlin, Tandi E. Matsha, Andre P. Kengne, Rajiv T. Erasmus
    Clinica Chimica Acta.2015; 448: 215.     CrossRef
  • Change in Corneal Biomechanical Parameters in Diabetes Mellitus
    Yeon Ggoch Park, Jin Young Rhew, Kyu Ryong Choi
    Journal of the Korean Ophthalmological Society.2015; 56(4): 567.     CrossRef
  • New Directions in Chronic Disease Management
    Hun-Sung Kim, Jae-Hyoung Cho, Kun-Ho Yoon
    Endocrinology and Metabolism.2015; 30(2): 159.     CrossRef
  • Insulin Initiation in Insulin-Naïve Korean Type 2 Diabetic Patients Inadequately Controlled on Oral Antidiabetic Drugs in Real-World Practice: The Modality of Insulin Treatment Evaluation Study
    Sang Soo Kim, In Joo Kim, Yong Ki Kim, Kun Ho Yoon, Ho Young Son, Sung Woo Park, Yeon Ah Sung, Hong Sun Baek
    Diabetes & Metabolism Journal.2015; 39(6): 481.     CrossRef
  • New insights into insulin action and resistance in the vasculature
    Camila Manrique, Guido Lastra, James R. Sowers
    Annals of the New York Academy of Sciences.2014; 1311(1): 138.     CrossRef
  • Current Status of Glycemic Control of Patients with Diabetes in Korea: The Fifth Korea National Health and Nutrition Examination Survey
    Ja Young Jeon, Dae Jung Kim, Seung-Hyun Ko, Hyuk-Sang Kwon, Soo Lim, Sung Hee Choi, Chul Sik Kim, Jee Hyun An, Nan Hee Kim, Jong Chul Won, Jae Hyeon Kim, Bong-Yun Cha, Kee-Ho Song
    Diabetes & Metabolism Journal.2014; 38(3): 197.     CrossRef
  • It's Still Not Too Late to Make a Change: Current Status of Glycemic Control in Korea
    Sang Yong Kim
    Diabetes & Metabolism Journal.2014; 38(3): 194.     CrossRef
  • Diabetes Update 2014 – das spannendste Diabetes-Update aller Zeiten
    W.A. Scherbaum
    Der Diabetologe.2014; 10(5): 363.     CrossRef
  • Higher Prevalence and Awareness, but Lower Control Rate of Hypertension in Patients with Diabetes than General Population: The Fifth Korean National Health and Nutrition Examination Survey in 2011
    Seung-Hyun Ko, Hyuk-Sang Kwon, Dae Jung Kim, Jae Hyeon Kim, Nan Hee Kim, Chul Sik Kim, Kee-Ho Song, Jong Chul Won, Soo Lim, Sung Hee Choi, Kyungdo Han, Yong-Moon Park, Bong-Yun Cha
    Diabetes & Metabolism Journal.2014; 38(1): 51.     CrossRef
  • Association Between Alcohol Consumption and Periodontal Disease: The 2008 to 2010 Korea National Health and Nutrition Examination Survey
    Jun‐Beom Park, Kyungdo Han, Yong‐Gyu Park, Youngkyung Ko
    Journal of Periodontology.2014; 85(11): 1521.     CrossRef
  • Glycaemic and haemoglobin A1c thresholds for detecting diabetic retinopathy: The fifth Korea National Health and Nutrition Examination Survey (2011)
    Yong-Moon Park, Seung-Hyun Ko, Jung-Min Lee, Dae-Jung Kim, Dong-Joon Kim, Kyungdo Han, Julie K. Bower, Yu-Bae Ahn
    Diabetes Research and Clinical Practice.2014; 104(3): 435.     CrossRef
  • Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives
    Cheol Whee Park
    Diabetes & Metabolism Journal.2014; 38(4): 252.     CrossRef
  • Insulin Resistance and Skeletal Muscle Vasculature: Significance, Assessment and Therapeutic Modulators
    Camila Manrique, James R. Sowers
    Cardiorenal Medicine.2014; 4(3-4): 244.     CrossRef
  • Metformin Based Dual-Combination Therapies in Drug Naïve Type 2 Diabetic Patients
    Dong-Lim Kim
    Diabetes & Metabolism Journal.2013; 37(6): 429.     CrossRef
Hemoglobin A1c May Be an Inadequate Diagnostic Tool for Diabetes Mellitus in Anemic Subjects
Jung Il Son, Sang Youl Rhee, Jeong-taek Woo, Jin Kyung Hwang, Sang Ouk Chin, Suk Chon, Seungjoon Oh, Sung Woon Kim, Young Seol Kim
Diabetes Metab J. 2013;37(5):343-348.   Published online October 17, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.5.343
  • 18,853 View
  • 157 Download
  • 38 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Recently, a hemoglobin A1c (HbA1c) level of 6.5% has been determined to be a criterion for diabetes mellitus (DM), and it is a widely used marker for the diagnosis of DM. However, HbA1c may be influenced by a number of factors. Anemia is one of the most prevalent diseases with an influence on HbA1c; however, its effect on HbA1c varies based on the variable pathophysiology of anemia. The aim of this study was to determine the effect of anemia on HbA1c levels.

Methods

Anemic subjects (n=112) and age- and sex-matched controls (n=217) who were drug naive and suspected of having DM were enrolled. The subjects underwent an oral glucose tolerance test and HbA1c simultaneously. We compared mean HbA1c and its sensitivity and specificity for diagnosing DM between each subgroup.

Results

Clinical characteristics were found to be similar between each subgroup. Also, when glucose levels were within the normal range, the difference in mean HbA1c was not significant (P=0.580). However, when plasma glucose levels were above the diagnostic cutoff for prediabetes and DM, the mean HbA1c of the anemic subgroup was modestly higher than in the nonanemic group. The specificity of HbA1c for diagnosis of DM was significantly lower in the anemic subgroup (P<0.05).

Conclusion

These results suggest that the diagnostic significance of HbA1c might be limited in anemic patients.

Citations

Citations to this article as recorded by  
  • Anemia risk and mitigation strategies in type 2 diabetic patients: The role of novel antidiabetic agents
    Petra Meliš, Maja Cigrovski Berkovic
    World Journal of Diabetes.2025;[Epub]     CrossRef
  • Type 2 Diabetes and Iron Deficiency: The Effect of Oral and Intravenous Iron Therapy on HbA1c
    Esra Timurkaan, Mustafa Timurkaan, Muhammed Fuad Uslu
    Hippocrates Medical Journal.2025; 5(3): 96.     CrossRef
  • Unlocking Optimal Glycemic Interpretation: Redefining HbA1c Analysis in Female Patients With Diabetes and Iron‐Deficiency Anemia Using Machine Learning Algorithms
    Kadra Mohamed Abdillahi, Fatma Ceyla Eraldemir, Irfan Kösesoy
    Journal of Clinical Laboratory Analysis.2024;[Epub]     CrossRef
  • Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
    Soravis Osataphan, Muhammad Awidi, Yu Jen Jan, Krishna Gunturu, Shriram Sundararaman, Hollis Viray, Edward Frankenberger, Melissa Mariano, Lauren O’Loughlin, Andrew Piper-Vallillo, Katherine Stafford, Aleksandra Kolnick, Hind Ghazalah, Kartik Sehgal, Mary
    Lung Cancer.2024; 198: 108023.     CrossRef
  • Establishment of a feline glycated hemoglobin reference interval for a novel dried‐blood‐spot assay and the effects of anemia on assay results
    Jocelyn Mott, Jacqueline K. Dolan, Chen Gilor, Shir Gilor
    Veterinary Clinical Pathology.2023; 52(3): 531.     CrossRef
  • Waist circumference and glycaemia are strong predictors of progression to diabetes in individuals with prediabetes in sub-Saharan Africa: 4-year prospective cohort study in Malawi
    Wisdom P. Nakanga, Amelia C. Crampin, Joseph Mkandawire, Louis Banda, Rob C. Andrews, Andrew T. Hattersley, Moffat J. Nyirenda, Lauren R. Rodgers, Julia Robinson
    PLOS Global Public Health.2023; 3(9): e0001263.     CrossRef
  • Implications of Iron Deficiency Anaemia on Glycemic Dynamics in Diabetes Mellitus: A Critical Risk Factor in Cardiovascular Disease
    Eman Elsheikh, Sereen S Aljohani , Munirah M Alshaikhmubarak, Meshari A Alhawl, Alhanouf W Alsubaie, Norah Alsultan, Asmaa F Sharif, Sayed Ibrahim Ali
    Cureus.2023;[Epub]     CrossRef
  • Serum Iron Profile in Type 2 Diabetes, A Role Beyond Anemic Marker!
    Happy Chutia, Sungdirenla Jamir, Md Yasir, Gautam Handique
    The Journal of Medical Research.2023; 9(5): 129.     CrossRef
  • Large-scale retrospective analyses of the effect of iron deficiency anemia on hemoglobin A1c concentrations
    Lokinendi V. Rao, George W. Pratt, Caixia Bi, Martin H. Kroll
    Clinica Chimica Acta.2022; 529: 21.     CrossRef
  • Glycemic Abnormalities Assessment on Children and Adolescents with Beta-Thalassemia Major
    Siska Mayasari Lubis, Bidasari Lubis, Nadhira Anindita Ralena
    Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 697.     CrossRef
  • Integrity loss of glycosylated hemoglobin with deepening anemia
    Bünyamin AYDIN, Aysun GÖNDEREN
    Journal of Health Sciences and Medicine.2022; 5(3): 839.     CrossRef
  • Effect of anemia and erythrocyte indices on hemoglobin A1c levels among pregnant women
    Zong-Hui Guo, Huai-Liang Tian, Xiao-Qian Zhang, Deng-Han Zhang, Zhi-Min Wang, Kun Wang, Wen-Wen Su, Fei Chen
    Clinica Chimica Acta.2022; 534: 1.     CrossRef
  • Genetic association of anthropometric traits with type 2 diabetes in ethnically endogamous Sindhi families
    Manju Mamtani, Manisha T. Jaisinghani, Sujeet G. Jaiswal, Kanchan V. Pipal, Ashwini A. Patel, Hemant Kulkarni, Lee-Ling Lim
    PLOS ONE.2021; 16(9): e0257390.     CrossRef
  • Influence of red blood cell indices on HbA1c performance in detecting dysglycaemia in a Singapore preconception cohort study
    See Ling Loy, Jinjie Lin, Yin Bun Cheung, Aravind Venkatesh Sreedharan, Xinyi Chin, Keith M. Godfrey, Kok Hian Tan, Lynette Pei-Chi Shek, Yap Seng Chong, Melvin Khee-Shing Leow, Chin Meng Khoo, Yung Seng Lee, Shiao-Yng Chan, Ngee Lek, Jerry Kok Yen Chan,
    Scientific Reports.2021;[Epub]     CrossRef
  • Increased risks of different grades of non‐alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7–6.4% in a Chinese population
    Chung‐Hao Li, Yu‐Tsung Chou, Wei‐Chen Shen, Feng‐Hwa Lu, Yi‐Ching Yang, Jin‐Shang Wu, Chih‐Jen Chang
    Journal of Diabetes Investigation.2020; 11(5): 1336.     CrossRef
  • Evaluation of continuous glucose monitoring system for detection of alterations in glucose homeostasis in pediatric patients with β-thalassemia major
    Mona H. El-Samahy, Azza A. Tantawy, Amira A. Adly, Abeer A. Abdelmaksoud, Eman A. Ismail, Nouran Y. Salah
    Pediatric Diabetes.2019; 20(1): 65.     CrossRef
  • Glycosylated Hemoglobin in Subjects Affected by Iron-Deficiency Anemia
    Jari Intra, Giuseppe Limonta, Fabrizio Cappellini, Maria Bertona, Paolo Brambilla
    Diabetes & Metabolism Journal.2019; 43(4): 539.     CrossRef
  • The role of telenursing in the management of diabetes:A systematic review and meta‐analysis
    Sa Yang, Qiuhuan Jiang, Hongfang Li
    Public Health Nursing.2019; 36(4): 575.     CrossRef
  • Glycated haemoglobin and iron deficiency anaemia: a case‐control study
    Jari Intra, Giuseppe Limonta, Fabrizio Cappellini, Maria Bertona, Paolo Brambilla
    Practical Diabetes.2018; 35(3): 90.     CrossRef
  • Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol
    Christoph Schindler, Andreas L. Birkenfeld, Markolf Hanefeld, Ulrike Schatz, Carsta Köhler, Martin Grüneberg, Diethelm Tschöpe, Matthias Blüher, Christoph Hasslacher, Stefan R. Bornstein
    Diabetes Therapy.2018; 9(1): 37.     CrossRef
  • Effectiveness of smartphone technologies on glycaemic control in patients with type 2 diabetes: systematic review with meta‐analysis of 17 trials
    I. X. Y. Wu, J. C. Y. Kee, D. E. Threapleton, R. C. W. Ma, V. C. K. Lam, E. K. P. Lee, S. Y. S. Wong, V. C. H. Chung
    Obesity Reviews.2018; 19(6): 825.     CrossRef
  • Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome
    Zubin Punthakee, Ronald Goldenberg, Pamela Katz
    Canadian Journal of Diabetes.2018; 42: S10.     CrossRef
  • Iron status and its association with HbA1c levels in Dutch children with diabetes mellitus type 1
    Marjolijn D. Akkermans, E. C. A. Mieke Houdijk, Boudewijn Bakker, Agnes Clement-de Boers, Daniëlle C. M. van der Kaay, Martine C. de Vries, M. Claire Woltering, Dick Mul, Johannes B. van Goudoever, Frank Brus
    European Journal of Pediatrics.2018; 177(4): 603.     CrossRef
  • Association between Hemoglobin and Hemoglobin A1c: A Data-Driven Analysis of Health Checkup Data in Japan
    Masato Takeuchi, Koji Kawakami
    Journal of Clinical Medicine.2018; 7(12): 539.     CrossRef
  • Glycated haemoglobin A1c (HbA1c) for detection of diabetes mellitus and impaired fasting glucose in Malawi: a diagnostic accuracy study
    Sujit D Rathod, Amelia C Crampin, Crispin Musicha, Ndoliwe Kayuni, Louis Banda, Jacqueline Saul, Estelle McLean, Keith Branson, Shabbar Jaffar, Moffat J Nyirenda
    BMJ Open.2018; 8(5): e020972.     CrossRef
  • Sex and age affect agreement between fasting plasma glucose and glycosylated hemoglobin for diagnosis of dysglycemia
    Mercedes Lorenzo-Medina, Begoña Uranga, Antonio Rus, Rosa Martínez, Carolina Puertas, María Dolores Blanco, Ernesto Casís, Rosa Corcoy
    Endocrinología, Diabetes y Nutrición.2017; 64(7): 345.     CrossRef
  • Sex and age affect agreement between fasting plasma glucose and glycosylated hemoglobin for diagnosis of dysglycemia
    Mercedes Lorenzo-Medina, Begoña Uranga, Antonio Rus, Rosa Martínez, Carolina Puertas, María Dolores Blanco, Ernesto Casís, Rosa Corcoy
    Endocrinología, Diabetes y Nutrición (English ed.).2017; 64(7): 345.     CrossRef
  • Impact of Mean Cell Hemoglobin on Hb A1c–Defined Glycemia Status
    Santiago Rodriguez-Segade, Javier Rodriguez Garcia, José M García-López, Francisco Gude, Felipe F Casanueva, Santiago RS-Alonso, Félix Camiña
    Clinical Chemistry.2016; 62(12): 1570.     CrossRef
  • Effect of iron deficiency anaemia on HbA1c levels is dependent on the degree of anaemia
    Juliana Frezza Silva, Ana Laura Pimentel, Joíza Lins Camargo
    Clinical Biochemistry.2016; 49(1-2): 117.     CrossRef
  • Glycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Cheol-Young Park, Chang Beom Lee, Sung-Hee Ihm
    Diabetes & Metabolism Journal.2016; 40(2): 167.     CrossRef
  • Non-alcoholic fatty liver disease associated with increased arterial stiffness in subjects with normal glucose tolerance, but not pre-diabetes and diabetes
    Chieh-Ying Chou, Yi-Ching Yang, Jin-Shang Wu, Zih-Jie Sun, Feng-Hwa Lu, Chih-Jen Chang
    Diabetes and Vascular Disease Research.2015; 12(5): 359.     CrossRef
  • Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants
    G Danaei, S Fahimi, Y Lu, B Zhou, K Hajifathalian, M Di Cesare, WC Lo, B Reis-Santos, MJ Cowan, JE Shaw, J Bentham, JK Lin, H Bixby, D Magliano, P Bovet, JJ Miranda, YH Khang, GA Stevens, LM Riley, MK Ali, M Ezzati, ZA Abdeen, KA Kadir, M Abu-Rmeileh, B A
    The Lancet Diabetes & Endocrinology.2015; 3(8): 624.     CrossRef
  • Derivation and validation of an HbA1c optimal cutoff for diagnosing prediabetes in a South African mixed ancestry population
    Annalise E. Zemlin, Tandi E. Matsha, Andre P. Kengne, Rajiv T. Erasmus
    Clinica Chimica Acta.2015; 448: 215.     CrossRef
  • Factors affecting A1C in non-diabetic individuals: Review and meta-analysis
    Gabriela Cavagnolli, Ana Laura Pimentel, Priscila Aparecida Correa Freitas, Jorge Luiz Gross, Joíza Lins Camargo
    Clinica Chimica Acta.2015; 445: 107.     CrossRef
  • Limitations of Hemoglobin A1c for the Diagnosis of Posttransplant Diabetes Mellitus
    Ivar Anders Eide, Thea Anine Strøm Halden, Anders Hartmann, Anders Åsberg, Dag Olav Dahle, Anna V Reisæter, Trond Jenssen
    Transplantation.2015; 99(3): 629.     CrossRef
  • The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review
    Emma English, Iskandar Idris, Georgina Smith, Ketan Dhatariya, Eric S. Kilpatrick, W. Garry John
    Diabetologia.2015; 58(7): 1409.     CrossRef
  • Relationship between Hb and HbA1c in Japanese adults: An analysis of the 2009 Japan Society of Ningen Dock database
    Eiko Takahashi, Kengo Moriyama, Minoru Yamakado
    Diabetes Research and Clinical Practice.2014; 104(3): e64.     CrossRef
  • Diagnosing Diabetes with Hemoglobin A1c: Current Debates and Considerations for Anemic Patients
    Tae Hyuk Kim, Sung Hee Choi
    Diabetes & Metabolism Journal.2013; 37(5): 340.     CrossRef
Low Levels of Physical Activity Are Associated with Increased Metabolic Syndrome Risk Factors in Korean Adults
Dong Hoon Lee, Yoon Myung Kim, Yoonsuk Jekal, Sukyung Park, Kyong-Chol Kim, Masayo Naruse, Sun Hyun Kim, Sang-Hwan Kim, Ji-Hye Park, Mi Kyung Lee, Sang Hui Chu, Justin Y. Jeon
Diabetes Metab J. 2013;37(2):132-139.   Published online April 16, 2013
DOI: https://doi.org/10.4093/dmj.2013.37.2.132
  • 8,116 View
  • 39 Download
  • 25 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Low levels of physical activity (PA) are strongly associated with the development of metabolic syndrome (MetS) and chronic diseases. However, few studies have examined this association in Koreans. The primary purpose of this study was to examine the associations between PA and MetS risks in Korean adults.

Methods

A total of 1,016 Korean adults (494 males and 522 females) participated in this study. PA levels were assessed using the International PA Questionnaire. MetS risk factors were determined using clinically established diagnostic criteria.

Results

Compared with the highest PA group, the group with the lowest level of PA was at greater risk of high triglyceride (TG) in males (odds ratio [OR], 1.87; 95% confidence interval [CI], 1.07 to 3.24) and of hemoglobin A1c ≥5.5% in females (OR, 1.75; 95% CI, 1.00 to 3.04) after adjusting for age and body mass index. Compared with subjects who met the PA guidelines, those who did not meet the guidelines were more likely to have low high density lipoprotein cholesterol in both males (OR, 1.69; 95% CI, 1.11 to 2.58), and females (OR, 1.82; 95% CI, 1.20 to 2.77). Furthermore, those who did not meet the PA guidelines were at increased risk of high TG levels in males (OR, 1.69; 95% CI, 1.23 to 2.86) and abnormal fasting glucose (OR, 1.93; 95% CI, 1.17 to 3.20) and MetS (OR, 2.10; 95% CI, 1.15 to 3.84) in females.

Conclusion

Increased levels of PA are significantly associated with a decreased risk of abnormal MetS components.

Citations

Citations to this article as recorded by  
  • Relationship between trait mindfulness and physical activity among emerging adults: The mediating roles of exercise-related cognitive errors and trait self-control
    Ding Yuan, Jin Kuang, Jinming Li, Rebecca Y.M. Cheung, Fabian Herold, Markus Gerber, Alyx Taylor, Arthur F. Kramer, Jiahui Wang, Albert S. Yeung, Liye Zou
    Complementary Therapies in Clinical Practice.2025; 59: 101953.     CrossRef
  • Global burden of ischemic heart disease in older adult populations linked to non-optimal temperatures: past (1990–2021) and future (2022–2050) analysis
    Lihui Liu, Yisong He, Gang Huang, Yangxi Zeng, Jiaan Lu, Ru He, Haiqing Chen, Yuheng Gu, Qingwen Hu, Bin Liao, Juyi Wan
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • Exploring the interplay between BMI, subjective body image perception, and health behaviors: A cross-sectional study
    Ho-Jun Kim, In-Whi Hwang, Kyu-Ri Hong, Hae-Young Chung, Jung-Min Lee, Ozra Tabatabaei-Malazy
    PLOS One.2025; 20(8): e0328283.     CrossRef
  • Effects of a Physical Exercise Programme through Service-Learning Methodology on Physical Activity, Physical Fitness and Perception of Physical Fitness and Health in University Students from Spain: A Preliminary Study
    Antonio Jesús Casimiro-Andújar, Eva Artés-Rodríguez, David M. Díez-Fernández, María-Jesús Lirola
    International Journal of Environmental Research and Public Health.2023; 20(4): 3377.     CrossRef
  • The Effect of a Mobile and Wearable Device Intervention on Increased Physical Activity to Prevent Metabolic Syndrome: Observational Study
    Hee Jin Kim, Kang Hyun Lee, Jung Hun Lee, Hyun Youk, Hee Young Lee
    JMIR mHealth and uHealth.2022; 10(2): e34059.     CrossRef
  • Does the Presence of Metabolic Syndrome Alter Serum Uric Acid Concentrations, Pain, and Well-Being in Patient with Chronic Musculoskeletal Pain?
    Şeyda TOPRAK ÇELENAY, Derya ÖZER KAYA, Senem ŞAŞ
    Clinical and Experimental Health Sciences.2022; 12(4): 793.     CrossRef
  • Associations of Preoperative Irisin Levels of Paired Cerebrospinal Fluid and Plasma with Physical Dysfunction and Muscle Wasting Severity in Residents of Surgery Wards
    Q. Ruan, Y. Huang, L. Yang, J. Li, W. Gu, Z. Bao, X. Zhang, Zhuowei Yu
    The Journal of nutrition, health and aging.2020; 24(4): 412.     CrossRef
  • The mulberry-derived 1-deoxynojirimycin (DNJ) inhibits high-fat diet (HFD)-induced hypercholesteremia and modulates the gut microbiota in a gender-specific manner
    Yougui Li, Shi Zhong, Jiaqi Yu, Yuqing Sun, Jianxun Zhu, Dongfeng Ji, Chongming Wu
    Journal of Functional Foods.2019; 52: 63.     CrossRef
  • Association between Metabolic Syndrome Criteria and Lifestyle Category among University Academic Staff in West Java, Indonesia
    Vita Murniati T, Siti Nur Fatima, Titing Nurhayati, Mohammad Rizki Akba, Putri Teesa Radh, Ambrosius Purba, Ieva Baniasih A, Hanna Goenawan
    Pakistan Journal of Nutrition.2018; 17(12): 709.     CrossRef
  • Association between serum lipids concentration and patients with age-related cataract in China: a cross-sectional, case–control study
    Shengjie Li, Danhui Li, Yudong Zhang, Jisen Teng, Mingxi Shao, Wenjun Cao
    BMJ Open.2018; 8(4): e021496.     CrossRef
  • Mediterranean diet, Dietary Approaches to Stop Hypertension (DASH) style diet, and metabolic health in U.S. adults
    Yong-Moon Mark Park, Susan E. Steck, Teresa T. Fung, Jiajia Zhang, Linda J. Hazlett, Kyungdo Han, Seung-Hwan Lee, Hyuk-Sang Kwon, Anwar T. Merchant
    Clinical Nutrition.2017; 36(5): 1301.     CrossRef
  • The association between metabolic health, obesity phenotype and the risk of breast cancer
    Yong‐Moon Mark Park, Alexandra J. White, Hazel B. Nichols, Katie M. O'Brien, Clarice R. Weinberg, Dale P. Sandler
    International Journal of Cancer.2017; 140(12): 2657.     CrossRef
  • Sedentary Occupation Workers Who Meet the Physical Activity Recommendations Have a Reduced Risk for Metabolic Syndrome
    Rodrigo Alberto Vieira Browne, Luiz Fernando Farias-Junior, Yuri Alberto Freire, Daniel Schwade, Geovani de Araújo Dantas de Macêdo, Vilma Bayma Montenegro, Thiago Jambo Alves Lopes, Filipe Fernandes Oliveira Dantas, Eduardo Caldas Costa
    Journal of Occupational & Environmental Medicine.2017; 59(11): 1029.     CrossRef
  • Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes
    Y-M Park, S E Steck, T T Fung, J Zhang, L J Hazlett, K Han, A T Merchant
    International Journal of Obesity.2016; 40(10): 1541.     CrossRef
  • Diet Quality and Mortality Risk in Metabolically Obese Normal-Weight Adults
    Yong-Moon Mark Park, Teresa T. Fung, Susan E. Steck, Jiajia Zhang, Linda J. Hazlett, Kyungdo Han, Seung-Hwan Lee, Anwar T. Merchant
    Mayo Clinic Proceedings.2016; 91(10): 1372.     CrossRef
  • Gender Difference in the Epidemiological Association between Metabolic Syndrome and Olfactory Dysfunction: The Korea National Health and Nutrition Examination Survey
    Se-Hwan Hwang, Jun-Myung Kang, Jae-Hyun Seo, Kyung-do Han, Young-Hoon Joo, Yiqing Song
    PLOS ONE.2016; 11(2): e0148813.     CrossRef
  • Renal posttransplantation diabetes mellitus: An overview
    Ana Laura Pimentel, Andrea Carla Bauer, Joíza Lins Camargo
    Clinica Chimica Acta.2015; 450: 327.     CrossRef
  • Metabolic Syndrome and Chronic Laryngitis
    Choung-Soo Kim, Seong-Soo Lee, Kyung-do Han, Young-Hoon Joo
    Medicine.2015; 94(43): e1890.     CrossRef
  • Gender differences in the association between food insecurity and insulin resistance among U.S. adults: National Health and Nutrition Examination Survey, 2005–2010
    Junxiu Liu, Yong-Moon Mark Park, Seth A. Berkowitz, Qingwei Hu, Kyungdo Han, Andrew Ortaglia, Robert E. McKeown, Angela D. Liese
    Annals of Epidemiology.2015; 25(9): 643.     CrossRef
  • Implication of Circulating Irisin Levels with Brown Adipose Tissue and Sarcopenia in Humans
    Hae Yoon Choi, Sungeun Kim, Ji Woo Park, Nam Seok Lee, Soon Young Hwang, Joo Young Huh, Ho Cheol Hong, Hye Jin Yoo, Sei Hyun Baik, Byung-Soo Youn, Christos S. Mantzoros, Kyung Mook Choi
    The Journal of Clinical Endocrinology & Metabolism.2014; 99(8): 2778.     CrossRef
  • Relationship between Physical Activity Level, Amount of Alcohol Consumption and Metabolic Syndrome in Korean Male Drinkers
    Byung-Sung Kim, Myeong-Jin Kim, Hyun-Rim Choi, Cahng-Won Won, Sun-Young Kim
    The Korean Journal of Sports Medicine.2014; 32(2): 97.     CrossRef
  • Association between cardiorespiratory fitness and the prevalence of metabolic syndrome among Korean adults: a cross sectional study
    Sunghyun Hong, Junga Lee, Jihye Park, Mikyung Lee, Ji Young Kim, Kyong-Chol Kim, Sun Hyun Kim, Jee Aee Im, Sang Hui Chu, Sang Hoon Suh, Sang Hwan Kim, Justin Y Jeon
    BMC Public Health.2014;[Epub]     CrossRef
  • Impact of lifestyle on metabolic syndrome in apparently healthy people
    Silvio Buscemi, Delia Sprini, Giuseppe Grosso, Fabio Galvano, Antonio Nicolucci, Giuseppe Lucisano, Fatima M. Massenti, Emanuele Amodio, Giovam B. Rini
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity.2014; 19(2): 225.     CrossRef
  • Gender Difference in the Association of Metabolic Syndrome and Its Components with Age-Related Cataract: The Korea National Health and Nutrition Examination Survey 2008-2010
    Young-Hoon Park, Jeong Ah Shin, Kyungdo Han, Hyeon Woo Yim, Won-Chul Lee, Yong-Moon Park, Yingfeng Zheng
    PLoS ONE.2014; 9(1): e85068.     CrossRef
  • Prevalence of Metabolic Syndrome and Its Relationship with Physical Activity in Suburban Beijing, China
    Wei-Hong Zhang, Peng Xue, Meng-Ying Yao, Hai-Min Chang, Yan Wu, Lei Zhang
    Annals of Nutrition and Metabolism.2013; 63(4): 298.     CrossRef
Review
The Roles of Glycated Albumin as Intermediate Glycation Index and Pathogenic Protein
Kwang Joon Kim, Byung-Wan Lee
Diabetes Metab J. 2012;36(2):98-107.   Published online April 17, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.2.98
  • 10,495 View
  • 101 Download
  • 78 Crossref
AbstractAbstract PDFPubReader   ePub   

The conventional glycemic indices used in management of diabetic patients includes A1c, fructosamine, 1,5-anhydroglucitol, and glycated albumin (GA). Among these indices, A1c is currently used as the gold standard. However, A1c cannot reflect the glycemic change over a relatively short period of time, and its accuracy is known to decrease when abnormalities in hemoglobin metabolism, such as anemia, coexist. When considering these weaknesses, there have been needs for finding a novel glycemic index for diagnosing and managing diabetes, as well as for predicting diabetic complications properly. Recently, several studies have suggested the potential of GA as an intermediate-term glycation index in covering the short-term effect of treatment. Furthermore, its role as a pathogenic protein affecting the worsening of diabetes and occurrence of diabetic complications is receiving attention as well. Therefore, in this article, we wanted to review the recent status of GA as a glycemic index and as a pathogenic protein.

Citations

Citations to this article as recorded by  
  • Fasting plasma glucose performs better than glycated hemoglobin and glycated albumin for diagnosing gestational diabetes
    Lungile Khambule, Lawrence Chauke, Nigel J. Crowther, Jaya A. George
    International Journal of Gynecology & Obstetrics.2026; 172(1): 549.     CrossRef
  • Insights into the conformational, secondary structural, dynamical and hydration pattern changes of glucose mediated glycated HSA: a molecular dynamics approach
    Jayanth Jeevanandam, N. Arul Murugan, N. T. Saraswathi
    Journal of Biomolecular Structure and Dynamics.2025; 43(8): 4125.     CrossRef
  • The association between serum albumin levels and metabolic syndrome based on the NHANES and two sample Mendelian randomization study
    Yile Tang, Yong Fan, Jin Su, Zisen Yang, Zaoling Liu
    Scientific Reports.2025;[Epub]     CrossRef
  • Albumin as a natural and moldable biomaterial for biomimetic drug delivery applications
    Ankit K. Rochani, Vivek S. Dave, Miriam Hernandez-Meadows, Aditya Bajaj, Quezia Lacerda, Tala Alzien, Sara Woytowicz, John Eisenbrey, Todd D. Camenisch, Gagan Kaushal
    International Journal of Pharmaceutics.2025; 683: 126056.     CrossRef
  • The effect of full glycation on structure and function of human serum albumin
    Prin Tadawattana, Sirin Sittiwanichai, Deanpen Japrung, Prapasiri Pongprayoon
    Journal of Biomolecular Structure and Dynamics.2025; : 1.     CrossRef
  • Simultaneous electrochemical detection of glycated and human serum albumin for diabetes management
    Monalisha Ghosh Dastidar, Krishnan Murugappan, David R. Nisbet, Antonio Tricoli
    Biosensors and Bioelectronics.2024; 246: 115876.     CrossRef
  • Association of the Ratio of Glycoalbumin to Hemoglobin A1c With Season Change and the COVID-19 Pandemic in Patients With Type 2 Diabetes Mellitus
    Kohzo Takebayashi, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Koshi Hashimoto
    Cureus.2024;[Epub]     CrossRef
  • Glucose metabolism and smaller hippocampal volume in elderly people with normal cognitive function
    Ayano Shima, Moeko Noguchi-Shinohara, Shutaro Shibata, Yuta Usui, Yasuko Tatewaki, Benjamin Thyreau, Jun Hata, Tomoyuki Ohara, Takanori Honda, Yasuyuki Taki, Shigeyuki Nakaji, Tetsuya Maeda, Masaru Mimura, Kenji Nakashima, Jun-ichi Iga, Minoru Takebayashi
    npj Aging.2024;[Epub]     CrossRef
  • Inverse correlation of free triiodothyronine with glycated albumin and the glycated albumin/glycated hemoglobin ratio in hemodialysis patients: a cross-sectional study
    Keiji Mimura, Takahiro Nishide, Toshihide Naganuma, Yui Katsube, Seiji Ishitani, Katsuhiko Nakahara, Naohisa Hirasaka, Rie Mizobata, Yuko Yamagata, Osamu Nishikawa, Susumu Yukawa
    Renal Replacement Therapy.2023;[Epub]     CrossRef
  • Correlation Analysis of Serum Glycated Albumin, Homocysteine Levels and the Severity of Acute Cerebral Infarction
    丽娅 陈
    Advances in Clinical Medicine.2023; 13(04): 6738.     CrossRef
  • Conformational variation of site specific glycated albumin: A Molecular dynamics approach
    Jayanth Jeevanandam, V. L. S. Prasad Burra, N.T. Saraswathi
    Computers in Biology and Medicine.2023; 164: 107276.     CrossRef
  • Multiple cardiometabolic diseases enhance the adverse effects of hypoalbuminemia on mortality among centenarians in China: a cohort study
    Haowei Li, Shengshu Wang, Shanshan Yang, Shaohua Liu, Yang Song, Shimin Chen, Xuehang Li, Zhiqiang Li, Rongrong Li, Yali Zhao, Qiao Zhu, Chaoxue Ning, Miao Liu, Yao He
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer’s Disease: The JPSC-AD Study
    Moeko Noguchi-Shinohara, Sohshi Yuki-Nozaki, Chiemi Abe, Ayaka Mori, Mai Horimoto, Masami Yokogawa, Natsuko Ishida, Yukio Suga, Junko Ishizaki, Mai Ishimiya, Hiroyuki Nakamura, Kiyonobu Komai, Hiroyuki Nakamura, Mao Shibata, Tomoyuki Ohara, Jun Hata, Tosh
    Journal of Alzheimer's Disease.2022; 85(1): 235.     CrossRef
  • Albumin Glycation Affects the Delivery of C-Peptide to the Red Blood Cells
    Monica J. Jacobs, Morgan K. Geiger, Suzanne E. Summers, Charles P. DeLuca, Kurt R. Zinn, Dana M. Spence
    ACS Measurement Science Au.2022; 2(3): 278.     CrossRef
  • Glycated Albumin and Glycated Albumin/HbA1c Predict the Progression of Coronavirus Disease 2019 from Mild to Severe Disease in Korean Patients with Type 2 Diabetes
    Jeongseon Yoo, Youngah Choi, Shin Ae Park, Ji Yeon Seo, Chul Woo Ahn, Jaehyun Han
    Journal of Clinical Medicine.2022; 11(9): 2327.     CrossRef
  • Antioxidant and inflammatory biomarkers in herpes zoster
    Tuba Oskay, Cem Keskin, Mehmet Özen
    Journal of Medical Virology.2022; 94(8): 3924.     CrossRef
  • The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
    Vitarani Dwi Ananda Ningrum, Ahmad Hamim Sadewa, Zullies Ikawati, Rika Yuliwulandari, M. Robikhul Ikhsan, Rohmatul Fajriyah, Santosh K. Patnaik
    PLOS ONE.2022; 17(7): e0271410.     CrossRef
  • Glycated albumin is associated with all-cause and cardiovascular mortality among U.S. adults with and without diabetes: A retrospective cohort study
    Stefano Ciardullo, Federico Rea, Gianluca Perseghin
    Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(10): 2375.     CrossRef
  • Comparative evaluation of antioxidant, antiglycation and α-glucosidase inhibitory potential of some indigenous medicinal Trigonella species
    Namdeo Gaonkar, Rakhee Dangi
    Vegetos.2022; 36(4): 1337.     CrossRef
  • Aptamer-Based Glycated Albumin Sensor for Capacitive Spectroscopy
    Toshiya Sakata, Reiko Shiratori, Shoichi Nishitani
    Analytical Chemistry.2022;[Epub]     CrossRef
  • Correlation between glycosylated serum albumin and glycosylated haemoglobin in the southwest Chinese population: Establishment of a regression model
    Li-Rui Kong, Yan Zhang, Feng Wu, Xue-Qin Wen, Da-Hai He, Chao-Qiong Zhou, Lin Wang
    Journal of Diabetes and its Complications.2021; 35(2): 107796.     CrossRef
  • Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
    Xiaojing Feng, Yanyi Yang, Siqi Zhuang, Yiyuan Fang, Yufeng Dai, Yaoyang Fu, Qian Hu, Qianqin Yuan, Haoneng Tang, Lingli Tang
    Frontiers in Medicine.2021;[Epub]     CrossRef
  • Pre-Stroke Glycemic Variability Estimated by Glycated Albumin Is Associated with Early Neurological Deterioration and Poor Functional Outcome in Prediabetic Patients with Acute Ischemic Stroke
    Sang-Hwa Lee, Yerim Kim, So Young Park, Chulho Kim, Yeo Jin Kim, Jong-Hee Sohn
    Cerebrovascular Diseases.2021; 50(1): 26.     CrossRef
  • Detection of Glycated Albumin Using a Novel Field Effect Aptasensor
    Mahdi Sasar, Azad Farzadfard, Yaser Abdi, Mehran Habibi-Rezaei
    IEEE Sensors Journal.2020; 20(18): 10387.     CrossRef
  • Elevated serum glycated albumin and glycated albumin : hemoglobin A1c ratio were associated with hippocampal atrophy in a general elderly population of Japanese: The Hisayama Study
    Tomoyuki Ohara, Yoshihiko Furuta, Naoki Hirabayashi, Jun Hata, Yoichiro Hirakawa, Takanori Honda, Daigo Yoshida, Mao Shibata, Takanari Kitazono, Toshiharu Ninomiya
    Journal of Diabetes Investigation.2020; 11(4): 971.     CrossRef
  • Effect of Prestroke Glycemic Variability Estimated Glycated Albumin on Stroke Severity and Infarct Volume in Diabetic Patients Presenting With Acute Ischemic Stroke
    Sang-Hwa Lee, Min Uk Jang, Yerim Kim, So Young Park, Chulho Kim, Yeo Jin Kim, Jong-Hee Sohn
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Association between serum glycated albumin and risk of cardiovascular disease in a Japanese community: The Hisayama Study
    Akane Mihara, Tomoyuki Ohara, Jun Hata, Takanori Honda, Sanmei Chen, Satoko Sakata, Emi Oishi, Yoichiro Hirakawa, Tomohiro Nakao, Takanari Kitazono, Toshiharu Ninomiya
    Atherosclerosis.2020; 311: 52.     CrossRef
  • Low Antioxidant Status of Serum Uric Acid, Bilirubin, Albumin, and Creatinine in Patients With Benign Paroxysmal Positional Vertigo
    Ke-Hang Xie, Ling-Ling Liu, Chu-Yin Su, Xiao-Feng Huang, Bao-Xing Wu, Run-Ni Liu, Hua Li, Qing-Qing Chen, Jia-Sheng He, Yong-Kun Ruan
    Frontiers in Neurology.2020;[Epub]     CrossRef
  • A Comparison of Biomarkers in the Assessment of Glycemic Control in Diabetes: Reviewing the Evidence
    Aga S. Sameer, Mujeeb Z. Banday, Saniya Nissar, Sheikh A. Saeed
    Current Diabetes Reviews.2019; 15(6): 471.     CrossRef
  • Evaluation of biological variation of glycated hemoglobin and glycated albumin in healthy Chinese subjects
    Libo Liang, He He, Yuping Zeng, Mei Zhang, Xia Wang, Xiaoling Li, Shanshan Liang, Zhenmei An, Hengjian Huang
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • The association between skin auto-fluorescence of palmoplantar sites and microvascular complications in Asian patients with type 2 diabetes mellitus
    Jong Jin Kim, Bosu Jeong, Yongin Cho, Mi-hyang Kwon, Yong-ho Lee, Uk Kang, Eun Seok Kang
    Scientific Reports.2018;[Epub]     CrossRef
  • Hemoglobin A1c, Not Glycated Albumin, Can Independently Reflect the Ankylosing Spondylitis Disease Activity Score
    Sejin Byun, Seung Min Jung, Jason Jungsik Song, Yong-Beom Park, Sang-Won Lee
    Journal of Rheumatic Diseases.2018; 25(2): 131.     CrossRef
  • Albumin Abundance and Its Glycation Status Determine Hemoglobin Glycation
    Mashanipalya G. Jagadeeshaprasad, Vinashya Venkatasubramani, Ambika G. Unnikrishnan, Mahesh J. Kulkarni
    ACS Omega.2018; 3(10): 12999.     CrossRef
  • The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges
    Ting Gan, Baoying Liao, Gaosi Xu
    Journal of Diabetes and its Complications.2018; 32(9): 876.     CrossRef
  • Influences of Anemia, Kidney Disease, Thyroid Dysfunction, and Liver Disease on the Ratio of Glycated Albumin to Hemoglobin A1c
    Hiroyasu Miyamoto, Xinran Tao, Takuji Kohzuma, Akihiro Ohnishi
    Journal of Diabetes Science and Technology.2018; 12(5): 1082.     CrossRef
  • Glycated albumin increases with disease activity in rheumatoid factor positive rheumatoid arthritis patients with normal fasting glucose and HbA1c
    Jin-Su Park, Jungsik Song, Yong-Beom Park, Soo-Kon Lee, Sang-Won Lee
    Joint Bone Spine.2017; 84(1): 115.     CrossRef
  • Variability in glycated albumin levels predicts the progression of diabetic nephropathy
    Su Bin Park, Sang Soo Kim, In Joo Kim, Yoon Jeong Nam, Kang Hee Ahn, Jong Ho Kim, Yun Kyung Jeon, Bo Hyun Kim, Sang Heon Song, Ihm Soo Kwak, Eun Kyung Lee, Yong Ki Kim
    Journal of Diabetes and its Complications.2017; 31(6): 1041.     CrossRef
  • Alternative Measures of Hyperglycemia and Risk of Alzheimer’s Disease in the Community: The Hisayama Study
    Naoko Mukai, Tomoyuki Ohara, Jun Hata, Yoichiro Hirakawa, Daigo Yoshida, Hiro Kishimoto, Masafumi Koga, Udai Nakamura, Takanari Kitazono, Yutaka Kiyohara, Toshiharu Ninomiya
    The Journal of Clinical Endocrinology & Metabolism.2017; 102(8): 3002.     CrossRef
  • Chicken albumin exhibits natural resistance to glycation
    Jessica Zuck, Chad R. Borges, Eldon J Braun, Karen L Sweazea
    Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology.2017; 203: 108.     CrossRef
  • Variations in native protein glycation and plasma antioxidants in several birds of prey
    Tana Ingram, Jessica Zuck, Chad R. Borges, Patrick Redig, Karen L. Sweazea
    Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology.2017; 210: 18.     CrossRef
  • Glycated albumin: from biochemistry and laboratory medicine to clinical practice
    Elena Dozio, Nicola Di Gaetano, Peter Findeisen, Massimiliano Marco Corsi Romanelli
    Endocrine.2017; 55(3): 682.     CrossRef
  • Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus
    Chan-Hee Jung, Bora Lee, Dug-Hyun Choi, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang, Ji-Oh Mok
    Diabetes Research and Clinical Practice.2017; 125: 53.     CrossRef
  • Glycated albumin and ratio of glycated albumin to glycated hemoglobin are good indicators of diabetic nephropathy in type 2 diabetes mellitus
    Nana Wang, Zhen Xu, Ping Han, Tiegang Li
    Diabetes/Metabolism Research and Reviews.2017;[Epub]     CrossRef
  • Importance of glycemic control in cancer patients with diabetes: Treatment through end of life
    Denise S Hershey
    Asia-Pacific Journal of Oncology Nursing.2017; 4(4): 313.     CrossRef
  • The association of serum glycated albumin with the prevalence of diabetic retinopathy in Korean patients with type 2 diabetes mellitus
    Won Seon Jeon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Cheol-Young Park
    Diabetes Research and Clinical Practice.2016; 116: 46.     CrossRef
  • Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study
    Ju-Ming Lu, Li-Nong Ji, Yu-Feng Li, Quan-Min Li, Shan-Shan Lin, Xiao-Feng Lv, Li Wang, Yuan Xu, Xiao-Hui Guo, Qi-Yu Guo, Li Ma, Jin Du, Ying-Li Chen, Cui-Ling Zhao, Qiu-Lan Zhang, Qi-Mei She, Xiu-Min Jiao, Mei-Hua Lu, Rong-Qing Pan, Ying Gao
    Journal of Diabetes and its Complications.2016; 30(8): 1609.     CrossRef
  • HCD Fragmentation of Glycated Peptides
    Eva C. Keilhauer, Philipp E. Geyer, Matthias Mann
    Journal of Proteome Research.2016; 15(8): 2881.     CrossRef
  • Glycated albumin indicates peripheral diabetic neuropathy
    Nana Wang, Chuanji Guo, Ping Han, Tiegang Li
    Acta Diabetologica.2016; 53(6): 973.     CrossRef
  • Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes
    Xueying Tan, Jingbo Hu
    Expert Opinion on Pharmacotherapy.2016; 17(9): 1285.     CrossRef
  • Change in serum albumin concentration is inversely and independently associated with risk of incident metabolic syndrome
    Sang-Man Jin, Yong Joo Hong, Jae Hwan Jee, Ji Cheol Bae, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim
    Metabolism.2016; 65(11): 1629.     CrossRef
  • Plasma Glycated Albumin Levels Clearly Detect Hearing Loss and Atherosclerosis in Patients with Impaired Fasting Glucose
    Hande Ezerarslan, Tuba Çandar, Sedat Özdemir, Gökçe Kaan Ataç, Sinan Kocatürk
    Medical Principles and Practice.2016; 25(4): 309.     CrossRef
  • Glycation of Nail Proteins: From Basic Biochemical Findings to a Representative Marker for Diabetic Glycation-Associated Target Organ Damage
    Antoine Sadiki Kishabongo, Philippe Katchunga, Elisabeth H. Van Aken, Reinhart Speeckaert, Sabrina Lagniau, Renaat Coopman, Marijn M. Speeckaert, Joris R. Delanghe, Frederique Lisacek
    PLOS ONE.2015; 10(3): e0120112.     CrossRef
  • A randomized, double‐blind, placebo‐controlled, phase II clinical trial to investigate the efficacy and safety of oral DA‐1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise
    Chang Hee Jung, Cheol‐Young Park, Kyu‐Joeng Ahn, Nan‐Hee Kim, Hak‐Chul Jang, Moon‐Kyu Lee, Joong‐Yeol Park, Choon‐Hee Chung, Kyung‐Wan Min, Yeon‐Ah Sung, Jeong‐Hyun Park, Sung Jin Kim, Hyo Jung Lee, Sung‐Woo Park
    Diabetes/Metabolism Research and Reviews.2015; 31(3): 295.     CrossRef
  • Salivary Protein Glycosylation as a Noninvasive Biomarker for Assessment of Glycemia
    Paturi V. Rao, Amber Laurie, Eric S. Bean, Charles T. Roberts, Srinivasa R. Nagalla
    Journal of Diabetes Science and Technology.2015; 9(1): 97.     CrossRef
  • Glycated Albumin Levels in Patients with Type 2 Diabetes Increase Relative to HbA1cwith Time
    Hye-jin Yoon, Yong-ho Lee, Kwang Joon Kim, So Ra Kim, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    BioMed Research International.2015; 2015: 1.     CrossRef
  • Glycated albumin and the risk of micro- and macrovascular complications in subjects with Type 1 Diabetes
    Hye-jin Yoon, Yong-ho Lee, So Ra Kim, Tyler Hyungtaek Rim, Eun Young Lee, Eun Seok Kang, Bong-Soo Cha, Hyun Chul Lee, Byung-Wan Lee
    Cardiovascular Diabetology.2015;[Epub]     CrossRef
  • Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study
    Naoko Mukai, Toshiharu Ninomiya, Jun Hata, Yoichiro Hirakawa, Fumie Ikeda, Masayo Fukuhara, Taeko Hotta, Masafumi Koga, Udai Nakamura, Dongchon Kang, Takanari Kitazono, Yutaka Kiyohara
    Cardiovascular Diabetology.2015;[Epub]     CrossRef
  • Recent Topics in Chemical and Clinical Research on Glycated Albumin
    Yuki Ueda, Hideyuki Matsumoto
    Journal of Diabetes Science and Technology.2015; 9(2): 177.     CrossRef
  • Glycated albumin triggers fibrosis and apoptosis via an NADPH oxidase/Nox4-MAPK pathway-dependent mechanism in renal proximal tubular cells
    Weiwei Qi, Jianying Niu, Qiaojing Qin, Zhongdong Qiao, Yong Gu
    Molecular and Cellular Endocrinology.2015; 405: 74.     CrossRef
  • The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status
    Ji Hye Huh, Kwang Joon Kim, Byung-Wan Lee, Dong Wook Kim, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Marta Letizia Hribal
    PLoS ONE.2014; 9(2): e89478.     CrossRef
  • Metabolomics Reveals Broad-Scale Metabolic Perturbations in Hyperglycemic Mothers During Pregnancy
    Denise M. Scholtens, Michael J. Muehlbauer, Natalie R. Daya, Robert D. Stevens, Alan R. Dyer, Lynn P. Lowe, Boyd E. Metzger, Christopher B. Newgard, James R. Bain, William L. Lowe
    Diabetes Care.2014; 37(1): 158.     CrossRef
  • Development of Magnetic Particle-Based Immunoassays and Their Applications in Diabetes Monitoring
    Cheng-Tai Chen, Chien-An Chen, Yu-Yin Tsai, Yi-Yen Yuan, Yi-Chau Huang, Ting-Shou Chen, Jane SC Tsai
    IEEE Transactions on Magnetics.2014; 50(1): 1.     CrossRef
  • Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro study
    Francesco Finamore, Feliciano Priego-Capote, Florent Gluck, Anne Zufferey, Pierre Fontana, Jean-Charles Sanchez
    EuPA Open Proteomics.2014; 3: 100.     CrossRef
  • Development of an HbA1c-Based Conversion Equation for Estimating Glycated Albumin in a Korean Population with a Wide Range of Glucose Intolerance
    Chang Hee Jung, You-Cheol Hwang, Kwang Joon Kim, Bong Soo Cha, Cheol-Young Park, Won Seon Jeon, Jae Hyeon Kim, Sang-Man Jin, Sang Youl Rhee, Jeong-taek Woo, Byung-Wan Lee, Sompop Bencharit
    PLoS ONE.2014; 9(4): e95729.     CrossRef
  • The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes
    Wonjin Kim, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes & Metabolism Journal.2014; 38(6): 456.     CrossRef
  • Optimal glycated albumin cutoff value to diagnose diabetes in Korean adults: A retrospective study based on the oral glucose tolerance test
    You-Cheol Hwang, Chang Hee Jung, Hong-Yup Ahn, Won Seon Jeon, Sang-Man Jin, Jeong-taek Woo, Bong Soo Cha, Jae Hyeon Kim, Cheol-Young Park, Byung-Wan Lee
    Clinica Chimica Acta.2014; 437: 1.     CrossRef
  • Inverse Association between Glycated Albumin and Insulin Secretory Function May Explain Higher Levels of Glycated Albumin in Subjects with Longer Duration of Diabetes
    Yong-ho Lee, Mi Hyang Kown, Kwang Joon Kim, Eun Young Lee, Daham Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Marià Alemany
    PLoS ONE.2014; 9(9): e108772.     CrossRef
  • Serum glycated albumin predicts the progression of diabetic retinopathy—a five year retrospective longitudinal study
    Jiemin Pan, Qing Li, Lei Zhang, Lili Jia, Junling Tang, Yuqian Bao, Weiping Jia
    Journal of Diabetes and its Complications.2014; 28(6): 772.     CrossRef
  • Astragaloside IV attenuates glycated albumin-induced epithelial-to-mesenchymal transition by inhibiting oxidative stress in renal proximal tubular cells
    Weiwei Qi, Jianying Niu, Qiaojing Qin, Zhongdong Qiao, Yong Gu
    Cell Stress and Chaperones.2014; 19(1): 105.     CrossRef
  • The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes
    Eun Yeong Choe, Yongin Cho, Younjeong Choi, Yujung Yun, Hye Jin Wang, Obin Kwon, Byung-Wan Lee, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee, Eun Seok Kang
    Diabetes & Metabolism Journal.2014; 38(3): 211.     CrossRef
  • The Ratio of Estimated Average Glucose to Fasting Plasma Glucose Level Is Superior to Glycated Albumin, Hemoglobin A1c, Fructosamine, and GA/A1c Ratio for Assessingβ-Cell Function in Childhood Diabetes
    Ji Eun Lee, Ji Woo Lee, Tatsuyoshi Fujii, Noriyoshi Fujii, Jong Weon Choi
    BioMed Research International.2014; 2014: 1.     CrossRef
  • Glycated albumin and HbA1c as predictors of mortality and vascular complications in type 2 diabetes patients with normal and moderately impaired renal function: 5-year results from a 380 patient cohort
    Christoph Hasslacher, Felix Kulozik, Isabel Platten, Justo Lorenzo Bermejo
    Journal of Diabetes Research and Clinical Metabolism.2014; 3(1): 9.     CrossRef
  • Angiotensin-(1–7) decreases glycated albumin-induced endothelial interleukin-6 expression via modulation of miR-146a
    Huang-Joe Wang, Wan-Yu Lo, Li-Jen Lin
    Biochemical and Biophysical Research Communications.2013; 430(3): 1157.     CrossRef
  • Glycated Albumin Causes Pancreatic β-Cells Dysfunction Through Autophagy Dysfunction
    Young Mi Song, Sun Ok Song, Young-Hye You, Kun-Ho Yoon, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Ji-Won Kim, Byung-Wan Lee
    Endocrinology.2013; 154(8): 2626.     CrossRef
  • Glycated albumin and diabetes mellitus
    Norihiro Furusyo, Jun Hayashi
    Biochimica et Biophysica Acta (BBA) - General Subjects.2013; 1830(12): 5509.     CrossRef
  • Le proteine glicosilate nel diabete
    Roberto Testa, Anna Rita Bonfigli
    La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2013; 9(4): 218.     CrossRef
  • Serum glycated albumin predicts the progression of carotid arterial atherosclerosis
    Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Atherosclerosis.2012; 225(2): 450.     CrossRef
  • Predicting Outcomes and Assessing Control with Alternate Glycemic Markers
    Kathleen M. Dungan
    Diabetes Technology & Therapeutics.2012; 14(9): 749.     CrossRef
Original Articles
Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea
Hong-Kyu Kim, Sung-Jin Bae, Jaeone Choe
Diabetes Metab J. 2012;36(2):151-156.   Published online April 17, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.2.151
  • 7,112 View
  • 40 Download
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

We performed the study to examine the impact of hemoglobin A1c (HbA1c) criterion on the screening of increased risk for diabetes among health check-up subjects in Korea.

Methods

We retrospectively analyzed clinical and laboratory data of 37,754 Korean adults (age, 20 to 89 years; 41% women) which were measured during regular health check-ups. After excluding subjects with previously diagnosed diabetes mellitus (n=1,812) and with overt anemia (n=318), 35,624 subjects (21,201 men and 14,423 women) were included in the analysis.

Results

Among the 35,624 subjects, 11,316 (31.8%) subjects were categorized as increased risk for diabetes (IRD) by fasting plasma glucose (FPG) criteria, 6,531 (18.1%) subjects by HbA1c criteria, and 13,556 (38.1%) subjects by combined criteria. Therefore, although HbA1c criteria alone identifies 42% [(11,316-6,531)/11,316] fewer subjects with IRD than does FPG criteria, about 20% [(13,556-11,316)/11,316] more subjects could be detected by including new HbA1c criteria in addition to FPG criteria. Among the 13,556 subjects with IRD, 7,025 (51.8%) met FPG criteria only, 2,240 (16.5%) met HbA1c criteria only, and 4,291 (31.7%) met both criteria. Among subjects with impaired fasting glucose, 65% were normal, 32% were IRD, and 3% were diabetes by HbA1c criterion. In receiver operating characteristic curve analysis, cutoff point of HbA1c with optimal sensitivity and specificity for identifying IRD was 5.4%.

Conclusion

Although HbA1c criteria alone identifies fewer subjects with IRD than does FPG criteria, about 20% more could be detected by addition of HbA1c criteria. Further studies are needed to define optimal cutoff point of HbA1c and to establish screening and management guidelines for IRD.

Citations

Citations to this article as recorded by  
  • Measuring the Burden of Disease in Korea Using Disability-Adjusted Life Years (2008–2020)
    Yoon-Sun Jung, Young-Eun Kim, Minsu Ock, Seok-Jun Yoon
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • The Relationship Between HbA1c and 25-hidroxy Vitamin D Levels in Adult Diabetic Patients
    Mehmet ÖZDİN, Durhasan MUNDAN
    Van Sağlık Bilimleri Dergisi.2023; 16(1): 25.     CrossRef
  • Association between Prediabetes and Meal Patterns Related to Meal Sharing among Korean Young Adults: Eighth Korean National Health and Nutrition Examination Survey, 2019–2020
    Saebom Kim, Sehee Kim, Youngmin Kim, Seonmi Seo, Yu Jin Chung, Sam Cheol Kim
    Korean Journal of Family Practice.2023; 13(3): 179.     CrossRef
  • Does reviewing fasting plasma glucose results patterns before glycosylated hemoglobin testing in type-2 diabetic patients lead to better testing decision?
    Wichaporn Intharachuti, Jiruth Sriratanaban
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(3): 2080.     CrossRef
  • Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia
    Bernd Richter, Bianca Hemmingsen, Maria-Inti Metzendorf, Yemisi Takwoingi
    Cochrane Database of Systematic Reviews.2018;[Epub]     CrossRef
  • Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) – Clinical based case control study
    N.A. Malini, K. Roy George
    General and Comparative Endocrinology.2018; 260: 51.     CrossRef
  • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
  • Risk of progression to diabetes from prediabetes defined by HbA1c or fasting plasma glucose criteria in Koreans
    Chul-Hee Kim, Hong-Kyu Kim, Eun-Hee Kim, Sung-Jin Bae, Jaewon Choe, Joong-Yeol Park
    Diabetes Research and Clinical Practice.2016; 118: 105.     CrossRef
  • Comparison of the clinical characteristics of diabetes mellitus diagnosed using fasting plasma glucose and haemoglobin A1c: The 2011 Korea National Health and Nutrition Examination Survey
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Chang Beom Lee, Sung-Hee Ihm
    Diabetes Research and Clinical Practice.2016; 113: 23.     CrossRef
  • Association of prediabetes, defined by fasting glucose, HbA1c only, or combined criteria, with the risk of cardiovascular disease in Koreans
    Hong‐Kyu Kim, Jung Bok Lee, Seon Ha Kim, Min‐Woo Jo, Eun Hee Kim, Jenie Yoonoo Hwang, Sung Jin Bae, Chang Hee Jung, Woo Je Lee, Joong‐Yeol Park, Gyung‐Min Park, Young‐Hak Kim, Jaewon Choe
    Journal of Diabetes.2016; 8(5): 657.     CrossRef
  • Fasting plasma glucose concentrations for specified HbA1c goals in Korean populations: data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2, 2011)
    Sangmo Hong, Jun Goo Kang, Chul Sik Kim, Seong Jin Lee, Chang Beom Lee, Sung-Hee Ihm
    Diabetology & Metabolic Syndrome.2016;[Epub]     CrossRef
  • Impact of hemoglobin A1c‐based criterion on diagnosis of prediabetes: The Korea National Health and Nutrition Examination Survey 2011
    Chul‐Hee Kim, Hong‐Kyu Kim, Bo‐Yeon Kim, Chan‐Hee Jung, Ji‐Oh Mok, Sung‐Koo Kang
    Journal of Diabetes Investigation.2015; 6(1): 51.     CrossRef
  • Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331 288 participants
    G Danaei, S Fahimi, Y Lu, B Zhou, K Hajifathalian, M Di Cesare, WC Lo, B Reis-Santos, MJ Cowan, JE Shaw, J Bentham, JK Lin, H Bixby, D Magliano, P Bovet, JJ Miranda, YH Khang, GA Stevens, LM Riley, MK Ali, M Ezzati, ZA Abdeen, KA Kadir, M Abu-Rmeileh, B A
    The Lancet Diabetes & Endocrinology.2015; 3(8): 624.     CrossRef
  • Prediabetes is not independently associated with microalbuminuria in Korean general population: The Korea National Health and Nutrition Examination Survey 2011–2012 (KNHANES V-2,3)
    Chul-Hee Kim, Kyu-Jin Kim, Bo-Yeon Kim, Chan-Hee Jung, Ji-Oh Mok, Sung-Koo Kang, Hong-Kyu Kim
    Diabetes Research and Clinical Practice.2014; 106(2): e18.     CrossRef
  • Estimation of blood glucose by non-invasive infrared thermography for diagnosis of type 2 diabetes: An alternative for blood sample extraction
    S. Sivanandam, M. Anburajan, B. Venkatraman, M. Menaka, D. Sharath
    Molecular and Cellular Endocrinology.2013; 367(1-2): 57.     CrossRef
  • Comparison of glycated hemoglobin with fasting plasma glucose in definition of glycemic component of the metabolic syndrome in an Iranian population
    Mohsen Janghorbani, Masoud Amini
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2012; 6(3): 136.     CrossRef
  • Usefulness of Glycated Hemoglobin as Diagnostic Criteria for Metabolic Syndrome
    Sang Hyun Park, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Journal of Korean Medical Science.2012; 27(9): 1057.     CrossRef
  • Letter: Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea (Diabetes Metab J 2012;36:151-6)
    Sung Hee Choi
    Diabetes & Metabolism Journal.2012; 36(3): 251.     CrossRef
Role of HbA1c in the Screening of Diabetes Mellitus in a Korean Rural Community
Jae Hyun Kim, Gun Woo Kim, Mi Young Lee, Jang Yel Shin, Young Goo Shin, Sang Baek Koh, Choon Hee Chung
Diabetes Metab J. 2012;36(1):37-42.   Published online February 17, 2012
DOI: https://doi.org/10.4093/dmj.2012.36.1.37
  • 7,997 View
  • 61 Download
  • 11 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Recently, the measurement of glycated hemoglobin (HbA1c) was recommended as an alternative to fasting plasma glucose or oral glucose tolerance tests for diagnosing diabetes mellitus (DM). In this study, we analyzed HbA1c levels for diabetes mellitus screening in a Korean rural population.

Methods

We analyzed data from 10,111 subjects from a Korean Rural Genomic Cohort study and generated a receiver operating characteristic curve to determine an appropriate HbA1c cutoff value for diabetes.

Results

The mean age of the subjects was 56.3±8.1 years. Fasting plasma glucose and 2-hour plasma glucose after 75 g oral glucose tolerance tests were 97.5±25.6 and 138.3±67.1 mg/dL, respectively. The mean HbA1c level of the subjects was 5.7±0.9%. There were 8,809 non-DM patients (87.1%) and 1,302 DM patients (12.9%). A positive relationship between HbA1c and plasma glucose levels and between HbA1c and 2-hour plasma glucose levels after oral glucose tolerance tests was found in a scatter plot of the data. Using Youden's index, the proper cutoff level of HbA1c for diabetes mellitus screening was 5.95% (sensitivity, 77%; specificity, 89.4%).

Conclusion

Our results suggest that the optimal HbA1c level for DM screening is 5.95%.

Citations

Citations to this article as recorded by  
  • Hyperinsulinemia: an early biomarker of metabolic dysfunction
    Rama A. Vaidya, Sharvari Desai, Panchali Moitra, Sheryl Salis, Shubhada Agashe, Rekha Battalwar, Anushree Mehta, Jagmeet Madan, Soumik Kalita, Shobha A. Udipi, Ashok B. Vaidya
    Frontiers in Clinical Diabetes and Healthcare.2023;[Epub]     CrossRef
  • A Novel Earwax Method to Measure Acute and Chronic Glucose Levels
    Andrés Herane-Vives, Susana Espinoza, Rodrigo Sandoval, Lorena Ortega, Luis Alameda, Allan H. Young, Danilo Arnone, Alexander Hayes, Jan Benöhr
    Diagnostics.2020; 10(12): 1069.     CrossRef
  • Risk Factors for Underdiagnosis of Diabetes Based on the Korean National Health and Nutrition Examination Survey 2013-2015
    Deulle Min, Eunhee Cho
    Asia Pacific Journal of Public Health.2019; 31(5): 404.     CrossRef
  • Recent advances of medical journals in Korea and and further development strategies: Is it possible for them to publish Nobel Prize-winning research?
    Sun Huh
    Journal of the Korean Medical Association.2018; 61(9): 524.     CrossRef
  • The clinical value of HbA1c in combination with FPG in the early screening of the elderly with type 2 diabetes
    Lihua Liu, Wenqing Chen, Minghua Dong, Lixia Jiang, Wei Qiu, Jian Li, Xiaoting Luo, Zhengchun Huang, Qin Wu, Qinfeng Wu, Shuiqin Chen, Lu Ou-Yang, Shumei Li, J.Q. Cheng, H.L. Moffitt, I. Kim, Z.T. Chi, J. Zhang
    BIO Web of Conferences.2017; 8: 01030.     CrossRef
  • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
  • Performance of HbA1c for the prediction of diabetes in a rural community in Korea
    B. M. Song, H. C. Kim, J. Y. Lee, J.‐M. Lee, D. J. Kim, Y.‐H. Lee, I. Suh
    Diabetic Medicine.2015; 32(12): 1602.     CrossRef
  • The Relationship between BMI and Glycated Albumin to Glycated Hemoglobin (GA/A1c) Ratio According to Glucose Tolerance Status
    Ji Hye Huh, Kwang Joon Kim, Byung-Wan Lee, Dong Wook Kim, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee, Marta Letizia Hribal
    PLoS ONE.2014; 9(2): e89478.     CrossRef
  • Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka – lessons learned from the WHO CKDu population prevalence study
    Jennifer Hoponick Redmon, Myles F Elledge, Donna S Womack, Rajitha Wickremashinghe, Kamani P Wanigasuriya, Roshini J Peiris-John, Joseph Lunyera, Kristin Smith, James H Raymer, Keith E Levine
    BMC Nephrology.2014;[Epub]     CrossRef
  • Diagnostic Efficiency of Hemoglobin A1c for Newly Diagnosed Diabetes and Prediabetes in Community-Based Chinese Adults Aged 40 Years or Older
    Kai Liang, Yu Sun, Wen-juan Li, Xiu-ping Zhang, Cheng-qiao Li, Wei-fang Yang, Ze-qiang Ma, Ai-xia Ma, Hui-zhen Zheng, Jun Song, Peng Lin, Xin-guo Hou, Li Chen
    Diabetes Technology & Therapeutics.2014; 16(12): 853.     CrossRef
  • Diagnostic accuracy of HbA1c in diabetes between Eastern and Western
    Shuang Yan, Siying Liu, Yashuang Zhao, Wencui Zhang, Xiaohui Sun, Jianing Li, Fuli Jiang, Jiaming Ju, Ning Lang, Yingqi Zhang, Weiyu Zhou, Qiang Li
    European Journal of Clinical Investigation.2013; 43(7): 716.     CrossRef
Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus
Fethiye Oztop Gunduz, Sembol Turkmen Yildirmak, Mustafa Temizel, Yilmaz Faki, Mustafa Cakmak, Mustafa Durmuscan, Funda Sezgin
Diabetes Metab J. 2011;35(5):523-528.   Published online October 31, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.5.523
  • 65,535 View
  • 45 Download
  • 13 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

Visfatin is an adipokine produced by visceral adipose tissue and has insulin-mimicking effects. Fetuin-A is a hepatic secretory protein that binds the insulin receptor and inhibits insulin action both in vivo and in vitro. The authors of the present study aimed to investigate the levels of serum visfatin and fetuin-A and their correlation with hemoglobin A1c (HbA1c) and urine albumin levels in patients with type 2 diabetes mellitus (T2DM).

Methods

A total of 40 obese patients with T2DM (11 males and 29 females; age, 54.47±10.83 years and 23 obese nondiabetic controls (8 males and 15 females; age, 53.04±11.33 years) were included in the study. Age, sex, and body mass index were similar in the 2 groups. Serum visfatin and fetuin-A levels were measured by enzyme-linked immunosorbent assay. HbA1c and urine albumin levels were measured by high performance liquid chromatography and nephelometric method, respectively.

Results

Serum levels of visfatin in patients with T2DM (4.03±2.44 ng/mL) were similar to the control group (3.65±3.02 ng/mL). Serum fetuin-A levels were significantly lower in patients with T2DM than the controls (298.75±78.86 and 430.73±94.46 µg/mL, respectively). HbA1c levels were significantly higher in the T2DM group compared with controls (7.33±1.32 and 5.44±0.84%, respectively). Correlations between visfatin, fetuin-A and HbA1c levels were not observed.

Conclusion

The present study suggests fetuin-A may play a role in the pathogenesis of T2DM.

Citations

Citations to this article as recorded by  
  • Interaction of fetuin-A with obesity related insulin resistance and diabetes mellitus
    Yıldız Öner-İyidoğan, Hikmet Koçak
    Turkish Journal of Biochemistry.2025; 50(2): 170.     CrossRef
  • Fetuin-A increases thrombosis risk in non-alcoholic fatty liver disease by binding to TLR-4 on platelets
    Peng Zhang, Zhiyong Qi, Huajie Xu, Luning Zhou, Xin Zhao, Haoxuan Zhong, Wenxuan Zhou, Bing Fan, Hongyi Wu, Junbo Ge
    Cardiovascular Research.2025; 121(7): 1091.     CrossRef
  • Role of Adipokines Chemerin, Visfatin, and Omentin in Obesity and Their Inflammatory and Metabolic Implications
    Wilson José S. Pedro, Flávio V. Barbosa Júnior, Fernanda N. B. R. Alves, Lenita V. Braga, Larissa R. Alves, João Pedro R. Afonso, Iranse O. Silva, Carlos Hassel M. Silva, Sergio Vencio, Paolo Capodaglio, Luis V. F. Oliveira, Wilson R. Freitas Júnior
    Biomedicines.2025; 13(10): 2321.     CrossRef
  • Assessment of serum and salivary visfatin levels in newly diagnosed patients of type-II DM
    Faith R. Jerusha, Vandana Raghunath
    Journal of Oral and Maxillofacial Pathology.2023; 27(4): 663.     CrossRef
  • Evaluation of the serum visfatin eotaxin and fetuin-A levels of patients with type 2 diabetes mellitus
    Hacer KAYHAN KAYA, Abdurrahman ŞERMET, Zafer PEKKOLAY, Ezel TAŞDEMİR, Dilek AYGÜN KEŞİM
    Anatolian Current Medical Journal.2022; 4(1): 113.     CrossRef
  • The Association Between Three Adipocytokines (Adiponectin, Resistin and Visfatin) And Thyroid Status in Patients With Type 2 Diabetes Mellitus and Autoimmune Thyroiditis
    Š. Sotak, Z. Schroner, I. Lazúrová, M. Felšőci, I. Jochmanová, D. Petrášová, I. Bertková, M. Mitníková, B. Nováková, H. Wagnerová, O. Bobelová
    Physiological Research.2021; (6): 865.     CrossRef
  • Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels
    Hatice Kansu-Celik, A. Seval Ozgu-Erdinc, Burcu Kisa, Rahime Bedir Findik, Canan Yilmaz, Yasemin Tasci
    Archives of Endocrinology and Metabolism.2019;[Epub]     CrossRef
  • The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies
    F. Roshanzamir, M. Miraghajani, M. H. Rouhani, M. Mansourian, R. Ghiasvand, S. M. Safavi
    Journal of Endocrinological Investigation.2018; 41(1): 33.     CrossRef
  • Fetuin-A level in type 2 diabetic patients: relation to microvascular complications
    Nehal H. Al-Said, Fatma M. Taha, Ghada M. Abdel-Aziz, Marwa S. Abdel-Tawab
    The Egyptian Journal of Internal Medicine.2018; 30(3): 121.     CrossRef
  • Serum levels of fetuin A are increased in women with gestational diabetes mellitus
    Ozlem Turhan Iyidir, Ceyla Konca Degertekin, Banu Aktas Yilmaz, Alev E. Altinova, Fusun B. Toruner, Nuray Bozkurt, Goksun Ayvaz, Mujde Akturk
    Archives of Gynecology and Obstetrics.2015; 291(4): 933.     CrossRef
  • Lower Fetuin-A, Retinol Binding Protein 4 and Several Metabolites after Gastric Bypass Compared to Sleeve Gastrectomy in Patients with Type 2 Diabetes
    Mia Jüllig, Shelley Yip, Aimin Xu, Greg Smith, Martin Middleditch, Michael Booth, Richard Babor, Grant Beban, Rinki Murphy, Pankaj K. Singh
    PLoS ONE.2014; 9(5): e96489.     CrossRef
  • Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome
    Hussein F. Sakr, Fahaid H. Al-Hashem, Waffaa M. Hassab El-Naby, Mahmoud A. Alkhateeb, Mohamed Samir A. Zaki, Hesham M. El Refaey, Mohamed D. Morsy
    Canadian Journal of Physiology and Pharmacology.2014; 92(2): 162.     CrossRef
  • Relationship between circulating visfatin/NAMPT, nutritional status and insulin resistance in an elderly population – results from the PolSenior substudy
    Magdalena Olszanecka-Glinianowicz, Aleksander Owczarek, Maria Bożentowicz-Wikarek, Aniceta Brzozowska, Małgorzata Mossakowska, Tomasz Zdrojewski, Tomasz Grodzicki, Andrzej Więcek, Jerzy Chudek
    Metabolism.2014; 63(11): 1409.     CrossRef
Association between Obesity and Physical Fitness, and Hemoglobin A1c Level and Metabolic Syndrome in Korean Adults
Yoonsuk Jekal, Mi-Kyung Lee, Sukyung Park, Seung-Hwan Lee, Jun-Young Kim, Jung-Ui Kang, Masayo Naruse, Sang-Hwan Kim, Sun-Hyeon Kim, Sang Hui Chu, Sang-Hoon Suh, Justin Y Jeon
Korean Diabetes J. 2010;34(3):182-190.   Published online June 30, 2010
DOI: https://doi.org/10.4093/kdj.2010.34.3.182
  • 6,838 View
  • 27 Download
  • 12 Crossref
AbstractAbstract PDFPubReader   ePub   
Background

The purpose of the current study was to investigate the association of obesity level, physical fitness level, hemoglobin A1c (HbA1c) level and metabolic syndrome (MetS) risk factors among Korean adults.

Methods

A total of 557 adults (272 males and 285 females) who underwent medical check-up at local hospital were recruited. In addition to regular health check-up, cardiopulmonary fitness, muscular endurance were measured and their association were analyzed.

Results

The prevalence of MetS was 31.7% for males and 23.7% for females. Females with the higher muscular endurance had lower waist circumference, triglyceride level, and HbA1c level than those with the lower muscular endurance. Males with the higher level of cardiopulmonary fitness had lower diastolic blood pressure, lower high-sensitivity C-reactive protein level and higher high density lipoprotein cholesterol level than males with the lower level of cardiopulmonary fitness. Females with the higher level of cardiopulmonary fitness had lower body weight, body mass index, systolic blood pressure, and fasting blood glucose level than females with the lower level of cardiopulmonary fitness. Participants with the higher level of adiposity and the lower level of physical fitness were 5.26 times (95% confidence interval [CI], 2.19 to 12.62), 5.71 times (95% CI, 2.23 to 14.60) more likely to have MetS, respectively, in male and female compared to participants who were neither obese nor have the lower level of fitness.

Conclusion

This study suggests that maintaining a healthy body weight as well as a certain level of fitness is important for the prevention of MetS.

Citations

Citations to this article as recorded by  
  • Muscular strength and cardiovascular risk factors in adults: a systematic review
    Tiago Rodrigues De Lima, Priscila Custódio Martins, Paulo Henrique Guerra, Diego Augusto Santos Silva
    The Physician and Sportsmedicine.2021; 49(1): 18.     CrossRef
  • Influences of Cardiovascular Fitness and Body Fatness on the Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis
    Junga Lee
    American Journal of Health Promotion.2020; 34(7): 796.     CrossRef
  • The Relationship between Resting Heart Rate and Prevalence of Metabolic Syndrome and Type 2 Diabetes Mellitus in Korean Adults: The Fifth Korea National Health and Nutrition Examination Survey (2012)
    Hyuna Park, Junga Lee, Ji Young Kim, Dong-Il Kim, Justin Y. Jeon
    The Korean Journal of Obesity.2015; 24(3): 166.     CrossRef
  • Cardiovascular Risk and Metabolic Syndrome in Obese Youth Enrolled in a Multidisciplinary Medical Weight Management Program: Implications of Musculoskeletal Pain, Cardiorespiratory Fitness, and Health-Related Quality of Life
    Matthew S. Briggs, Colleen Spees, Sharon Bout-Tabaku, Christopher A. Taylor, Ihuoma Eneli, Laura C. Schmitt
    Metabolic Syndrome and Related Disorders.2015; 13(3): 102.     CrossRef
  • Development and Effect of a Metabolic Syndrome Prevention Program for University Students using Mobile Application.
    Han Kyu Kang, Tae Bin Kim, Kyu Hyung Kim, Min Jin Kim, Jin Hyun Kim, Hyun Yong Kim, Kyung Hoon Yeom, Ka Hyun Lee, Eun Young Choi, Kyung Ah Kang
    Child Health Nursing Research.2014; 20(3): 205.     CrossRef
  • Carnitine Palmitoyltransferase 1B 531K Allele Carriers Sustain a Higher Respiratory Quotient after Aerobic Exercise, but β3-Adrenoceptor 64R Allele Does Not Affect Lipolysis: A Human Model
    Eduardo Gómez-Gómez, Martín Efrén Ríos-Martínez, Elena Margarita Castro-Rodríguez, Mario Del-Toro-Equíhua, Mario Ramírez-Flores, Ivan Delgado-Enciso, Ana Lilia Pérez-Huitimea, Luz Margarita Baltazar-Rodríguez, Gilberto Velasco-Pineda, Jesús Muñiz-Murguía,
    PLoS ONE.2014; 9(6): e96791.     CrossRef
  • Combined Impact of Cardiorespiratory Fitness and Visceral Adiposity on Metabolic Syndrome in Overweight and Obese Adults in Korea
    Sue Kim, Ji-Young Kim, Duk-Chul Lee, Hye-Sun Lee, Ji-Won Lee, Justin Y. Jeon, Reury F P. Bacurau
    PLoS ONE.2014; 9(1): e85742.     CrossRef
  • The Relationship Between Resting Heart Rate and Risk Factors of Metabolic Syndrome in Korean Adults
    Choae Lee, Junga Lee, Justin Y. Jeon
    The Korean Journal of Obesity.2013; 22(4): 222.     CrossRef
  • The Relationship Between Fitness, BMI and Risk Factors of Metabolic Syndrome Among University Students in Korea
    Dong-il Kim, Ji Young Kim, Mi Kyoung Lee, Hae-Dong Lee, Ji-Won Lee, Justin Y. Jeon
    The Korean Journal of Obesity.2012; 21(2): 99.     CrossRef
  • Lifestyle Habits and Physical Capacity in Patients with Moderate or Severe Metabolic Syndrome
    Martin Sénéchal, Danielle R. Bouchard, Isabelle J. Dionne, Martin Brochu
    Metabolic Syndrome and Related Disorders.2012; 10(3): 232.     CrossRef
  • Effects of 6 Weeks of Lifestyle Modification Including Combined Exercise Program on the Risk of Metabolic Parameters and Macrovascular Complications in Type 2 Diabetic Patients
    Dong Hoon Lee, Seung Hwan Lee, Kiyong An, Jin Young Moon, So Hun Kim, Yoon Jin Choi, Moonsuk Nam, Justin Y. Jeon
    The Korean Journal of Obesity.2011; 20(3): 147.     CrossRef
  • Epidemiology of Physical Activity Participation and Type 2 Diabetes in Korea
    Yoonsuk Jekal, Justin Y Jeon
    Journal of Korean Diabetes.2011; 12(1): 13.     CrossRef
The Cutoff Value of HbA1c in Predicting Diabetes in Korean Adults in a University Hospital in Seoul.
Ji Cheol Bae, Eun Jung Rhee, Eun Suk Choi, Ji Hoon Kim, Won Jun Kim, Seung Hyun Yoo, Se Eun Park, Cheol Young Park, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim
Korean Diabetes J. 2009;33(6):503-510.   Published online December 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.6.503
  • 4,506 View
  • 47 Download
  • 6 Crossref
AbstractAbstract PDF
BACKGROUND
Glycated hemoglobin (HbA1c) levels represent a 2~3 month average of blood glucose concentration. The use of HbA1c as a diagnostic tool for diabetes is gaining interest. Therefore, we determined the cutoff point of HbA1c for predicting abnormal glucose tolerance status in non-diabetic Korean subjects. METHODS: We analyzed the data from 1,482 subjects without diabetes mellitus in whom a 75-g oral glucose tolerance test (OGTT) was performed due to suspected abnormal glucose tolerance. We obtained an HbA1c cutoff point for predicting diabetes using Receiver Operating Characteristic (ROC) curve analysis. RESULTS: A cut-off point of 5.95% HbA1c yielded sensitivity of 60.8% and specificity of 85.6%, respectively, for predicting diabetes. There was a difference in HbA1c cut-off value between men and women, 5.85% and 6.05%, respectively. CONCLUSION: To use the cut-off point of 5.95% HbA1c for predicting undiagnosed diabetes in Koreans may be reliable. However, studies of different ethnic groups have reported disparate HbA1c cut-off points. Thus, ethnicity, age, gender, and population prevalence of diabetes are important factors to consider in using elevated HbA1c value as a tool to diagnose diabetes.

Citations

Citations to this article as recorded by  
  • The Cutoff Value of HbA1c in Predicting Diabetes and Impaired Fasting Glucose
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(2): 114.     CrossRef
  • Role of HbA1c in the Screening of Diabetes Mellitus in a Korean Rural Community
    Jae Hyun Kim, Gun Woo Kim, Mi Young Lee, Jang Yel Shin, Young Goo Shin, Sang Baek Koh, Choon Hee Chung
    Diabetes & Metabolism Journal.2012; 36(1): 37.     CrossRef
  • Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea
    Hong-Kyu Kim, Sung-Jin Bae, Jaeone Choe
    Diabetes & Metabolism Journal.2012; 36(2): 151.     CrossRef
  • The Utility of HbA1c as a Diagnostic Criterion of Diabetes
    Hee-Jung Kim, Eun Young Choi, Eal Whan Park, Yoo Seock Cheong, Hong-Yoen Lee, Ji Hyun Kim
    Korean Journal of Family Medicine.2011; 32(7): 383.     CrossRef
  • 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
    Seung-Hyun Ko, Sung-Rea Kim, Dong-Joon Kim, Seung-Joon Oh, Hye-Jin Lee, Kang-Hee Shim, Mi-Hye Woo, Jun-Young Kim, Nan-Hee Kim, Jae-Taik Kim, Chong Hwa Kim, Hae Jin Kim, In-Kyung Jeong, Eun-Kyung Hong, Jae-Hyoung Cho, Ji-Oh Mok, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2011; 35(5): 431.     CrossRef
  • 2011 Clinical Practice Guidelines for Type 2 Diabetes in Korea
    Seung-Hyun Ko, Dong-Joon Kim, Seung-Joon Oh, Hye-Jin Lee, Kang-Hee Shim, Mi-Hye Woo, Jun-Young Kim, Nan-Hee Kim, Jae-Taik Kim, Chong Hwa Kim, Hye Jin Kim, In-Kyung Jeong, Eun-Gyoung Hong, Jae-Hyoung Cho, Ji-Oh Mok, Kun-Ho Yoon, Sung-Rea Kim
    Journal of Korean Diabetes.2011; 12(4): 183.     CrossRef
Incidence of Diabetic Foot and Associated Risk Factors in Type 2 Diabetic Patients: A Five-year Observational Study.
Shin Ae Park, Seung Hyun Ko, Seung Hwan Lee, Jae Hyoung Cho, Sung Dae Moon, Sang A Jang, Hyun Shik Son, Ki Ho Song, Bong Yun Cha, Ho Young Son, Yu Bae Ahn
Korean Diabetes J. 2009;33(4):315-323.   Published online August 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.4.315
  • 3,871 View
  • 51 Download
  • 14 Crossref
AbstractAbstract PDF
BACKGROUND
The frequency of lower extremity amputation due to diabetic foot has been increasing in type 2 diabetic patients. The aim of this study was to observe the incidence, clinical aspects and associated risk factors for diabetic foot. METHODS: We evaluated the incidence of diabetic foot through a five-year observation of type 2 diabetic patients who presented to St. vincent's Hospital between January and December 2003. To identify the risk factors for diabetic foot, we evaluated mean glycosylated hemoglobin A1c (HbA1c) every six months and assessed renal function based on the existence of proteinuria and estimated glomerular filtration rate (GFR) using the Modification of Diet in Renal Disease (MDRD) equation. Patients were also evaluated for retinopathy, peripheral neuropathy and autonomic neuropathy using Ewing's method. RESULTS: From an initial pool of 613 patients, the observational study of 508 patients (82.9%) was completed. The mean age, duration of diabetes and HbA1c were 50.3 +/- 10.6 yrs, 7.2 +/- 6.5 yrs and 8.8 +/- 2.1%, respectively. Diabetic foot occurred in 32 patients (6.3%). The incidence of diabetic foot increased when diabetic retinopathy (OR = 6.707, 2.314~19.439), peripheral neuropathy (OR = 2.949, 1.075~8.090), and autonomic neuropathy (OR = 3.967, 1.476~10.660) were present and when the MDRD GFR (OR = 5.089, 1.712~15.130) decreased. Mean HbA1c (OR = 12.013, 1.470~98.179) was found to be an independent risk factor for diabetic foot. CONCLUSION: The present study confirmed the importance of intensive glycemic control and the role of autonomic dysfunction in the development of diabetic foot. In addition, diabetic retinopathy and impaired renal function proved to be factors associated with the occurrence of diabetic foot. Therefore, intensive glycemic control, as well as periodic examination of renal function, are essential for the prevention of diabetic foot.

Citations

Citations to this article as recorded by  
  • The Risk of the Aggravation of Diabetic Foot According to Air Quality Factors in the Republic of Korea: A Nationwide Population-Based Study
    Saintpee Kim, Sungho Won, Young Yi
    International Journal of Environmental Research and Public Health.2024; 21(6): 775.     CrossRef
  • Microbiological, Clinical and Radiological Aspects of Diabetic Foot Ulcers Infected with Methicillin-Resistant and -Sensitive Staphylococcus aureus
    Maria Stańkowska, Katarzyna Garbacz, Anna Korzon-Burakowska, Marek Bronk, Monika Skotarczak, Anna Szymańska-Dubowik
    Pathogens.2022; 11(6): 701.     CrossRef
  • Potential of Nanoencapsulated Quercetin Topical Formulations in the Management of Diabetic Foot Ulcer
    Shashank Chaturvedi, Shruti Agrawal, Anuj Garg, Vaibhav Rastogi
    Revista Brasileira de Farmacognosia.2022; 33(3): 484.     CrossRef
  • Development of a Diabetic Foot Ulceration Prediction Model and Nomogram
    Eun Joo Lee, Ihn Sook Jeong, Seung Hun Woo, Hyuk Jae Jung, Eun Jin Han, Chang Wan Kang, Sookyung Hyun
    Journal of Korean Academy of Nursing.2021; 51(3): 280.     CrossRef
  • Regional Variation in the Incidence of Diabetes-Related Lower Limb Amputations and Its Relationship with the Regional Factors
    Sung Hun Won, Jahyung Kim, Dong-Il Chun, Young Yi, Suyeon Park, Kwang-Young Jung, Gun-Hyun Park, Jaeho Cho
    Journal of Korean Foot and Ankle Society.2019; 23(3): 121.     CrossRef
  • The Changes of Trends in the Diagnosis and Treatment of Diabetic Foot Ulcer over a 10-Year Period: Single Center Study
    Choong Hee Kim, Jun Sung Moon, Seung Min Chung, Eun Jung Kong, Chul Hyun Park, Woo Sung Yoon, Tae Gon Kim, Woong Kim, Ji Sung Yoon, Kyu Chang Won, Hyoung Woo Lee
    Diabetes & Metabolism Journal.2018; 42(4): 308.     CrossRef
  • The Relationship between Body Mass Index and Diabetic Foot Ulcer, Sensory, Blood Circulation of Foot on Type II Diabetes Mellitus Patients
    Yi Kyu Park, Jun Young Lee, Sung Jung, Kang Hyeon Ryu
    Journal of the Korean Orthopaedic Association.2018; 53(2): 136.     CrossRef
  • Factors Contributing to Diabetic Foot Ulcer among Patients with Type 2 Diabetes Mellitus
    Seo Jin Park, Taeyoung Yang, Jun Young Lee, Jinhee Kim
    Korean Journal of Adult Nursing.2018; 30(1): 106.     CrossRef
  • A Report on Diabetic Foot and Amputation from the Korean Health Insurance Review & Assessment Service Data
    Jong-Kil Kim, Young-Ran Jung, Kyung-Tae Kim, Chung-Shik Shin, Kwang-Bok Lee
    Journal of Korean Foot and Ankle Society.2017; 21(2): 66.     CrossRef
  • Prevalence and Current Status of Treatment of Diabetic Foot in South Korea
    Jae-Ik Bae, Je Hwan Won, Jun Su Kim, Man Deuk Kim, Chang Jin Yoon, Yun Ku Cho
    Journal of the Korean Society of Radiology.2016; 74(3): 169.     CrossRef
  • Diabetic Foot Disease—Incidence and Risk Factors: A Clinical Study
    Rajesh Kapila, Rakesh Sharma, Ashwani K Sharma, Jagsir Mann
    Journal of Foot and Ankle Surgery (Asia Pacific).2016; 3(1): 41.     CrossRef
  • Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
    Seung-Hyun Ko, Bong-Yun Cha
    Diabetes & Metabolism Journal.2012; 36(1): 6.     CrossRef
  • Diabetics' Preference in the Design Factors and Performance Requirements of Diabetic Socks
    Ji-Eun Lee, Young-Ah Kwon
    Journal of the Korean Society of Clothing and Textiles.2011; 35(5): 527.     CrossRef
  • Epidemiology of Diabetic Foot Disease
    Kyu Jeung Ahn
    Journal of Korean Diabetes.2011; 12(2): 72.     CrossRef
The Combination of Fasting Plasma Glucose and Glycosylated Hemoglobin as a Predictor for Type 2 Diabetes in Korean Adults.
Chan Hee Lee, Woo Jin Chang, Hyun Hee Chung, Hyun Jung Kim, Sang Hyun Park, Jun Sung Moon, Ji Eun Lee, Ji Sung Yoon, Kyung Ah Chun, Kyu Chang Won, Ihn Ho Cho, Hyoung Woo Lee
Korean Diabetes J. 2009;33(4):306-314.   Published online August 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.4.306
  • 4,475 View
  • 30 Download
  • 8 Crossref
AbstractAbstract PDF
BACKGROUND
The oral glucose tolerance test (OGTT) for detection of diabetes is difficult to perform in clinical settings. The aim of this study is to evaluate the performance of a more practical detection test, combined fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c), as a predictor of diabetes mellitus (DM) in a Korean sample. METHODS: We examined 2,045 (M = 1,276, mean age = 47.8 +/- 9.0 yrs) medical check-up program participants between January 2002 to December 2003. FPG, HbA1c and a number of other biochemical tests were performed at baseline and four after years after initial screening. Patients who originally presented with diabetes were excluded. The characteristics of newly-diagnosed DM patients and non-diabetic patients were compared. RESULTS: The incidence of newly diagnosed diabetes was 1.6% (32/2,045) after four years of follow up. The subjects in the DM group were older, had higher levels of SBP, DBP, FPG, HbA1c, triglyceride, HDL cholesterol, GGT and LDH (P < 0.05). In multivariate logistic regression analysis, FPG (odds ratio [OR] 1.124) and HbA1c (OR 4.794) were significantly correlated with onset of diabetes (P < 0.05). The interaction parameter between FPG and HbA1c was more than 1.0, indicating that the two effects are synergistic. The predictive cut-off values of HbA1c and FPG were 5.35% (area under curve [AUC] = 0.944) and 102.5 mg/dL (AUC = 0.930), respectively. CONCLUSION: The combination of HbA1c above 5.35% and FPG above 102.5 mg/dL predicted the onset of diabetes in a Korean sample. These results suggest that the combination of FPG and HbA1c may be useful for predicting progression to type 2 diabetes in east Asians.

Citations

Citations to this article as recorded by  
  • The Distribution and Characteristics of Abnormal Findings Regarding Fasting Plasma Glucose and HbA1c - Based on Adults Except for Known Diabetes
    Seyoung Kwon, Youngak Na
    The Korean Journal of Clinical Laboratory Science.2017; 49(3): 239.     CrossRef
  • Factors Affecting Diabetic Screening Behavior of Korean Adults: A Multilevel Analysis
    Hyeongsu Kim, Minjung Lee, Haejoon Kim, Kunsei Lee, Sounghoon Chang, Vitna Kim, Jun Pyo Myong, Soyoun Jeon
    Asian Nursing Research.2013; 7(2): 67.     CrossRef
  • Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea
    Hong-Kyu Kim, Sung-Jin Bae, Jaeone Choe
    Diabetes & Metabolism Journal.2012; 36(2): 151.     CrossRef
  • The Utility of HbA1c as a Diagnostic Criterion of Diabetes
    Hee-Jung Kim, Eun Young Choi, Eal Whan Park, Yoo Seock Cheong, Hong-Yoen Lee, Ji Hyun Kim
    Korean Journal of Family Medicine.2011; 32(7): 383.     CrossRef
  • Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus
    Soon Ae Kim, Woo Ho Shim, Eun Hae Lee, Young Mi Lee, Sun Hee Beom, Eun Sook Kim, Jeong Seon Yoo, Ji Sun Nam, Min Ho Cho, Jong Suk Park, Chul Woo Ahn, Kyung Rae Kim
    Diabetes & Metabolism Journal.2011; 35(2): 159.     CrossRef
  • Optimal range of HbA1c for the prediction of future diabetes: A 4-year longitudinal study
    Ji Cheol Bae, Eun Jung Rhee, Won Young Lee, Se Eun Park, Cheol Young Park, Ki Won Oh, Sung Woo Park, Sun Woo Kim
    Diabetes Research and Clinical Practice.2011; 93(2): 255.     CrossRef
  • The Combination of Fasting Plasma Glucose and Glycosylated Hemoglobin as a Predictor for Type 2 Diabetes in Korean Adults (Korean Diabetes J 33(4):306-314, 2009)
    Soo Lim
    Korean Diabetes Journal.2009; 33(5): 448.     CrossRef
  • The Combination of Fasting Plasma Glucose and Glycosylated Hemoglobin as a Predictor for Type 2 Diabetes in Korean Adults (Korean Diabetes J 33(4):306-314, 2009)
    Chan Hee Lee, Hyoung Woo Lee
    Korean Diabetes Journal.2009; 33(5): 451.     CrossRef
A Nationwide Survey about the Current Status of Glycemic Control and Complications in Diabetic Patients in 2006: The Committee of the Korean Diabetes Association on the Epidemiology of Diabetes Mellitus.
Soo Lim, Dae Jung Kim, In Kyung Jeong, Hyun Shik Son, Choon Hee Chung, Gwanpyo Koh, Dae Ho Lee, Kyu Chang Won, Jeong Hyun Park, Tae Sun Park, Jihyun Ahn, Jaetaek Kim, Keun Gyu Park, Seung Hyun Ko, Yu Bae Ahn, Inkyu Lee
Korean Diabetes J. 2009;33(1):48-57.   Published online February 1, 2009
DOI: https://doi.org/10.4093/kdj.2009.33.1.48
  • 4,509 View
  • 83 Download
  • 43 Crossref
AbstractAbstract PDF
BACKGROUND
The Committee of the Korean Diabetes Association on the Epidemiology of Diabetes Mellitus performed a nationwide survey about the current status of glycemic control and diabetic complications in 2006. METHODS: The current study included 5,652 diabetic patients recruited from the rosters of endocrinology clinics of 13 tertiary hospitals in Korea. Age, gender, height, weight, waist circumference and blood pressure were investigated by standard method. Fasting and postprandial 2 hour glucose, glycosylated hemoglobin (HbA1c), lipid profiles, fasting insulin and c-peptide levels were measured. Microvascular (microalbuminuria, retinopathy and neuropathy) and macrovascular (coronary artery disease [CAD], cerebrovascular disease [CVD] and peripheral artery disease [PAD]) complications were reviewed in their medical records. RESULTS: Mean age of total subjects was 58.7 (+/- 11.6) years and duration of diabetes was 8.8 (0~50) years. Mean fasting and postprandial 2 hour glucose levels were 145.9 +/- 55.0 and 208.0 +/- 84.4 mg/dL, respectively. Their mean HbA1c was 7.9 +/- 1.9%: the percentage of patients within target goal of glycemic control (< 7% of HbA1c) was 36.7%. In this study, 30.3%, 38.3% and 44.6% of patients was found to have microalbuminuria, retinopathy and nephropathy, respectively. Prevalence of CAD, CVD and PAD was 8.7%, 6.7% and 3.0%, respectively. Diabetic complications were closely related with age, duration of diabetes and glycemic control, and this relationship was stronger in microvascular complications than macrovascular ones. CONCLUSION: Only about one third of patients with diabetes was found to reach target glycemic control in tertiary hospitals of Korea. More tight control is needed to reduce deleterious complications of diabetes in Korea.

Citations

Citations to this article as recorded by  
  • Risk of Diabetic Complications in Type 2 Diabetes Patients with Dementia: A Population-Based Study Using National Health Insurance Claims Data
    Eun Sik Jeong, Ah-Young Kim, Hye-Young Kang
    Drug Targets and Therapeutics.2023; 2(1): 49.     CrossRef
  • Prevalence of thyroid disorders in type 2 diabetic patients – A 1-year cross-sectional study
    Rikita Ramesh Mudhol, Shivakumar Veeranna Turamari, Rekha Ramesh Mudhol, B. Srinivas
    BLDE University Journal of Health Sciences.2022; 7(1): 56.     CrossRef
  • Associations of fasting glucose and glycated hemoglobin with vitamin D levels according to diabetes mellitus status in Korean adults
    Yerin Hwang, Jiyoung Jang, Myung-Hee Shin
    Epidemiology and Health.2022; 44: e2022025.     CrossRef
  • Atherectomy in Peripheral Artery Disease: Current and Future
    Yohan Kwon, Jinoo Kim, Je-Hwan Won, Seong Ho Kim, Jeong-Eun Kim, Sung-Joon Park
    Journal of the Korean Society of Radiology.2021; 82(3): 551.     CrossRef
  • Diabetic Retinopathy and Related Clinical Practice for People with Diabetes in Korea: A 10-Year Trend Analysis
    Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, Dae Jung Kim
    Diabetes & Metabolism Journal.2020; 44(6): 928.     CrossRef
  • Current status of treatment of type 2 diabetes mellitus in Ningbo, China
    Tianmeng Yang, Rongjiong Zheng, Qingmei Chen, Yushan Mao
    Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
  • Recently Uncontrolled Glycemia in Diabetic Patients Is Associated with the Severity of Intracranial Atherosclerosis
    Nari Choi, Jeong-Yoon Lee, Jun-Sang Sunwoo, Hakjae Roh, Moo-Young Ahn, Sung-Tae Park, Kyung Bok Lee
    Journal of Stroke and Cerebrovascular Diseases.2017; 26(11): 2615.     CrossRef
  • The effect of educational program based on the precede-proceed model on improving self-care behaviors in a semi-urban population with type 2 diabetes referred to health centers of Bavi, Iran
    Neda Barasheh, Ghodratollah Shakerinejad, Sedigheh Nouhjah, Mohammad Hossein Haghighizadeh
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017; 11: S759.     CrossRef
  • Increased prevalence of albuminuria in individuals with higher range of impaired fasting glucose: the 2011 Korea National Health and Nutrition Examination Survey
    Jong Chul Won, Jae Won Hong, Jung Min Kim, Tae Nyun Kim, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim
    Journal of Diabetes and its Complications.2015; 29(1): 50.     CrossRef
  • Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin–sulfonylurea combination: Results of a multicenter, cross‐sectional, observational study in Korea
    Sin Gon Kim, Jong Ryeal Hahm, Duk Kyu Kim, Sung Rae Cho, Dong Seop Choi
    Journal of Diabetes Investigation.2015; 6(3): 317.     CrossRef
  • Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South Korea
    Jin-Hee Jung, Jung-Hwa Lee, Jin-Won Noh, Jeong-Eun Park, Hee-Sook Kim, Joo-Wha Yoo, Bok-Rye Song, Jeong-rim Lee, Myeong-Hee Hong, Hyang-Mi Jang, Young Na, Hyun-Joo Lee, Jeong-Mi Lee, Yang-Gyo Kang, Sun-Young Kim, Kang-Hee Sim
    Diabetes & Metabolism Journal.2015; 39(4): 307.     CrossRef
  • Kidney injury molecule-1 (Kim-1): an early biomarker for nephropathy in type II diabetic patients
    Nahla E. El-Ashmawy, Enas A. El-Zamarany, Naglaa F. Khedr, Abeer I. Abd El-Fattah, Shereen A. Eltoukhy
    International Journal of Diabetes in Developing Countries.2015; 35(S3): 431.     CrossRef
  • The Effect of the Experience of Diabetes Education on Knowledge, Self-Care Behavior and Glycosylated Hemoglobin in Type 2 Diabetic Patients
    Seung Hei Moon, Young Whee Lee, Ok-Kyung Ham, Soo-Hyun Kim
    The Journal of Korean Academic Society of Nursing Education.2014; 20(1): 81.     CrossRef
  • Clinical Characteristics of Diabetic Patients Transferred to Korean Referral Hospitals
    Min Young Oh, Sang Soo Kim, In Joo Kim, In Kyu Lee, Hong Sun Baek, Hyoung Woo Lee, Min Young Chung
    Diabetes & Metabolism Journal.2014; 38(5): 388.     CrossRef
  • Current Status of Prescription in Type 2 Diabetic Patients from General Hospitals in Busan
    Ji Hye Suk, Chang Won Lee, Sung Pyo Son, Min Cheol Kim, Jun Hyeob Ahn, Kwang Jae Lee, Ja Young Park, Sun Hye Shin, Min Jeong Kwon, Sang Soo Kim, Bo Hyun Kim, Soon Hee Lee, Jeong Hyun Park, In Joo Kim
    Diabetes & Metabolism Journal.2014; 38(3): 230.     CrossRef
  • The Influence of Admission Hypoglycemia on Clinical Outcomes in Acute Myocardial Infarction Patients with Diabetes Mellitus
    Eun Jung Kim, Myung Ho Jeong, In Seok Jeong, Sang Gi Oh, Sang Hyung Kim, Young keun Ahn, Ju Han Kim, Young Jo Kim, Shung Chull Chae, Taek Jong Hong, In Whan Seong, Jei Keon Chae, Chong Jin Kim, Myeong Chan Cho, Ki Bae Seung, Hyo Soo Kim
    Korean Journal of Medicine.2014; 87(5): 565.     CrossRef
  • Duration of diabetes and effectiveness of insulin in the management of insulin-naïve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry results
    Sang Soo Kim, In Joo Kim, Yong Ki Kim, Kun Ho Yoon, Ho Young Son, Sung Woo Park, Yeon Ah Sung, Hong Sun Baek, Kyoung Soo Ha
    Acta Diabetologica.2014; 51(4): 655.     CrossRef
  • Is the Indicator Magnifying Window for Insulin Pens Helpful for Elderly Diabetic Patients?
    Ju Hee Lee, Eun Shil Hong, Jung Hun Ohn, Young Min Cho
    Diabetes & Metabolism Journal.2013; 37(2): 149.     CrossRef
  • Prevalence of and Factors Associated with Albuminuria in the Korean Adult Population: The 2011 Korea National Health and Nutrition Examination Survey
    Jong Chul Won, Yun Jeong Lee, Jung Min Kim, Sang Youb Han, Jung Hyun Noh, Kyung Soo Ko, Byoung Doo Rhee, Dong-Jun Kim, Harald Mischak
    PLoS ONE.2013; 8(12): e83273.     CrossRef
  • The Epidemiology of Diabetic Nephropathy
    Jin Hwa Kim
    The Journal of Korean Diabetes.2013; 14(1): 11.     CrossRef
  • The Relationship between Neuropathic Pain and Glycemic Control, Self Management in Type II Diabetes Mellitus Patients
    Yeong-Mi Seo, Won-Hee Choi
    Journal of the Korea Academia-Industrial cooperation Society.2013; 14(4): 1774.     CrossRef
  • Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study
    Kee-Ho Song, Jung Min Kim, Jung-Hyun Noh, Yongsoo Park, Hyun-Shik Son, Kyong Wan Min, Kyung Soo Ko
    Diabetes & Metabolism Journal.2013; 37(2): 117.     CrossRef
  • Comorbidity Study on Type 2 Diabetes Mellitus Using Data Mining
    Hye Soon Kim, A Mi Shin, Mi Kyung Kim, Yoon Nyun Kim
    The Korean Journal of Internal Medicine.2012; 27(2): 197.     CrossRef
  • Low ankle-brachial index is an independent predictor of poor functional outcome in acute cerebral infarction
    Jinkwon Kim, Dong Hyun Lee, Myoung-Jin Cha, Tae-Jin Song, Ji Hye Park, Hye Sun Lee, Chung Mo Nam, Hyo Suk Nam, Young Dae Kim, Ji Hoe Heo
    Atherosclerosis.2012; 224(1): 113.     CrossRef
  • Glucose, Blood Pressure, and Lipid Control in Korean Adults with Diagnosed Diabetes
    Sun-Joo Boo
    Korean Journal of Adult Nursing.2012; 24(4): 406.     CrossRef
  • Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
    Seung-Hyun Ko, Bong-Yun Cha
    Diabetes & Metabolism Journal.2012; 36(1): 6.     CrossRef
  • The Association of Self-Reported Coronary Heart Disease with Diabetes Duration in Korea
    Hye Mi Kang, Yun Jeong Lee, Dong-Jun Kim
    Diabetes & Metabolism Journal.2012; 36(5): 350.     CrossRef
  • Response: The Prevalence of Peripheral Arterial Disease in Korean Patients with Type 2 Diabetes Mellitus Attending a University Hospital (Diabetes Metab J 2011;35:543-50)
    Ji Hee Yu, Ki-Up Lee
    Diabetes & Metabolism Journal.2012; 36(1): 77.     CrossRef
  • Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments
    H. K. Won, K. J. Kim, B.‐W. Lee, E. S. Kang, B. S. Cha, H. C. Lee
    Diabetic Medicine.2012; 29(1): 74.     CrossRef
  • Management of Blood Pressure in Patients with Type 2 Diabetes Mellitus: A Nationwide Survey in Korean
    Mi Hae Seo, Woo Je Lee, Cheol Young Park, Sung Rae Kim, Joong Yeol Park, Kun-Ho Yoon, Moon Kyu Lee, Sung Woo Park
    Diabetes & Metabolism Journal.2011; 35(4): 348.     CrossRef
  • Accuracy Evaluation of the Alternative Site Blood Glucose Test Using Error Grid
    Kyung-Soon Park, Eun-Jong Cha
    Journal of Biomedical Engineering Research.2011; 32(1): 25.     CrossRef
  • Glycated albumin is a useful glycation index for monitoring fluctuating and poorly controlled type 2 diabetic patients
    Eun Young Lee, Byung-Wan Lee, Daham Kim, Yong-ho Lee, Kwang Joon Kim, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Hyun Chul Lee
    Acta Diabetologica.2011; 48(2): 167.     CrossRef
  • Group Classification on Management Behavior of Diabetic Mellitus
    Sung-Hong Kang, Soon-Ho Choi
    Journal of the Korea Academia-Industrial cooperation Society.2011; 12(2): 765.     CrossRef
  • Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus
    Soon Ae Kim, Woo Ho Shim, Eun Hae Lee, Young Mi Lee, Sun Hee Beom, Eun Sook Kim, Jeong Seon Yoo, Ji Sun Nam, Min Ho Cho, Jong Suk Park, Chul Woo Ahn, Kyung Rae Kim
    Diabetes & Metabolism Journal.2011; 35(2): 159.     CrossRef
  • Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
    Jung Hee Kim, Dae Jung Kim, Hak Chul Jang, Sung Hee Choi
    Diabetes & Metabolism Journal.2011; 35(6): 571.     CrossRef
  • Increasing Trend in the Number of Severe Hypoglycemia Patients in Korea
    Jin Taek Kim, Tae Jung Oh, Ye An Lee, Jun Ho Bae, Hyo Jeong Kim, Hye Seung Jung, Young Min Cho, Kyong Soo Park, Soo Lim, Hak Chul Jang, Hong Kyu Lee
    Diabetes & Metabolism Journal.2011; 35(2): 166.     CrossRef
  • Prevalence and Associated Factors of Diabetic Retinopathy in Rural Korea: The Chungju Metabolic Disease Cohort Study
    Ji-Hyun Kim, Hyuk-Sang Kwon, Yong-Moon Park, Jin-Hee Lee, Man-Soo Kim, Kun-Ho Yoon, Won Chul Lee, Bong-Yun Cha, Ho-Young Son
    Journal of Korean Medical Science.2011; 26(8): 1068.     CrossRef
  • The Prevalence of Peripheral Arterial Disease in Korean Patients with Type 2 Diabetes Mellitus Attending a University Hospital
    Ji Hee Yu, Jenie Yoonoo Hwang, Mi-Seon Shin, Chang Hee Jung, Eun Hee Kim, Sang Ah Lee, Eun Hee Koh, Woo Je Lee, Min-Seon Kim, Joong-Yeol Park, Ki-Up Lee
    Diabetes & Metabolism Journal.2011; 35(5): 543.     CrossRef
  • Prevalence, Awareness, and Control of Hypertension among Diabetic Koreans
    Hyun Hee Chung, Kyu Chang Won
    Diabetes & Metabolism Journal.2011; 35(4): 337.     CrossRef
  • Factors Influencing Physical Activity Behavior among Iranian Women with Type 2 Diabetes Using the Extended Theory of Reasoned Action
    Alireza Didarloo, Davoud Shojaeizadeh, Hassan Eftekhar Ardebili, Shamsaddin Niknami, Ebrahim Hajizadeh, Mohammad Alizadeh
    Diabetes & Metabolism Journal.2011; 35(5): 513.     CrossRef
  • Factors that Affect Medication Adherence in Elderly Patients with Diabetes Mellitus
    Kyung-Ae Park, Jung-Guk Kim, Bo-Wan Kim, Sin Kam, Keon-Yeop Kim, Sung-Woo Ha, Sung-Taek Hyun
    Korean Diabetes Journal.2010; 34(1): 55.     CrossRef
  • The Effects of Tailored Diabetes Education on Blood Glucose Control and Self-Care
    Kyung Sun Hyun, Kwang Mi Kim, Sook Hee Jang
    Journal of Korean Academy of Nursing.2009; 39(5): 720.     CrossRef
  • Epidemiologic Characteristics of Diabetes Mellitus in Korea: Current Status of Diabetic Patients Using Korean Health Insurance Database
    Ie Byung Park, Sei Hyun Baik
    Korean Diabetes Journal.2009; 33(5): 357.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP